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Abstract 
We performed an innovative systematic meta-analysis of gene expression profiles of whole 
normal human brain and heart to provide a quantitative transcriptome reference map of it, i.e. a 
typical reference value of expression for all the known, mapped and uncharacterized (unmapped) 
transcripts. For this reason, we used the software named TRAM (Transcriptome Mapper), which 
is able to generate transcriptome maps based on gene expression data from multiple sources. We 
also analyzed differential gene expression by comparing brain with human foetal brain, with a 
pool of non-brain tissues and with the three brain sub-region: cerebellum, cerebral cortex and 
hippocampus, the main regions severely affected with cognitive impairment, as seen in the case 
of trisomy 21. Data were downloaded from microarray databases, processed and analyzed using 
TRAM software and validated in vitro by assaying gene expression through several magnitude 
orders by "Real Time" reverse transcription polymerase chain reaction (RT-PCR). The excellent 
agreement between in silico and experimental data suggested that our transcriptome maps may 
be a useful quantitative reference benchmark for gene expression studies related to the human 
brain and heart. 
 We also generated an integrated quantitative transcriptome map by systematic meta-analysis 
from all available gene expression profile datasets related to AMKL in paediatric age. The 
incidence of Acute Megakaryoblastic Leukemia (AMKL) is 500-fold higher in children with 
Down Syndrome (DS) compared with non-DS children. We present an integrated original model 
of the DS AMLK transcriptome, providing the identification of genes relevant for its 
pathophysiology which can potentially be new clinical markers. 
 Finally, computational and molecular analysis of a highly restricted region of chromosome 
21, which represents a strong candidate for typical DS features and is considered as intergenic, 
was performed. Northern Blot analysis and computational biology results show that HR-DSCR 
contain active loci bidirectionally transcribed. 
 
Key words: Human Brain; Human Heart; Gene Expression Profile; Integrated Transcriptome 
Reference Map; Meta-analysis; Human chromosome 21;  Down Syndrome (Trisomy 21); Acute 
Megakaryoblastic Leukemia (AMKL); Down syndrome critical region (DSCR); Intellectual 
disability. 
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Introduction 
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1.1 Down syndrome 
 
 Down Syndrome (DS) is the most frequent human chromosomal disorder, with a frequency 
of 1 in ~400 conceptions and 1 in ~700 births (Morris et al., 1999; Parker et al., 2010). Main 
symptoms include intellectual disability (ID), cardiovascular defects and craniofacial 
dysmorphisms (Gardiner, 2010). More in detail, these symptoms may be observed: distinct facial 
and physical features among which are almond shaped eyes (due to epicanthal folds), a small, 
somewhat flat nose, a small mouth with a protruding tongue, a single crease across the palms, 
inturned fifth finger of their hands, a larger than normal space between the first and second toes; 
language production deficiency; cognitive impairment, which is present to some degree of 
severity in all affected individuals and which involves symbolic thought, whereas affectivity and 
social skills are conserved; cardiac defects in about 40% of cases; Hirschprung's disease; 
hypotonia; visual and hearing impairments; increased risk of leukemia, in particular 
megakaryoblastic; immune disorders, including increased susceptibility to infections and to 
autoimmune pathologies such as alopecia and celiac disease (CD); endocrine disorders, 
including hypothyroidism; and early-onset cognitive decline with neuropathological alterations 
similar to those observed in the brains of patients with Alzheimer’s disease (AD) (Epstein, 1989; 
Roizen and Patterson, 2003; Mégarbané et al., 2009; Gardiner, 2010; Letourneau and 
Antonarakis, 2012; Hickey et al., 2012).  
 In 1959, the young French doctor Jérôme Lejeune (1926-1994) published, together with 
Marthe Gautier and Raymond Turpin, the finding of an additional chromosome 21 in nine 
children with DS (Lejeune et al., 1959). This condition has been called trisomy 21, a genetic 
mutation leading to the presence of three copies of human chromosome 21 (Hsa21), instead of 
the normal two, in the cells of the affected individuals. This discovery is commonly recognized 
as a milestone in the history of genetics (National Human Genome Research Institute 2013), 
because it introduced the notion that a given clinical symptom may be connected to a specific 
alteration of the human genetic material for the first time, giving origin to the field of medical 
genetics. The DS phenotype is expected to be associated with an altered expression of the genes 
located on Hsa21 (Sinet et al., 1975; Gardiner and Costa, 2006; Roper and Reeves, 2006; 
Pritchard et al., 2008; Korenberg, 2009; Patterson, 2009). Although DS was the first genetic 
alteration to have been described in humans and the most frequent form of ID caused by a 
microscopically demonstrable chromosomal aberration, its molecular pathogenesis is still 
unknown. 
 There has been much debate about the existence of selected, critical regions or genes on 
Hsa21 as the main one responsible for ID or for the other symptoms (Rahmani et al., 1990; 
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Korenberg et al., 1990; Delabar et al., 1993). Since the first reports in the '70's (e.g. Raoul et al., 
1976 from the group of Lejeune), descriptions of partial (segmental) trisomies have accumulated, 
although at slow pace. Two landmark studies in 2009, each analyzing about 30 cases of these 
conditions, have concluded that it is not likely that there is a single region candidate for DS 
phenotype (Down Syndrome Candidate/Critical Region, DSCR) on Hsa21 (Lyle et al., 2009; 
Korbel et al., 2009). However, it remains to be explained how such a homogeneous phenotype, 
though with its natural individual variability, may be generated by completely different portions 
of the same chromosome when involvement of a single different gene is usually associated with 
completely different phenotypes of monofactorial origin. We believe that this is still a 
fundamental line of research. In fact, even if it would not be possible to affirm with certainty that 
a gene, if present in an extra copy, is more responsible than the other for a symptom, it can 
always be excluded that a gene not present in three copies in at least one subject with a typical 
DS phenotype is critical for ID, the nearly universal symptom in DS. On the other hand, subjects 
with nearly absent ID and partial trisomy 21 might offer complementary clues to critical regions. 
It is important to critically evaluate all described cases and to continue searching for partial 
trisomy proposing molecular cytogenetics (CGH-Array) investigations (Melis et al., 2011) in 
particular in cases with a discordant genotype-phenotype relationship.  
 
1.2 Gene expression profiling 
 
Firm conclusions about the role of a DNA element based on its chromosomal localization 
can be derived only if the annotated physical map of the chromosome is actually complete and 
accurate as much as possible. Gene expression analysis performed by TRAM software (Lenzi et 
al., 2011) shows that there are hundreds of uncharacterized transcripts on Hsa21 (preliminary 
data). Although continuing the patient reconstruction of each single locus structure, expression 
and function appears to have fallen out of research trends in the last 10 years, without a really 
complete list of Hsa21 elements we could miss the identification of a critical component on an 
interesting Hsa21 region because it is not highlighted on the map (e.g., ENCODE Project 
Consortium et al., 2012). As it was shown by identifying a large novel gene extending for more 
than 100,000 bp on Hsa21, encoding a protein (CYYR1) conserved in vertebrates (Vitale et al., 
2002; Vitale et al., 2007) and having gone unrecognized in the putatively complete gene 
catalogue published with the report of the whole Hsa21 sequence (Hattori et al., 2000), due to 
plasticity of gene expression the "manual" characterization of individual genomic regions is an 
ever-going process that should deserve active attention even in the post-genomic era. 
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The most complex organ for gene expression profile investigation is the brain (Oldham et 
al., 2008). The brain is the main organ of the Central Nervous System (CNS). It is an immensely 
complex organ composed of billions of precisely interconnected neurons which together allow it 
to carry out sensory, motor and cognitive functions. Impaired development of cognitive 
functions is the cause of intellectual disability (ID). The causes of ID may be genetic or non-
genetic: they are of genetic origin if they are due to abnormalities in a single gene or to structural 
or numerical abnormalities of chromosomes. Trisomy 21 (Down syndrome) is the best known 
genetic cause of ID (Mégarbané et al., 2013). Homo sapiens is the mammal with the highest 
number of genes expressed in the brain (Lockhart and Barlow, 2001; Enard et al., 2002). 
Numerous studies show that children with DS exhibit cerebral developmental delay beginning in 
the first year of life, including reductions in dendritic ramification, synaptogenesis and neuronal 
cell numbers. Specific reductions in the number of principle neurons affect the hippocampus, in 
particular, the pyramidal cells of the Ammon's horn 1 and 3 sub-regions (CA1 and CA3) (Haydar 
and Reeves, 2012). The majority of studies have shown that these hippocampal abnormalities 
affect the long-term storage of explicit memories in DS patients, causing syndrome specific 
symptoms which are more severe in individuals with DS than with other mental retardation 
conditions (Carlesimo et al., 1997; Dierssen et al., 2009). 
The altered gene dosage in trisomy 21 also increases the susceptibility to congenital heart 
defects in DS individuals (Ramachandran et al., 2015). Several hereditary cardiovascular 
malformations syndromes are caused by gene products implied in the disease processes and in 
the pathways regulating cardiac development (Vaughan and Basson, 2000). Common 
cardiovascular malformations are, for example, atrial (ASDs) and ventricular septal defects. 
Atrioventricular septal defects (AVSDs) are uncommon cardiovascular malformations in the 
general population (Hartman et al., 2011) but they are a common type of congenital heart defect 
in Down syndrome individuals. Much progress has been made about the cardiovascular 
malformation repair since the first successful classification of the atrioventricular canal and the 
surgical procedure developed by Rastelli and coll. (Rastelli et al., 1966; Rastelli et al., 1968). 
 Transcriptome studies are used to understand physiologic mechanisms and pathways or 
genes involved in many biologic processes (Caracausi et al., 2014). Alteration of the gene 
expression level could help to identify alterations in cell function. Transcriptome is a promising 
approach for diagnostic evaluation in routine clinical practice and could be useful to predict 
disease development and progression.    
RNA microarrays and RNA sequencing (RNA-Seq) are considered the two main kinds of 
high-throughput technologies employed to assess gene expression studies (Costa and Franco, 
2015). Recently, several aspects of data obtained from microarrays and RNA-seq have been 
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compared in a number of published studies (reviewed by Wang et al., 2014). RNA-seq was 
found to be superior to microarray due to a higher sensitivity in detecting low abundance 
transcripts (Wang et al., 2014; Zhao et al., 2014) as well as to a broader dynamic range (Zhao et 
al., 2014), and it also allows avoidance of cross-hybridization (Zhao et al., 2014) and detection 
of new transcripts (Guo et al., 2013). Despite the benefits of RNA-Seq, microarrays remain an 
accurate tool for measuring the levels of gene expression (Malone and Oliver, 2011), and gene 
expression-based predictive models generated from RNA-seq and microarray data were found to 
be similar (Wang et al., 2014). Overall, in large comparative studies, these two methods have 
produced comparable results in terms of gene expression profiling (Guo et al., 2013; Zhao et al., 
2014). Microarrays still appear to be the most common choice of researchers when conducting 
transcriptional profiling experiments. This is probably because: RNA-Seq sequencing 
technology is new to most researchers, it is still more expensive than microarray, and data 
storage and analysis are more complex (Zhao et al., 2014).  
The huge amount of transcriptomic studies performed with microarray technology, stored 
in publicly available databases, still provide excellent data mining resources for researchers (Guo 
et al., 2013). There have been several microarray experiments performed on the whole human 
brain and its sub-regions, and on the whole human heart, to analyze the gene expression profile 
of the whole organs, to compare gene expression patterns between different brain sub-regions 
(Khaitovich et al., 2004; Roth et al., 2006) and to compare pathophysiological states (Iwamoto et 
al., 2004; Hodges et al., 2006). 
Our goal in this study was to perform a systematic meta-analysis of the gene expression 
profile of the whole normal human brain and of its sub-region, and of the whole normal human 
heart in order to provide a quantitative transcriptome reference map of them, i.e. a reference 
typical value of expression for each of the known, mapped and uncharacterized (unmapped) 
transcripts assayed by any of the experimental platforms used to this regard. This task implied 
the possibility of performing cross-platform, inter-array and intra-array data normalization in 
order to incorporate any publicly available dataset in the calculation. To this aim, we used the 
software named TRAM (Transcriptome Mapper), which is able to generate transcriptome maps 
of this type from any source listing gene expression values for a given gene set, e.g. expression 
microarray (Lenzi et al., 2011). In addition to providing reference gene expression values (in the 
form of percentages of the mean value), allowing quantitative comparisons among the 
expression of all investigated genes, it maps gene expression along the chromosome's physical 
map, thus also allowing discovery of regional over- or under-expression within a biological 
condition or while comparing two different biological conditions.  
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 The European Bioinformatics Institute (EBI) and National Center for Biotechnology 
Information (NCBI) provide Array Express (Brooksbank et al., 2014) and GEO (Gene 
Expression Omnibus) (Barrett and Edgar, 2006) databases respectively, which are repositories of 
high throughput sequencing studies and hybridization array data that can be searched for and 
downloaded.  
 The use of whole (in toto) brain is justified by its recognition as a specific organ performing 
superior cognitive functions, and a wealth of gene expression data has been produced from 
whole brain RNA by different methods (among many others, for example: Northern Blot 
analysis, expressed sequence tag (EST) libraries, polymerase chain reaction (PCR) assays and 
microarray experiments). Due to the very recent demonstration of differences in adult brain 
regional gene expression according to sex (Trabzuni et al., 2013), we extended our analysis of 
the whole brain to the comparison of male- vs. female-derived samples.  
 In addition, we extended our analysis to a comparison with human foetal brain gene 
expression, with a pool of human tissues and to three normal human brain regions: cerebellum, 
cerebral cortex and hippocampus: three of the main brain regions severely affected when 
cognitive impairment occurs (Kesslak et al., 1994; Nadel, 2003; Pennington et al., 2003), as 
happens in the case of trisomy 21 (Haydar and Reeves, 2012).  
 This also yielded biological insights about those genes which have an intrinsic over/under-
expression in the brain or brain subregions, thereby offering a basis for the regional 
(chromosomal) analysis of gene expression. This could be useful for the study of chromosomal 
alterations associated to cognitive impairment, such as trisomy 21, the most common genetic 
cause of ID. 
To date, human studies of gene expression profile in cardiac muscle are limited. Those 
available are often not comparable, not comprehensive or not related to the position of each gene 
on the genome map. The whole heart transcriptome map could be used to infer a very high rate 
of information about the healthy cardiac muscle, and could be used to analyse the differential 
transcription profile respect to a different biological condition, as for example the diseased 
myocardium. 
Finally, data obtained by our meta-analysis were validated by assaying gene expression 
through several magnitude orders by "Real Time" reverse transcription polymerase chain 
reaction (RT-PCR). We found an excellent agreement between in silico and experimental data, 
thus suggesting that our transcriptome maps may be a useful tools as a quantitative references for 
gene expression studies related to these human tissues. 
Basic research on DS is now rapidly accelerating, and there is the possibility that the 
results will be beneficial for individuals with DS (Antonarakis and Epstein, 2006). Several 
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studies have shown that individuals with DS have a specific cancer risk pattern, or tumor profile: 
their risk of developing leukemia and testicular cancer is much higher than age-matched 
controls, while women with DS almost never develop breast cancers (Hasle et al., 2000; Patja et 
al., 2006). In particular, children with DS show an increased prevalence of acute leukemia, both 
lymphoid (ALL) and myeloid (AML), with relative risk ranging from 10 to 20 times higher than 
the normal population (Hitzler and Zipursky, 2005; Massey, 2005). In nearly half of the cases, 
these childhood leukemias are classified as megakaryoblastic leukemia (AMKL), a relatively 
rare subtype of AML also known as AML M7, according to French–American–British (FAB) 
classification, whose incidence increases by 500-fold in children with DS by the age of 4 years 
as compared to the chromosomally normal population (reviewed in (Khan et al., 2011). This 
observation strongly suggests that trisomy 21 directly contributes to the neoplastic 
transformation of hematopoietic cells, in particular in the megakaryocyte lineage cells. 
Interestingly, acute leukemia cells harboring megakaryocyte markers and presenting in subjects 
without DS may show trisomy 21 (Paolini et al., 2003). We also described a cell line derived 
from blast cells of a patient with type M2 AML wich has trisomy 21 and megakaryocyte features 
(Bonsi et al., 1997). More recently, mutations of the gene encoding for the transcription factor 
GATA1 have been shown to cooperate with trisomy 21 in initiating megakaryoblastic 
proliferation in nearly all DS AMKL cases while they are absent in non-DS AMKL (Wechsler et 
al., 2002; Khan et al., 2011). GATA1 mutations in DS cells give rise to a short, truncated form of 
GATA1 (GATA1s) transcription factor that, in this form, is not able to establish normal 
interactions with other gene regulators (Klusmann et al., 2010a).  
 Transient myeloproliferative disorder (TMD) is a clonal pre-leukemia condition, occurring 
in 10% of children with DS during the neonatal period, presenting at a median age of 3-7 days 
with accumulation of immature megakaryoblasts (Khan et al., 2011). TMD cases usually resolve 
spontaneosuly, but DS AMKL may develop within 1-4 years in 20-30% of these children. 
AMKL may develop in non-DS children, usually at an higher age in comparison to DS subjects 
(median 8 vs. 1.8 years, respectively) and in absence of a trisomy 21 background. Cytogenetic 
abormalities described in non-DS AMKL cells include trisomy 8 and 1 and monosomy 7 (Khan 
et al., 2011). 
 An open issue is the relevance of trisomy 21 as a specific background for the higher 
incidence of AMKL in DS. A few previous studies have used gene expression profiling by 
microarray analysis in order to identify specific transcriptome alterations in DS and/or non-DS 
AMKL, as well as in TMD (Klusmann et al., 2010a; Klusmann et al., 2010b; Yagi et al., 2003; 
Lightfoot et al., 2004; McElwaine et al., 2004; Bourquin et al., 2006; Ge et al., 2006; Radtke et 
al., 2009). Due to the rarity of AMKL, these works often analyze a small number of cases, using 
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a variety of experimental platforms. Results were consequently affected by a small grade of 
comparability.  
One of the first goals of this work was to perform a systematic meta-analysis using any 
available gene expression profile dataset related to AMKL in pediatric age in order to produce a 
differential transcriptome map between DS and non-DS related AMKL. For the generation and 
the analysis of quantitative transcriptome maps we used TRAM (Transcriptome Mapper) (Lenzi 
et al., 2011). The comparison of 43 DS-AMKL samples with 45 non-DS AMKL samples 
represents the largest study on the subject, highlighting the relevance of trisomy 21 in the 
development of AMKL in comparison with AMKL originating from non-trisomic cells. Results 
show significant over- or under-expression of distinct chromosomal segments and of single key 
genes in the whole genome, as well as on chr21, adding new knowledge compared with that 
produced by the single works from which the data were originally obtained. In addition, each 
considered type of leukemia was compared with the expression profile of TMD cells and normal 
human megakaryoblast/megakaryocyte cells (MK), allowing the building of a model for the 
disorder in differentiation process that lead to DS and non-DS AMKL. Comparisons with cord 
blood-derived MK cells (CB MK) have also been performed, due to the fact that leukemias in 
infants or young children originate from fetal hematopoietic cells (Klusmann et al., 2010a; 
Klusmann et al., 2010b; Chou et al., 2008; Tunstall-Pedoe et al., 2008) and the progenitor cells 
(fetal/neonatal MKP) are present in the cord blood (CB) (Olson et al., 1992; Liu and Sola-
Visner, 2011). For each cell type investigated, reference expression data for about 17,000-26,000 
mapped sequences have been generated and validated through a sample comparison with known 
data. The biological and clinical significance of these data is discussed. 
 
1.3 HR-DSCR on human chromosome 21 and gene hunting 
 
 A "Down Syndrome critical region" (DSCR) sufficient to induce the most constant 
phenotypes of Down syndrome (DS) had been identified by studying partial (segmental) trisomy 
21 (PT21) as an interval of 0.6-8.3 Mb within human chromosome 21 (Hsa21), although its 
existence was later questioned. In the work of Pelleri and coll. (2016) an innovative, systematic 
reanalysis of all described PT21 cases (from 1973 to 2015) was performed. In particular, an 
integrated, comparative map from 126 cases with or without DS fulfilling stringent cytogenetic 
and clinical criteria was built (Pelleri et al., 2016). The map allowed us to define or exclude fine 
Hsa21 sequence intervals as candidates for DS, also integrating duplication copy number 
variants (CNVs) data. A highly restricted DSCR (HR-DSCR) of only 34 kb (kilobase) on distal 
21q22.13 has been identified as the minimal region whose duplication is shared by all DS 
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subjects and is absent in all non-DS subjects. Also being spared by any duplication CNV in 
healthy subjects, HR-DSCR represents a strong candidate for the typical DS features, the 
intellectual disability and some facial phenotypes. HR-DSCR contains no known gene and has 
homology only to the chimpanzee genome. Searching for HR-DSCR functional loci should 
become a priority for understanding the fundamental genotype-phenotype relationships in DS. 
We performed a systematic analysis of computational and molecular biology on HR-
DSCR, a region known as an intergenic region, but suspected by the study of partial trisomy 21 
as a potential host of active loci involved in critical functions for the manifestation of the 
intellectual disabilities in DS. This analysis was performed to test the hypothesis that it is not an 
intergenic region, but rather expressing transcripts not yet identified. For this reason, we applied 
systematically advanced tools of gene identification by computational biology (Blastn, 
BLASTX, FGENESH, miRBase), verifying, through different methods of molecular biology, the 
validity of the predictions in vitro using human tissues (Northern Blot, polymerase chain reaction 
(PCR), sequencing automatic). The results show that the systematic analysis of the region leads 
to the classification of a critical region of human chromosome 21 as a new active locus 
transcribed in both directions. This locus is formally identified and an initial characterization of 
its structure and expression is also presented.  
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 The research project has the objective to study and analyse the human chromosome 21 genes 
to understand the molecular mechanism of DS and to find therapeutic approaches for the cure of 
the syndrome. The cause of the syndrome is a genetic mutation that results in the presence of 
chromosome 21 in 3 copies in the cells of the affected individuals. The typical symptoms and 
signs are attributed to altered expression of genes located on chromosome 21 and include a 
"facies" feature; intellectual disabilities; heart defects; muscle hypotonia; increased risk of 
leukemia, in particular megakaryoblastic; and early biological aging in some cases similar to that 
of Alzheimer's disease. The molecular mechanisms of the syndrome are still unknown and it 
is difficult to identify specific chromosome 21 genes responsible for different symptoms. 
 Full identification and characterization of these genes is not yet complete; currently about 
420 genes and gene models on the long arm of chromosome 21, and 4 on the short arm of 
chromosome 21 are described, but there is information  available for only 145 of them 
(Patterson, 2009). Basic research on trisomy 21 could propose possible therapeutic approaches 
for DS (Antonarakis and Epstein, 2009). 
 The research conducted during the doctoral period enabled us to create and analyze tissue 
specific gene activity maps of normal human tissues primarily involved in DS and to make 
comparisons of gene expression between normal and trisomic cells. In particular, we have 
created transcriptome maps of the whole normal human brain and of three brain sub-regions 
(cerebellum, cerebral cortex and hippocampus), of the whole heart, and of blood cells, searching 
for all data available in the literature and in the databases of gene expression profiles performed 
on microarray platforms and integrating these data using the TRAM software (mapper 
transcriptome) (Lenzi et al., 2011). We focused on these organs and tissues because 100% of 
individuals with DS have intellectual disabilities, and the cerebellum, cerebral cortex and 
hippocampus are the three sub-regions severely affected when ID occurs, 30-40% of DS 
individuals suffer from congenital heart defects, and furthermore because the risk to have acute 
megakaryoblastic leukemia (AMKL) is 500-fold higher in DS compared with non-DS children. 
 These maps provide a  typical reference value of expression for each of the known, mapped 
and uncharacterized loci of the whole human tissues and organs cited above. These global 
portraits of gene expression could be used to test hypotheses about localized gene expression 
levels of human transcripts and could also contribute to a better understanding on a regional 
(chromosomal) basis of the chr21 genes expression. The comparison between normal and 
trisomy 21 cells was done for the blood cells in particular between AMKL and MK 
(megakaryocytes) in conditions and not of trisomy 21 in order to identify new molecular markers 
for the progression to AMKL in DS. These analyses allowed us to confirm that chr21 genes have 
an average of expression higher than the genes of other chromosomes both in DS and non-DS 
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AMKL cells, and to identify possible markers of progression from normal MK cells to neoplastic 
cells. 
 Another objective was to perform computational and molecular biology analysis of a highly 
restricted region of chr21, critical for DS (HR-DSCR) located within the larger critical region for 
DS (DSCR) (unpublished preliminary data). This region has been identified by a systematic 
study of 127 cases of partial trisomy 21, in which different segments of chromosome 21 
associated or not to the cardinal signs of the syndrome are present in three copies. This region of 
only 34 kb on distal 21q22.13 is the minimal region whose duplication is shared by all DS 
subjects and is absent in all non-DS subjects.  
 To date the HR-DSCR was defined as an intergenic region, but it represents a strong 
candidate for the typical DS features, the intellectual disability and some facial phenotypes. The 
analysis was performed to demonstrate that it potentially hosts active loci involved in critical 
functions which causes DS symptoms. Searching for HR-DSCR functional loci should become a 
priority for understanding the fundamental genotype-phenotype relationships in DS. 
 
 All these goals converge to elaborate on theories of the functioning of chromosome 21, to 
build an overall pathogenetic model for the symptoms of trisomy 21 and to identify new 
therapeutic approaches. 
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Chapter 3 
 
Materials and Methods 
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3.1 Systematic meta-analysis of gene expression profiles of normal human tissues  
 
3.1.1 Gene expression database search 
 
  In order to retrieve datasets derived from whole normal adult human brain, foetal brain, 
cerebellum, cerebral cortex, hippocampus and whole normal adult heart, we made a systematic 
search in gene expression data repositories for any single sample available listing gene 
expression values for these tissues. Gene Expression Omnibus (GEO) functional genomics 
repository was searched for: "Homo sapiens [ORGANISM] AND brain" (or "cerebellum", or 
"cortex", or "hippocampus", or "heart"). ArrayExpress database of functional genomics 
experiments was searched at http://www.ebi.ac.uk/arrayexpress/ for the terms "brain" (or 
"cerebellum", or "cortex", or "hippocampus", or "heart"), choosing "Homo sapiens" as organism. 
This strategy was used to ensure high sensitivity in the search. Search results were then filtered 
using inclusion and exclusion criteria as explained below in the Dataset selection section.  
 In addition, the term "Tissue" was used to retrieve datasets derived from collection of 
different human tissues analyzed in the same databases (in GEO: "Homo sapiens [ORGANISM] 
AND tissue*[TI] OR organ*[TI]"; in ArrayExpress: "Tissue", choosing "Homo sapiens" as 
organism). This led to generate a pool of samples including all the main human organs and 
tissues to generate a comparison set to highlight brain-specific or heart-specific differential gene 
expression compared to all the other anatomical human structures.  
 The searches were made up to May 2013.  
 
3.1.2 Gene expression dataset selection 
 
 The inclusion criteria of datasets in the analysis were: experiments carried out on the whole 
organ or tissue; normal phenotype of individuals; adult or foetal (for the foetal brain 
transcriptome map only) age of the subject from whom the sample was obtained; availability of 
the raw or pre-processed data.  
 Exclusion criteria were: exon arrays (hampering data elaboration by TRAM due to an 
exceedingly high number of data rows) or platforms using probes split into several distinct arrays 
for each sample (hampering intra-sample normalization); lack of identifiers corresponding to 
those found in the GEO Sample records (GSM) or Array Express sample records; platforms 
assaying an atypical number of genes (i.e. <5.000 or >60.000); data derived from cell lines, 
pathological or treated tissue, children or foetal (except in foetal brain transcriptome map) 
tissues. 
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 In order to obtain a quantitative transcriptome map, values from each dataset were linearized 
when provided as logarithms. In some cases we used raw files (e.g. File CEL) to be converted 
into pre-processed data, using the software "Alt Analyze" (Emig et al., 2010). 
 
3.1.3 TRAM (Transcriptome Mapper) analysis 
 
 TRAM (Transcriptome Mapper) software (Lenzi et al., 2011) allows the import of gene 
expression data recorded in the NCBI GEO (Gene Expression Omnibus) and EBI Array Express 
databases in tab-delimited text format. It also allows the integration of all data by decoding probe 
set identifiers to gene symbols via UniGene data parsing (Lenzi et al., 2006), normalizing data 
from multiple platforms using intra-sample and inter-sample normalization (scaled quantile 
normalization) (Piovesan et al., 2013), creating graphical representation of gene expression 
profile through two ways, "Map" and "Cluster" mode, and determining the statistical 
significance of results.  
 We created a directory (folder) for each tissue, containing all the sample datasets related to 
the same source and selected for the study. To compare brain samples with a pool of human 
tissues (without brain samples) we collected the first in a folder named Pool 'A' and the second in 
a folder named Pool 'B' (Table 1); to compare foetal brain with adult total brain we collected the 
first in a folder named Pool 'C (Table 1)'; to compare the brain regions with total brain we 
collected the samples from cerebellum in a folder named Pool 'D', the samples from cerebral 
cortex in a folder named Pool 'E', the samples from hippocampus in a folder named Pool 'F' 
(Table 1). In addition, we also provided two datasets deriving from the adul brain samples for 
which the sex of the sample donor was available: male brain (Pool 'A.1') and female brain (Pool 
'A.2') (Table 1). We performed the same thing for the hippocampus, providing two datasets 
deriving from the hippocampus samples for which the sex of the sample donor was available: 
male hippocampus (Pool 'F.1') and female hippocampus (Pool 'F.2') (Table 1). We did not 
consider samples deriving from male/female mix of tissue. To compare whole heart samples 
with a pool of non-cardiac tissues, we collected the first in a folder named Pool 'G' and the 
second in a folder named Pool 'H' (Table 1).  
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Pool Sample type Sample number TRAM mapped loci 
Pool 'A' Whole adult brain n=60 39,250 
Pool 'A.1' Male adult brain n=13 27,437 
Pool 'A.2' Female adult brain n=5 27,954 
Pool 'B' Pool of non-brain tissue n=622 34,985 
Pool 'C' Foetal brain n=35 38,482 
Pool 'D' Cerebellum n=140 38,163 
Pool 'E' Cerebral cortex n=18 27,504 
Pool 'F' Hippocampus n=41 30,739 
Pool 'F.1' Male hippocampus n=15 26,045 
Pool 'F.2' Female hippocampus n=14 26,045 
Pool 'G' Whole heart n=32 43,360 
Pool 'H' Pool of non-cardiac tissue n=629 35,000 
 
Table 1. Sample pools selected for the meta-analysis of gene expression profiles in adult brain (pool 'A'), male adult 
brain (pool 'A.1'), female adult brain (pool 'A.2'), pool of non-brain tissues (pool 'B'), foetal brain (pool 'C'), 
cerebellum (pool 'D'), cerebral cortex (pool 'E'), hippocampus (pool 'F'), male hippocampus (pool 'F.1'), female 
hippocampus (pool 'F.2'), whole hart (pool 'G'), pool of non-cardiac tissue (pool 'H').  
 
 
The comparisons allowed the analysis of differential transcriptome maps, using the ratio 
of the mean expression values for each locus, in addition to the maps related to each single type 
of sample.  
 We ran the whole set of analyses permitted by TRAM (in both "Map" and "Cluster" mode, 
although we focused on the "Map" mode) using default parameters as described (Lenzi et al., 
2011). We used an updated version of TRAM including enhanced resolution of gene identifiers 
and updated UniGene and Entrez Gene databases (TRAM 1.1, June 2013), in comparison with 
the original 2011 version (Lenzi et al., 2011). TRAM is freely available at 
http://apollo11.isto.unibo.it/software. Briefly, gene expression values were assigned to individual 
loci via UniGene, intra-sample normalized as percentage of the mean value and inter-sample 
normalized by scaled quantile. The value for each locus, in each biological condition, is the 
mean value of all available values for that locus. The whole genome gene expression median 
value was used in order to determine percentiles of expression for each gene. Although TRAM is 
a map-centred transcriptome analysis tool it can also summarize and allow the analysis of gene 
expression data of unmapped genes, exploiting its capability of parsing and normalization in 
order to highlight differential expression of single genes between two biological conditions even 
in the absence of data about genomic location of the gene (Lenzi et al., 2011). 
 Using the "Map" mode graphical representation we searched for over/under-expressed 
genome segments, which have a window size of 500,000 bp and a shift of 250,000 bp. The 
expression value for each genomic segment is the mean of the expression values of the loci 
included in that segment. A segment is defined over/under-expressed if it has an expression 
value which is significantly different between two conditions analyzed, and contains at least 3 
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individually over/under-expressed genes, e.g. genes which have expression values within the 
highest and the lowest 2.5th percentile. Significance of the over/under-expression for single 
genes was determined by running TRAM in "Map" mode with a segment window of 12,500 bp. 
This window size corresponds to about a fifth of the mean length of a gene, so the significant 
over/under-expression of a segment almost always corresponds with that of a gene. When the 
segment window contains more than one gene, the significance is maintained if the expression 
value of the over/under-expressed gene prevails over the others. 
 For the creation of the maps, TRAM software does not consider probes where the 
expression values is not available, assuming that an expression level has not been measured. 
Furthermore, it gives 95% of the minimum positive value present in a sample to those expression 
values equal to or lower than "0", in order to obtain meaningful numbers when we need to obtain 
a ratio between values in pool 'A' and pool 'B'. Assuming that in these cases an expression level 
is too low to be detected under the experimental conditions used, this transformation is useful to 
highlight differential gene expression. 
 
3.1.4 Housekeeping gene search 
 
 We determined the predicted genes that behave like housekeeping genes, in that they are 
mainly involved in fundamental cellular function and are universally and constantly expressed in 
all tissues (Butte et al., 2001; Tu et al., 2006). A search of housekeeping genes in the 
transcriptome maps was performed using the following parameters in combination: expression 
value >100, in order to select genes expressed above the mean value and so at an appreciable 
level; data points number ≥ of half the number of samples of the map, in order to select 
commonly expressed genes; SD, expressed as a percentage of the mean value, ≤30 or ≤40, in 
order to identify genes with a low expression variation among different samples. We searched 
for SD ≤30 to identify the first gene with the lowest SD, instead SD ≤40 to identify multiple 
genes which behave like housekeeping genes.  
 
3.1.5  Gene expression level in the heart and association to cardiac phenotypes 
 
 The availability of a measured ratio of the expression level of a gene in the heart vs. non-
cardiac tissues provided means to formally test the hypothesis that the mutation in a gene with a 
typical high expression level in the heart in comparison with non-cardiac tissues will result in a 
pathologic heart-related phenotype. For this reason, we chose the set of potassium channel 
encoding genes, due to their relevance for normal heart functioning. For each gene named by a 
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KCN root, the certain or suspected association to a cardiac phenotype was recorded by manual 
searching of the OMIM database (Amberger et al., 2015). The significance of the association of 
a differential expression in the heart in comparison to non-cardiac tissues to the description or 
not of a cardiac phenotype when each gene is mutated was tested by Fisher exact test. 
 
3.1.6 Gene selection for map validation 
 
 In order to obtain a sample experimental confirmation of the meta-analysis derived maps, 
for each tissue we selected a group of genes with these features: range of expression values 
covering the whole range of the expression magnitude order as calculated by TRAM; regular 
spacing of the expected expression values, i.e. each gene is expected to have a fold increase 
detectable through "Real Time" RT-PCR (at least 1 PCR cycle) in comparison with the 
subsequent gene with a lower expression in the group; the gene is known and characterized; 
when possible, the chosen gene is known to have a specific function in each tissue.  
 
3.1.7  RT-PCR (Reverse transcriptase - polymerase chain reaction) 
 
 cDNA (complementary DNA) templates were obtained from reverse transcription of 
commercial human brain total RNA, human cerebellum total RNA, human cortex total RNA, 
human hippocampus total RNA and human heart total RNA (Clontech, Mountain View, CA). 
They were derived from the normal whole brain of an 18 year old Caucasian male, normal 
cerebellum pooled from 10 male/female Caucasians, age 22-68 years, normal cerebral cortex 
pooled from 5 male Asians, age 20-44 years, normal hippocampus of a 27 years old Asian male, 
normal whole heart pooled from 3 male Caucasians, aged between 30 and 39 years. 
 Reverse transcription conditions used were: 4 µg of total RNA (1 µg/µL), SuperScriptIII 
First-strand Synthesis Supermix (Invitrogen by Life Technologies, Grand Island, NY, USA) 
containing RT enzyme mix (includes SuperScript III RT 200 U/µL) 8 µL and RT reaction mix 
(includes oligo dT-20 2.5 µM, random hexamers 2.5 ng/µL, MgCl2 10 mM and dNTPs 10 mM) 
40 µL. The RT-PCR reaction was performed in a final volume of 80 µL to have the same 
template for all the subsequent reactions. 
 The reaction consisted of three steps: an incubation of 10 min at 25°C, followed by an 
incubation at 50°C for 30 min and a final step of 5 min at 85°C. E.coli RNase H 4 µL (8 U) was 
then added to the reaction for 20 min at 37°C. 
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3.1.8 Primer design 
 
 Primers pairs were designed with "Amplify 3" software (Engels 1993) following standard 
criteria (Sharrocks, 1994). They are designed to specifically recognise expressed sequences 
(each primer being designed on a different exon) and to bind to regions common to all isoforms 
of the same gene because microarray probe sequences complement the known isoform sequences 
of the same gene. These constrains cause a variation in the amplicon lengths between 82 and 247 
bp. Each primer is about 20-23 nt long, with an annealing temperature of 61° C. 
 
3.1.9 PCR (polymerase chain reaction) 
 
 First, a qualitative analysis of reverse transcription products was performed using PCR and 
agarose gel electrophoresis. PCR experiments were performed in a 25 µL final volume, 
containing 2.5 µL of cDNA, 1 U Taq polymerase (TaKaRa, Shiga, Japan) with companion 
reagents (0.2 mM each dNTPs, 2 mM MgCl2, 10× PCR buffer) and 0.2 µM of each primer. An 
initial denaturation step of 2 min at 94°C was followed by 25 cycles of 30 sec at 94°C, 30 sec at 
annealing temperature (Ta 61°C ), 30 sec at 72°C, and a final extension of 7 min at 72°C. All 
RT-PCR products obtained were gel analyzed following a standard method (Davis et al., 1994). 
 
3.1.10 Real-Time PCR profile and melting curve 
 
 Real-Time PCR assays were performed in triplicate, using the CFX96 instrument (Bio-Rad 
Laboratories, Hercules, CA). The reactions were performed in a total volume of 20 µL 
containing: 2.5 µL of cDNA (heart, brain, cerebral cortex, cerebellum final concentration: 0.78 
ng/µL; hippocampus final concentration: 3.125 ng/µL); 10 µL of Sybr Select Master Mix 2× for 
CFX (Applied Biosystem, by Life Technologies) containing AmpliTaq® DNA Polymerase, UP 
(high purified), SYBR® GreenER™ dye and Heat-labile uracil-DNA glycosylase (UDG); 0.8 
µL (0.3 µM) of both forward and reverse primer (MWG, Life Technologies); 5.9 µL of RNase-
free water. Cycling parameters were: 2 min at 50°C (UDG activation), 2 min at 95°C (AmpliTaq 
Fast DNA Polymerase UP activation), 40 cycles of 15 sec at 95°C (denature) and of 1 min at 
60°C (anneal and extend). A melting step needs to be performed to assay amplification 
specificity. This step consisted of an increase in temperature of 0.5°C/sec from 65°C to 95°C. 
 For each gene we used the primer pair that gave between 90-110 % efficiency. We used the 
∆Ct (delta cycle threshold) method, a variation of the Livak method (Livak and Schmittgen, 
2001), that uses the difference between reference and target gene Ct values for each sample to do 
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a relative quantification normalized to a reference gene (Observed Ratio(reference/target) = 
2Ct(reference) – Ct(target)). For each gene group we set the gene with an intermediate expression value 
and a low standard deviation (SD, expressed as percentage of the mean value) in TRAM analysis 
as reference gene. The ratio among the transcriptome map expression values was calculated by 
dividing each expression value of the target gene by the expression value of the reference 
(expected ratio). Then we compared this value with the observed ratio and we examined the 
relationship between these two variables through bivariate statistical analysis using JMP 5.1 
software (SA Institute, Campus Drive Cary, NC). 
 
3.2 DS AMKL transcriptome 
 
3.2.1 AMKL gene expression literature search 
 
 A systematic biomedical literature search was performed up to January 2013 in order to 
identify articles related to global gene expression profile experiments in AMKL patients (DS 
AMKL, non-DS AMKL and TMD conditions). A general search using the commonly used 
acronym "AMKL" retrieved 157 articles. 
 The MeSH term "Leukemia, Megakaryoblastic, Acute" was also used for a PubMed search 
in the expression: "Leukemia, Megakaryoblastic, Acute"[Mesh] AND ("Gene Expression 
Profiling"[MeSH] OR "Oligonucleotide Array Sequence Analysis"[Mesh] OR "Microarray 
Analysis"[Mesh] OR microarray* OR "Expression profile" OR SAGE).  
 
3.2.2 AMKL gene expression database search 
 
 Gene Expression Omnibus (GEO) (Barrett and Edgar, 2006) functional genomics repository 
was searched for: (AMKL[All Fields] OR (AML[All Fields] AND M7[All Fields])) AND 
"Homo sapiens"[Organism]. A more general search using the expression "Down 
Syndrome"[MeSH] AND "Homo sapiens"[Organism] was also used. 
 ArrayExpress database (Sarkans et al., 2005) of functional genomics experiments was 
searched for the terms: "AMKL", "Megakaryoblastic", "AML M7".   
 In order to obtain gene expression profile datasets for normal human MK cells, in addition 
to the 9 used in the original description of the TRAM software (Lenzi et al., 2011), we searched 
GEO for the expression ("Megakaryocytes"[Mesh] OR Megakaryoblast*) AND "Homo 
sapiens"[ORGANISM]. The ArrayExpress database was searched for the expressions 
"Megakaryocyte", "Megakaryocytic", "Megakaryoblast", "MK". 
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 The searches were performed up to January 2013. 
   
3.2.3 AMKL gene expression dataset selection 
 
 The inclusion criteria of datasets in the analysis were: availability of the raw or pre-
processed data; pediatric age of the subject from whom the sample was obtained; diagnosis of 
DS or non-DS AMKL or TMD.  
 Exclusion criteria were: exon arrays (hampering data elaboration by TRAM due to 
exceedingly high number of data rows) or platforms using probes split into several distinct arrays 
for each sample (hampering intra-sample normalization); lack of identifiers corresponding to 
those found in the GEO sample records (GSM) or Array Express sample records; platforms 
assaying an atypical number of genes (i.e. <5.000 or >60.000); cell line derived data; specific 
subtype of non-DS AMKL (e.g. t 1;22); trisomy 21 in non-DS AMKL samples. 
 Normal MK samples were considered for the analysis when fulfilling these criteria: late MK 
colonies (10-14 days) or MK sorted cells, obtained from peripheral blood (PB), bone marrow 
(BM) or cord blood (CB). MK cultured for less than 10 days or Colony Forming Unit-
Megakaryocytic (CFU-MK) were excluded. 
 In order to obtain a quantitative transcriptome map, values from each dataset were linearized 
when provided as logarithms. In some cases we used raw files (e.g. File CEL) to be converted 
into pre-processed data, using the software "Alt Analyze" (Emig et al., 2010). 
 
3.2.4 AMKL TRAM (Transcriptome Mapper) analysis 
 
 We created a directory (folder) for each condition, containing all the sample datasets related 
to the same source and selected for the study: DS AMKL (pool 'A'); non-DS AMKL (pool 'B'); 
TMD (pool 'C'); normal MK (pool 'D'); normal CB MK (pool 'E'). 
 We ran the whole set of analyses permitted by TRAM (in both "Map" and "Cluster" mode, 
although we focused on the "Map" mode) using default parameters as described (Lenzi et al., 
2011). We used an updated version of TRAM including enhanced resolution of gene identifiers 
and updated UniGene and Entrez Gene databases (TRAM 1.1, June 2013), in comparison with 
the original 2011 version (Lenzi et al., 2011). When the gene location cytoband was not 
available in the Gene database (Gene database (http://www.ncbi.nlm.nih.gov/gene)), it was 
manually derived from UCSC Genome Browser (University of California Santa Cruz (UCSC) 
Genome Browser. (http://genome-euro.ucsc.edu/cgi-bin/hgGateway)). 
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3.2.5 Other Analysis 
 
 FuncAssociate analysis (Berriz et al., 2003) was used to obtain Gene Ontology attributes in 
order to functionally characterize large sets of genes derived from the TRAM analysis. 
 
3.3 HR-DSCR on human chromosome 21 and gene hunting 
 
3.3.1 HR-DSCR computational biology analysis  
 
 It was possible to perform an analysis of computational biology in the highly restricted 
Down syndrome critical region (HR-DSCR) through the use of different programs which analyze 
the homology between nucleotide and amino acid sequences. 
 In order to verify the presence of coding sequences in the HR-DSCR, we analyzed 
successive sections of 10,000 bp within the region, including between the coordinates 
37,929,229 to 37,963,130 (34 Kb), using the program BLASTX, without a search filter, which 
compares a nucleotide sequence to a database of proteins, translating it into all of the 6 possible 
reading frames. The sequence of interest was compared with the ESTs cataloged in the GenBank 
database (http://www.ncbi.nlm.nih.gov/genbank/) in order to verify the presence of transcripts 
not necessarily characterized as known genes. With the BLASTN program you can run an 
alignment of the sequence of interest (query) against the EST sequences. We entered as a query: 
NC_000021, with limits 37,929,229 - 37,963,130 placed in boxes labeled "from" "to", selecting 
as filters: "ESTs" and "Homo sapiens". 
 The results obtained by the search for homology (BLAST) were integrated using the 
program FGENESH (www.softberry.com/), which allows you to make an ab initio gene 
prediction in a fast and accurate way (Yu et al., 2002). This program, starting from a nucleotide 
sequence, detects the presence of the classical elements of gene functioning gene, such as: 
promoters, exons, start and termination codons of translation, etc. We started the ab initio 
research  with FGENESH, inserting the genomic sequence corresponding to the region of 
interest of the human chromosome 21 (chr21). To validate the results of the prediction made 
with FGENESH you can use its variants, FGENESH +, FGENESHC and FEGENESH-2, which, 
through a homology search, comparing the prediction respectively with amino acid sequences, 
cDNA sequences and sequences orthologous notes, greatly improves the accuracy of the 
prediction of a gene sequence. 
 Finally, with the aim to check the presence of small regulatory sequences, miRNAs, within 
the HR-DSCR, we used the program miRBase (http://www.mirbase.org/). The region of 10,000 
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bp was divided into blocks of sequences of 1,000 bp and each block of sequences in FASTA 
format, was analyzed. 
  
3.3.2 Putative miRNA1 Northern Blot analysis  
 
 Northern Blot allows the identification and quantification of specific RNA molecules due to 
hybridization with DNA probes (Alwine et al., 1977). We used this method to check for the 
putative precursor and mature miRNA1 forms. The method consists of six basic stages: 
preparation of a denaturant agarose gel for electrophoresis of RNA from different tissues; 
transfer of the RNA from the agarose gel to a membrane (filter) of nitrocellulose or nylon with 
surface charge; labelling with radioisotopes of a DNA probe complementary to the transcript of 
interest; hybridization of the probe to the filter; and exposure of the filter to an autoradiographic 
sheet resulting in the development of the same. 
 We used a commercial filter including poly-A RNA from twelve human tissues: brain, heart, 
skeletal muscle, colon, thymus, spleen, kidney, liver, intestine, placenta, lung and peripheral 
blood leukocytes. The filter named MTN2 ("multiple normal tissue", Clontech, MountainView, 
CA) consists of a nylon membrane with a charged surface. 
 To highlight the presence in the filter of the RNA target, it exploits the properties of nucleic 
acid molecules to pair with complementary sequences radioactively labelling the DNA 
sequences (radioactive probes) complementary to the target RNA. To label the probe, we added 
nucleotides labeled with phosphorus 32 (32P) to the 3' end of the molecule. The reaction was 
performed with the enzyme terminal deoxynucleotidyl transferase (TdT) (Thermo Fischer 
Scientific, Waltham, Massachusetts, United States) in the presence of alpha 32P dATP (3,000 
Ci/mmol). The manufacturer's instructions suggest to perform the reaction in 50 µL of final 
volume with 10 pmol of the probe.  
 The TdT designed and labeled probes were probe miRNA1, which binds to all three forms 
of the putative miRNA1 (primary, precursor and mature) and pri-miRNA1 probe, 
complementary to the primary putative miRNA1 form (Table 2). 
  
Probe Sequence 
miRNA1 GAGACAGAGTTTTGCTCTTGTTGCCC 
pri-
miRNA1 
CCAGATTTGTTTTTATTTGATGTGTCTGGCCTCACTTGCTCAGCATGATGG 
 
Table 2. Probes used to perform Northern Blot hybridization. 
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 The labeled probe was purified using the "Illustrates Microspin G-25 Columns" kit (GE 
Healthcare, Little Chalfont, UK) according to the manufacturer's instructions. These columns 
allow to discard the nucleotides that were not incorporated into the probe during labelling. A 
qualitative analysis of the purification of the labeled probe was performed, checking the number 
of counts per minute (cpm) of the radioactive probe at this stage through a "beta-counter" 
measurement tool. The measurement was made on 1 µL of probe in 3 mL of scintillation liquid 
to determine the volume of the probe to be added in the hybridization solution for a total of 2 
Mcpm/mL. 
 For the hybridization reaction we prepared 30 mL of hybridization solution containing: 1 M 
EDTA pH 8, 250 mM Na2HPO4 pH 7.2, 7% SDS. 20 mL of hybridization solution were put in a 
bottle. The filters were soaked in sterile distilled water and subsequently placed in the bottle. 
 A pre-hybridization step was performed for 30 minutes at 65°C. Subsequently, the bottle 
was emptied and was added to 10 mL of hybridization solution and the volume of labeled probe 
corresponding to 20 Mcpm. Hybridization was performed over night at 65°C. 
 After the hybridization reaction, the filter was washed with a solution containing a lower 
percentage of SDS (5%) to eliminate the excess of radioactive probe that did not bind to the 
filter. Finally the filters were exposed to an autoradiographic sheet, within a specific 
radiographic cassette, and stored at -80 ° C. The plates were developed after 24 hours. 
 On the autoradiographic sheet, signals of hybridization of the probe are visible in the form 
of bands, the height of which corresponds to the size of the target transcript. For the 
determination of the size of the transcript, we used the molecular markers indicated on the filter 
MTN2 (Figure 1) as reference. We used a sheet of graph paper in logarithmic scale with the 
length in millimeters (mm) of the distance between each molecular marker and the point 
corresponding to the loading well on the abscissa and the size in Kb of each molecular marker 
(Figure 1) on the ordinates. Starting from the axiom that for two points passes only one straight 
line, it was possible to draw a straight line that passes through the points designated by the 
molecular weight markers. Reporting the distance between the band visible on the 
autoradiographic sheet and the well on the abscissa, it is possible to derive the point of 
intersection with the straight line, which will allow to extrapolate the length in Kb of the 
transcript. 
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Figure 1 Diagram of commercial filter MTN2. The filter contains polyadenylated RNA from 12 human tissues: lane 
1) brain, 2) heart, 3) skeletal muscle, 4) colon, 5) thymus, 6) spleen, 7) kidney, 8) liver, 9) intestine, 10) placenta, 
11) lung, 12) peripheral blood leukocytes. The black dots indicate the loading well of RNA samples. To the left of 
the filter is shown the lengths in kb of molecular markers.  
 
 
 The hybridized filter was washed with a 0.1% solution of SDS brought to boiling to remove 
the probe remained tied. 
Another method of detection of the hybridization signal on the filter is the exposure of the filter 
to a phosphorus screen (Storage Phosphor Screen, Kodak, Rochester, NY) and the acquisition of 
the image to PhophorImager (Storm 840, Molecular Dynamics, Amersham Pharmacia Biotech , 
Uppsala, Sweden). The activity of the radioisotope incorporated in the probe impresses the 
screen of phosphorus, which has a sensitivity of 10 to 100 times greater than the 
autoradiographic sheet. A few hours of exposure are needed to detect the hybridization signal 
impressed on the screen of phosphorus. The PhosphorImager is equipped with a helium or neon 
lamp that emits rays which excite the most common radioisotopes 14C, 3H, 125I, 32P, 33P, 35S. 
Radioisotopes, when excited, emit a phosphorescence that is collected by an optical fiber and 
channeled into a photomultiplier tube. The resulting data consists of positional information 
which, scanned with a precision of 16 bits, leads to the formation of an image. 
 
3.3.3 Genomic organization of DSCR4 locus 
 
 The locus DSCR4 is adjacent to the HR-DSCR. For this reason we felt it essential to 
perform a bioinformatic study of the organization of this locus. To get an overview of the locus 
organization we used UCSC Genome Browser, a database in which the reference sequences and 
assembly projects that constitute a rich gene bank are stored. You can access the database from 
the link: "https://genome.ucsc.edu/" and enter the reference chromosome using a universal 
nomenclature in which the chromosome is referred to by the initials "chr" followed by the 
number of chromosome and two points (eg. chr21:), along with the start and end coordinates of 
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the locus to be studied, using thousands separator commas (37,929,229 - 37,963,130). After 
entering the coordinates, you can observe the genomic organization of the locus: the exons are 
shown as rectangles, the introns are shown as arrows, and the EST sequences, detectable by 
selecting "Human EST that have been spliced", are linked to an access code. We used the 
BLAST program "2 seq", which allows the alignment of the two sequences to compare EST 
sequences (highlighted in previous research) with the genomic sequence of chromosome 21, 
including as a reference their access codes. To find ESTs also partially homologous to the 
reference EST sequence, we used the program BLASTN, by entering the EST identification code 
as a query and  the terms "Expressed sequence tags (est)" and "Homo sapiens" as filters.  
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Chapter 4 
 
Results 
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4.1 Systematic meta-analysis of gene expression profiles of normal human tissues  
 
4.1.1 Gene expression database search and database building 
 
 The performed search, followed by checking for exclusion and inclusion criteria as 
described in the "Materials and Methods" section above, retrieved 60 samples from 15 
microarray experiments on whole adult brain, 35 samples from 13 microarray experiments on 
whole foetal brain, 140 samples from 15 microarray experiments on whole cerebellum, 18 
samples from 4 microarray experiments on whole cerebral cortex, 41 samples from 7 microarray 
experiments on the whole hippocampus, 32 samples from 11 microarray experiments on the 
whole heart, 622 samples from 12 microarray experiments on non-brain tissue pool, and 629 
samples from 13 microarray experiments on non-cardiac tissue pool. Datasets search on different 
human tissues retrieved ten articles describing gene expression profile for 53 different tissues or 
organs. Sample identifiers and main sample features of brain, foetal brain, cerebellum and 
cerebral cortex are listed in Supplementary Table 1 and for human non-brain comparison pool in 
Supplementary Table 2, both available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/. 
Sample identifiers and main sample features of hippocampus are listed in Supporting 
Information Table S1, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/. Sample 
identifiers and main sample features of whole heart and pool of non-cardiac tissues are listed in 
the Table I and II of the Data Supplement, both available at: http://apollo11.isto.unibo.it/heart, in the 
event of acceptance of the manuscript they will be available at: http://apollo11.isto.unibo.it/suppl/). 
 Datasets were loaded into TRAM and analyzed obtaining eighteen transcriptome maps: 
adult brain (pool 'A'); adult brain (pool 'A') vs. pool of tissues minus brain (pool 'B'); male brain 
(pool 'A.1'); female brain (pool 'A.2'); male brain (pool 'A.1') vs. female brain (pool 'A.2'); foetal 
brain (pool 'C'); foetal brain (pool 'C') vs. adult brain (pool 'A'); cerebellum (pool 'D'); 
cerebellum (pool 'D') vs. adult brain (pool 'A'); cerebral cortex (pool 'E'); cerebral cortex (pool 
'E') vs. adult brain (pool 'A'); hippocampus (pool 'F'); hippocampus (pool 'F') vs. whole brain 
(pool 'A'); male hippocampus (pool 'F.1'); female hippocampus (pool 'F.2'); male hippocampus 
(pool 'F.1') vs. female hippocampus (pool 'F.2'); heart (pool 'G'); heart (pool 'G') vs. pool of 
tissues minus heart (pool 'H'). All the folders corresponding to each single transcriptome map are 
listed in the Table 1. 
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4.1.2 Transcriptome differential maps  
 
 Each map provides: the total of data points analyzed for each tissue, i.e. gene expression 
values (expressed as percentage of the mean value) for all human mapped loci following intra- 
and inter-sample normalization (Lenzi et al., 2011); the number of loci for each tissue and for 
which the comparison between two conditions (different tissues) was possible, due to the 
presence of values for those loci in both sample pools considered; the number (at least three 
over/under-expressed genes) and the gene content of each genomic segment found to be 
statistically significantly over/under-expressed in the comparison between the two tissues. Each 
genomic segment was identified among the 12,373 segments generated using the default window 
of 500,000 bp with a sliding window of 250,000 bp and following removal of overlapping 
segments with similar gene content.  
 A segment or a gene was considered to be statistically significantly over/under-expressed for 
q<0.05, where q is the p-value obtained by the method of hypergeometric distribution (Lenzi et 
al., 2011) and corrected for multiple comparison.  
 
4.1.3 Adult brain and Adult brain vs. Pool of tissues minus brain transcriptome map 
analysis 
 
 In the adult brain transcriptome map analysis 1,803,680 data points corresponding to 39,250 
mapped loci (Supplementary Table 3, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/) were 
included. 22,699 data points of the map correspond to 565 chr21 mapped loci. Results obtained 
by analysis included 28 significantly over-expressed segments. 
 The genome segment that has the highest statistically significant expression value is on 
chromosome 12 (12q13.12) (Table 3a), including the over-expressed known genes TUBA1A, 
TUBA1B and TUBA1C, encoding respectively for brain-specific tubulin alpha 1a, alpha 1b and 
alpha 1c. There are no statistically significant under-expressed segments. 
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Table 3 List of the three most a) over- or b) under- expressed genes and genomic segments (all significantly, with 
q<0.05). In a) all genes and segments are sorted by decreasing expression value, in b) by increasing expression 
value. Data refer to the transcriptome map of whole adult brain; whole foetal brain; cerebellum and cerebral cortex. 
    
   a) 
                      TISSUE 
 
 
SEGMENT 
OR GENE 
Whole adult 
brain 
Whole foetal 
brain 
Cerebellum Cerebral Cortex 
Over-expressed segments 
I 12q13.12 
566.00 
12q13.12 
981.68 
11q13.1 
492.10 
12q13.12 
1051.22  
TUBA1B 
TUBA1A 
TUBA1C 
TUBA1B  
TUBA1A 
TUBA1C  
Hs.736281 
Hs.593027  
MALAT1 
Hs.712678 
Hs.732685  
TUBA1B  
TUBA1A  
TUBA1C  
II Xp11.23a 
561.23 
4q21.3a 
702.21 
6p21.3 
490.85 
12q12 
785.70 
BEX1  
BEX4  
TCEAL5  
BEX2  
TCEAL7 
NGFRAP1 
 RPS29  
RPL36AL 
KLHDC2 
GRM4  
Hs.592692  
RPS10  
PACSIN1 
ARF3  
DDN  
TUBA1B  
TUBA1A  
TUBA1C  
III 6p21.3 
524.86  
6p21.3 
658.07  
11q13.1a 
487.38 
11q13.1 
738.20 
Hs.743967 
Hs.592692 
Hs.597332  
RPS10  
PACSIN1 
C6orf1 
Hs.743967  
RPS10  
MALAT1 
Hs.712678 
Hs.732685 CFL1  
Hs.736281 
Hs.593027  
MALAT1 
Hs.712678 
Hs.732685 
Over-expressed genes 
I  BCYRN1  
7,875.54 
TUBA1B 
6,954.44 
BCYRN1  
12,372.42 
Hs.732685 
12,387.16 
II TUBA1B  
4,876.25 
TUBA1A 
6,810.31 
Hs.732685 
8,742.11 
TUBA1B  
6,343.86 
III Hs.732685  
4,680.24 
EEF1A1 
6,336.99 
CALM2 
4,704.56 
TUBA1C 
6,093.47 
Over-expressed chr21 genes 
I SOD1 
1,727.39 
DNAJC28 
2,817.20  
DNAJC28  
1,447.08 
OLIG1 
726.82 
II DNAJC28 
878.57 
SOD1 
1,657.36 
SOD1 
1,432.22 
PCP4 
700.08 
III APP 
791.87 
ATP5O 
1,074.36 
TIAM1 
1,229.18 
SOD1 
629.70 
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       b) 
                             TISSUE 
 
 
SEGMENT  
OR GENE 
Whole adult 
brain 
Whole foetal 
brain 
Cerebellum Cerebral 
Cortex 
Under-expressed segments 
I   13q21.31a 
3.19 
 
Hs.375745 
Hs.735749 
Hs.551057 
Under-expressed genes 
I TRG 
2.93 
Hs.439634 
0.17 
Hs.707129 
0.99 
ZNF852 
3.59 
II Hs.737002 
3.00 
Hs.674562 
0.73 
Hs.680393 
1.01 
Hs.28723 
3.71 
III Hs.729885 
3.73 
Hs.599650 
1.01 
OR2T29 
1.1 
Hs.441636 
3.74 
Under-expressed chr21 genes 
I Hs.542623 
5.08 
Hs.729539 
2.31 
Hs.561029 
1.82 
Hs.50927 
5.48 
II Hs.561029 
5.13 
LOC339622 
3.10 
Hs.677645 
1.89 
LOC339622 
6.29  
III Hs.542565 
5.18 
Hs.666775 
3.16 
Hs.580903 
1.93 
Hs.290805 
6.44 
 
Analysis was performed using default parameters (see "Methods" section). Under each segments the expression 
value and the genes included in the segment are indicated, under each gene the expression value is indicated. Some 
segments are not shown for simplicity because they are over-lapping with those highlighted in one of the listed 
regions. The listed gene for each segments are only the significantly over-/under-expressed genes. The complete 
results for these models are available as online supplementary material. In bold are marked the results overlapping 
among the transcriptome maps. In the 'Map' mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in 
the case of H. sapiens) only if they have an expression value. a Cytoband was derived from the UCSC Genome 
Browser. 
 
 
  At single gene level, BCYRN1 (chr2), encoding for a brain cytoplasmic RNA 1, has the 
highest expression value (7,875.54) (Table 3a); TRG (chr7), encoding for T cell receptor gamma, 
has the lowest expression value (2.93) (Table 3b). Among the chr21 genes SOD1, encoding for 
superoxide dismutase 1 soluble, has the highest expression value (1,727.39), followed by 
DNAJC28 (878.57), encoding for DnaJ (Hsp40) homolog, subfamily C, member 28, and APP 
(791.87), encoding for amyloid beta (A4) precursor protein (Table 3a). 
 
 In the analysis of the Adult brain vs. Pool of tissues minus brain TRAM map, regional 
differential expression of pool 'A' (60 total brain samples) versus pool 'B' (622 pool of tissues 
minus brain samples and 34,985 mapped loci listed in the Supplementary Table 4, available at: 
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http://apollo11.isto.unibo.it/suppl/2014_Caracausi/) was investigated. Results included 23 
significantly over- (n=7) or under-expressed (n=16) segments. 
 The genome segment that has the highest statistically significant expression value is on 
chromosome 5 (5q34) (Table 4a), including the over-expressed known genes GABRA6, GABRA1 
and GABRG2, encoding respectively for gamma-aminobutyric acid (GABA) A receptor, subunit 
alpha 6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 and gamma-
aminobutyric acid (GABA) A receptor, gamma 2. The genome segment that has the lowest 
statistically significant expression value is on chromosome 2 (2p12) (Table 4b), including the 
under-expressed known genes REG1B, REG1A and REG3A, encoding respectively for 
regenerating islet-derived 1 beta, regenerating islet-derived 1 alpha and regenerating islet-
derived 3 alpha. 
 At single gene level, an increase of more than 10 times was observed in all the first 125 loci 
(Supplementary Table 5, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In 
particular, a fold increase of 79.69 was observed for the known gene ANKRD30B (Table 4a), 
encoding for ankyrin repeat domain 30B. We also observed that in this range of expression ratio, 
five chr21 genes are included: DNAJC28, LINC00320, LINC00323, OLIG1 and OLIG2 
(Supplementary Table 5, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In 
particular, DNAJC28 had a 65.06-fold increase with respect to all tissues, followed by 
LINC00320, encoding for a long intergenic non-protein coding RNA 320, that had a 39.82-fold 
increase (Table 4a).  
 Among the genes with the lowest 'A'/'B' expression ratio, a fold decrease of 100 was 
observed for the EST clusters Hs.633942, Hs.554169, Hs.727036, Hs.720702 and for the known 
genes CSTA, KRT13 and MSMB, encoding for cystatin A (stefin A), keratin 13 and beta-
microseminoprotein, respectively (Supplementary table 5, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 
 When the 24 spinal cord samples were removed from the non-brain sample pool, using the 
"Exclude" sample function provided by the TRAM graphical interface in order to test if the 
removal of a central nervous system organ from the human tissue set could alter the 
transcriptome comparison of the brain with non-brain tissue pool, substantially analogous results 
were obtained (data not shown). 
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Table 4 List of the three most a) over- or b) under- expressed genes and segments (all significantly, with q<0.05). 
In a) all genes and segments are sorted by decreasing gene expression ratio, in b) by increasing gene expression 
ratio. Data refer to the differential transcriptome map: whole adult brain vs. pool of non-brain tissue; whole foetal 
brain vs. whole adult brain; cerebellum vs. whole adult brain and cerebral cortex vs. whole adult brain.  
           
 a) 
              TISSUE 
 
 
SEGMENT  
OR GENE 
Whole adult brain 
vs. Pool of tissue 
Whole foetal brain 
vs. Whole adult 
brain 
Cerebellum vs. 
whole adult 
brain 
Cerebral 
Cortex vs. 
whole adult 
brain 
Over-expressed segments 
I 5q34 
11.35 
8q13.1a 
7.51 
15q22.2 
5.23 
1q23.1 
17.55 
GABRA6 GABRA1 
GABRG2 
LOC100130155 
Hs.388788 
BHLHE22 
RORA  
Hs.660127 
Hs.655820 
OR6Y1  
OR6K2 OR6N1  
PYHIN1  
II 13q21.32 
9.25 
2q33 
6.99 
12q22a 
4.05 
11q12.1 
7.8 
PCDH9 Hs.656886 
Hs.676018  
SATB2 Hs.151184 
SATB2-AS1  
Hs.585087 
BTG1 
Hs.434392  
OR5F1  OR5T2 
OR8U1 
III 3q24 
6.86 
10p14 a 
4.06 
1p31.3 
3.87 
11q11 
7.33 
ZIC4 Hs.720460 
ZIC1  
Hs.734120 
Hs.676705 
Hs.735675 
Hs.655681  
INADL 
Hs.737385 
Hs.673484  
OR5L2  OR5F1  
OR5T2 
Over-expressed genes 
I ANKRD30B 
79.69 
TMSB15A 
63.15 
CBLN3 
81.34 
ZNF790 
225.06 
II DNAJC28 
65.06 
DCX 
42.79 
Hs.665664  
17.65 
Hs.197693 
110.78 
III CDR1 
57.38 
Hs.712990 
40.03 
Hs.12316  
16.97 
Hs.594912 
86.53 
Over-expressed chr21 genes 
I DNAJC28 
65.06 
CXADR 
7.40 
Hs.657183  
6.83 
KRTAP13-2 
32.77 
II LINC00320 
39.82 
LRRC3DN 
4.86 
ADAMTS5 
 6.36 
KRTAP15-1 
7.10 
III OLIG1 
11.12 
Hs.675532 
4.24 
TIAM1 
5.29 
Hs.657999 
6.49 
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           b) 
                     TISSUE 
 
 
SEGMENT  
OR GENE 
Whole adult 
brain vs. Pool 
of tissue 
Whole foetal 
brain vs. Whole 
adult brain 
Cerebellum vs. 
whole adult 
brain 
Cerebral 
Cortex vs. 
whole adult 
brain 
Under-expressed segments 
I 2p12 
0.16 
2q31.1 
0.38 
  
REG1B  
REG1A  
REG3A 
LRP2  
BBS5  
KLHL41  
Hs.593163 
II 12q21.3-q22 
0.17 
5q31 
0.41 
  
LUM 
Hs.539252 
DCN  
Hs.658232  
NR3C1  
Hs.703520 
III 18q12.1 
0.19 
7q22.2 
0.54 
  
DSC3   
DSC2   
DSC1 
 Hs.718842 
LOC100216546   
Hs.656426 
Hs.657627  
Under-expressed genes 
I Hs.633942 
0.01 
TNNC1 
0.01 
NRGN  
0.01 
Hs.683165 
0.01 
II Hs.554169 
0.01 
Hs.80714 
0.01 
LCE5A  
0.01 
CKM 
0.01 
III CSTA 
0.01 
GGT6 
0.01 
CKM 
0.01 
DNAJC28 
0.02 
Under-expressed chr21 genes 
I COL6A2 
0.09 
LINC00320 
0.03 
LINC00320  
0.04 
DNAJC28 
0.02 
II Hs.663673 
0.11 
S100B 
0.05 
KRTAP10-10  
0.11 
LINC00320 
0.10 
III FAM3B 
0.14 
C21orf91 
0.08 
LINC00323  
0.15 
LINC00323 
0.11  
 
Analysis was performed using default parameters (see "Methods" section). Under each segments the expression 
ratio and the genes included in the segment are indicated, under each gene the expression ratio is indicated. Some 
segments are not shown for simplicity because they are over-lapping with those highlighted in one of the listed 
regions. The listed gene for each segments are only the significantly over-/under-expressed genes. The complete 
results for these models are available as online supplementary material. In bold are merked the results overlapping 
among the transcriptome maps. In the 'Map' mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in 
the case of H. sapiens) only if they have an expression value. a Cytoband was derived from the UCSC Genome 
Browser. 
 
 
 
 
 
 
	  	   35	  	  	  	  
4.1.4 Male brain vs. Female brain  transcriptome map analysis 
 
 The adult brain samples for which the sex of the sample donor was available were grouped 
into two additional datasets: pool 'A.1' including 13 male samples and pool 'A.2' including 5 
female samples and the corresponding transcriptome maps were generated and compared. 
 The gene expression value for each of the 27,437 loci of the male brain transcriptome map 
(Supplementary Table 6, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/) and 
for each of the 25,954 loci of the female brain transcriptome map (Supplementary Table 7, 
available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/) are available. The differential 
transcriptome map produced a gene expression ratio for each of the 25,954 shared loci 
(Supplementary Table 8, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 
Results included 6 significantly over-expressed segments. The genome segment that has the 
highest statistically significant expression value is on chromosome Y, including the known genes 
TTTY15, USP9Y and DDX3Y encoding respectively for testis-specific transcript, Y-linked 15 
(non-protein coding), ubiquitin specific peptidase 9, Y-linked and DEAD (Asp-Glu-Ala-Asp) 
box helicase 3, Y-linked (supplementary full results for transcriptome maps are available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/)  
 At single gene level, a more than ten-fold increase was observed in all the first 84 loci 
(Supplementary Table 8, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In 
particular, a more than 100-fold increase was observed for the uncharacterized locus 
LOC613126 (378.56) and the known genes LBX1 (366.49), DRD4 (332.51) and CDC42EP5 
(115.26), encoding respectively for ladybird homeobox 1, D4 subtype of the dopamine receptor 
and for the CDC42 effector protein (Rho GTPase binding) 5 (Table 5).   
 Among the genes with the lowest 'A.1'/'A.2' expression ratio, a 25-fold decrease was 
observed for the  known gene XIST, encoding for the X inactive specific transcript (non-protein 
coding) (Table 5). 
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Table 5 List of the ten most over- and under-expressed genes in male brain  (pool 'A.1') vs. female brain (pool 'A.2').  
 
Gene name Value 
'A.1' 
Value 
'A.2' 
Ratio 
'A.1'/'A.2' 
Chr Data 
points 
'A.1' 
Data 
points 
'A.2' 
SD as % of 
expression 
'A.1' 
SD as % of 
expression 
'A.2' 
Over-expressed genes     
LOC613126 2,019.28 5.33 378.56 chr7 6 3 110.66 71.16 
LBX1 529.57 1.44 366.49 chr10 16 5 214.23 75.11 
DRD4 1,268.15 3.81 332.51 chr11 16 5 213.44 125.06 
CDC42EP5 1,433.81 12.44 115.26 chr19 6 3 109.49 88.48 
LOC100133315 578.64 7.97 72.59 chr11 9 3 148.30 106.70 
EDARADD 126.93 1.89 67.15 chr1 6 3 103.76 35.84 
HIST3H3 182.62 2.73 66.94 chr1 13 5 182.15 70.33 
HES7 1,244.07 18.79 66.22 chr17 6 3 110.37 48.39 
PPIAL4A 279.32 4.75 58.77 chr1 25 5 110.99 120.25 
FTHL17 154.68 2.78 55.58 chrX 6 3 117.92 4.55 
Under-expressed genes     
CCL4 27.16 201.40 0.13 chr17 13 5 54.58 172.86 
IL1B 27.82 208.20 0.13 chr2 50 10 92.63 112.94 
Hs.434622 0.90 6.78 0.13 chr1 3 3 50.62 63.74 
Hs.611927 2.23 19.15 0.12 chr6 3 3 70.55 85.33 
Hs.25345 0.38 3.42 0.11 chr6 3 3 19.05 44.69 
NPAS4 8.37 80.07 0.10 chr11 9 6 144.65 158.20 
LOC400768 0.41 4.24 0.10 chr1 3 3 8.38 57.81 
CCL3 19.43 201.78 0.10 chr17 13 5 136.51 140.44 
Hs.710548 0.75 7.94 0.09 chr17 3 3 27.09 63.80 
XIST 7.97 203.97 0.04 chrX 44 31 78.75 131.58 
 
Value: mean gene expression value normalized across all the pool samples; Data points: number of samples with an 
expression value for the locus; SD: standard deviation for the expression value expressed as a percentage of the 
mean. All these gene result statistically significant in the transcriptome map with a segment window of 12,500 bp. 
Full results available as supplementary material (see text).  
 
 
4.1.5 Foetal brain and Foetal brain vs. Adult brain transcriptome map analysis 
 
 In the foetal brain transcriptome map analysis, 855,662 data points corresponding to 38,483 
mapped loci were included (Supplementary Table 9, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/).  
11,583 data points of the map correspond to 559 chr21 mapped loci. Results obtained by analysis 
included 38 significantly over-expressed segments. 
 The genome segment that has the highest statistically significant expression value is on 
chromosome 12 (Table 3a), including the over-expressed known genes TUBA1A, TUBA1B and 
TUBA1C. There are no statistically significant under-expressed segments. 
 At single gene level, TUBA1B (chr12), has the highest expression value (6,954.45) (Table 
3a); the EST cluster Hs.439634 (chr14) has the lowest expression value (0.17) (Table 3b). 
Among the genes of chromosome 21 (chr21), DNAJC28, has the highest expression value 
(2,817.20); followed by SOD1 (1,657.36) and ATP5O (1,074.36), encoding for ATP synthase, 
H+ transporting, mitochondrial F1 complex, O subunit (Table 3a).  
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 In the analysis of the Foetal brain vs. Adult brain TRAM map, regional differential 
expression of pool 'C' (35 foetal brain samples) versus pool 'A' (60 adult brain samples) was 
investigated. Results included 22 significantly over- (n=19) or under-expressed (n=3) segments. 
 The genome segment that has the highest statistically significant expression value is on 
chromosome 8 (Table 4a), including the over-expressed known gene BHLHE22, encoding for 
basic helix-loop-helix family, member e22, the uncharacterized locus LOC100130155 and the 
EST cluster Hs.388788. The genome segment that has the lowest statistically significant 
expression value is on chromosome 2 (2q31.1) (Table 4b), including the under-expressed known 
genes LRP2, BBS5, KLHL41, encoding for low density lipoprotein receptor-related protein 2, 
Bardet-Biedl syndrome 5, and kelch-like family member 41 respectively, and the EST cluster 
Hs.593163. 
 At single gene level, an increase of more than 10 times was observed in all the first 44 loci 
(Supplementary Table 10, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/), 
including TMSB15A, encoding for thymosin beta 15a, and DCX, encoding for doublecortin, 
which have a fold increase of 63.15 and 42.79 (Table 4a), respectively. 
 All the chr21 loci have an increase of less than 10 times, and an increase between 2 and 10 
times was observed for 28 loci (Supplementary Table 10, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In particular, CXADR, encoding for 
coxsackie virus and adenovirus receptor, has a 7.4-fold increase compared to adult brain (Table 
4a). LINC00320 has the lowest 'C'/'A' expression ratio (0.03) preceded by the known gene S100B 
(0.05), encoding for S100 calcium binding protein B (Table 4b). Among the genes with the 
lowest 'C'/'A' expression ratio a fold decrease of 100 was observed for the EST clusters 
Hs.80714, and for the known genes LCE5A, ANKK1, GGT6 and TNNC1, encoding respectively 
for late cornified envelope 5A, ankyrin repeat and kinase domain containing 1, gamma-
glutamyltransferase 6 and troponin C type 1 (slow) (Supplementary Table 10, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 
 
4.1.6 Cerebellum and Cerebellum vs. Adult brain transcriptome map analysis 
 
 In the analysis of the cerebellum TRAM map, 3,862,253 data points corresponding to 
38,163 mapped loci were included (Supplementary Table 11, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 49,004 data points of the map correspond to 
554 chr21 mapped loci. Results obtained by analysis included 28 significantly over-expressed 
segments and 1 significantly under-expressed segment.  
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 The genome segment that has the highest statistically significant expression value is on 
chromosome 11 (11q13.1) (Table 3a), including four over-expressed UniGene EST clusters 
(Hs.736281, Hs.593027, Hs.712678, Hs.732685) and the known gene MALAT1, encoding for 
metastasis-associated lung adenocarcinoma transcript 1 (non-protein coding). The genome 
segment that has the lowest statistically significant expression value is on chromosome 13 (Table 
3b), including the under-expressed EST clusters Hs.375745, Hs.735749 and Hs.551057.  
 At single gene level, BCYRN1 has the highest expression value (12,372.42) (Table 3a); the 
UniGene EST cluster Hs.707129 has the lowest expression value (0.99) (Table 3b). Among the 
chr21 genes, DNAJC28 has the highest expression value (1,447.08), followed by SOD1 
(1,432.22) (Table 3a). 
 In the analysis of the Cerebellum vs. Adult brain TRAM map, regional differential 
expression of pool 'D' (140 cerebellum samples) versus pool 'A' (60 total brain samples) was 
investigated. Results included 42 significantly over-expressed segments.  
 The genome segment that has the highest statistically significant expression value is on 
chromosome 15 (15q22.2) (Table 4a), including the over-expressed known gene RORA, 
encoding for RAR-related orphan receptor A, and the two UniGene EST clusters Hs.660127 and 
Hs.655820. There are no statistically significant under-expressed segments. 
 At single gene level, an increase of more than 10 times was observed in all the first 23 loci, 
including the gene FSTL5, encoding for follistatin-like 5 (Supplementary Table 12, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In particular, a fold increase of 81.34 was 
observed for the known gene CBLN3, encoding for cerebellin 3 precursor (Table 4a). Among the 
genes with the lowest 'D'/'A' expression ratio a fold decrease of 100 was observed for the known 
gene NRGN, encoding for neurogranin (protein kinase C substrate, RC3) (Table 4b). All the 
chr21 loci have an increase of less than 10 times, and an increase between 2 and 10 times was 
observed for 40 loci in particular. The DNAJC28 and LINC00320 genes mentioned above have a 
1.65-fold change and a 0.04-fold change respectively compared to total brain (Supplementary 
Table 12, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 
 
4.1.7 Cerebral cortex and Cerebral cortex vs. Adult brain transcriptome map analysis 
 
 In the analysis of the cerebral cortex TRAM map 780,661 data points corresponding to 
27,504 mapped loci were included (Supplementary Table 13, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 9,846 data points of the map correspond to 
336 chr21 loci. Results obtained by analysis included 21 significantly over-expressed segments.  
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 The segment that has the highest statistically significant expression value is on chromosome 
12 (12q13.12) (Table 3a), including the over-expressed known genes TUBA1A, TUBA1B and 
TUBA1C. There are no statistically significant under-expressed segments. 
 At single gene level, the EST cluster Hs.732685 has the highest expression value 
(12,387.16), followed by TUBA1B, which is the first known gene with the highest expression 
value (6,343.86) (Table 3a). The known gene ZNF852 has the lowest expression value (3.59) 
(Table 3b). Among the chr21 genes, OLIG1, encoding for oligodendrocyte transcription factor 1, 
has the highest expression value (726.82), followed by PCP4, encoding for Purkinje cell protein 
4 (700.08), and SOD1 (629.7) (Table 3a). 
 In the analysis of the cerebral cortex vs. adult brain TRAM map, regional differential 
expression of pool 'E' (18 cortex samples) versus pool 'A' (60 total brain samples) was 
investigated. Results included 10 significantly over-expressed segments. 
 The segment that has the highest statistically significant expression value is on chromosome 
1 (1q23.1), including the over-expressed known genes OR6Y1, OR6K2 and OR6N1 encoding 
olfactory receptors, and PYHIN1, encoding pyrin and HIN domain family, member 1 (Table 4a). 
There are no statistically significant under-expressed segments. 
 At single gene level, an increase higher than 10 times was observed in all the first 178 loci 
(Supplementary Table 14, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). In 
particular, an increase of 255.06 times was observed for the gene ZNF790, encoding for zinc 
finger protein 790 (Table 4a). Among the genes with the lowest 'E'/'A' expression ratio, a fold 
decrease of 100 was observed for the EST cluster Hs.683165 and for the known gene CKM, 
encoding for creatine kinase, muscle (Table 4b). We also observed that only one chr21 gene, 
KRTAP13-2, encoding for keratin associated protein 13-2, has an increase of 32.77 times, while 
the other chr21 loci have an increase of less than 7.1 times (Table 4a). The DNAJC28 gene has 
the lowest 'E'/'A' expression ratio (0.02), preceded by LINC00320 (0.1), both previously 
mentioned (Table 4b). Furthermore, we noted that SOD1, despite being among the genes of 
chr21 with a high expression value, has a low expression ratio compared to total brain (0.36) 
(Supplementary Table 14, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/). 
 
4.1.8 Hippocampus and Hippocampus vs. Whole brain transcriptome map analysis 
  
 In the hippocampus transcriptome map analysis, 1,339,820 data points corresponding to 
30,739 mapped loci were included (Supporting Information Table S2, available at: 
http://apollo11.isto.unibo.it/suppl/2015_Caracausi/, where the Pool 'F' here is named 'A'). 16,996 
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data points of the map corresponded to 403 chr21 mapped loci. Results obtained by analysis 
included 18 significantly over-expressed segments.   
 The genome segment that has the highest statistically significant expression value is on 
chromosome 12 (12q13.12) (Table 6), including the over-expressed known genes TUBA1B, 
TUBA1A and TUBA1C, encoding respectively for brain-specific tubulin alpha 1a, alpha 1b and 
alpha 1c. There are no statistically significant under-expressed segments. 
 
Table 6 The first five genomic segments significantly over-/under-expressed in the hippocampus (pool 'F') 
transcriptome map. 
 
Hippocampus transcriptome map 
Chra and 
Location 
Segment 
Startb 
Segment 
Endb 
Value 
'F' 
q-value Genes in the segmentc 
Over-expressed segments 
chr12 
12q13.12 
49,500,001 50,000,000 804.67 0.0098 TUBA1B, TUBA1A, TUBA1C 
chr8 
8p21.2 
26,000,001 26,500,000 657.94 0.00088 BNIP3L, PNMA2, DPYSL2 
chrX 
Xq22.1-
q22.2d 
102,250,001 102,750,000 653.12 0.0004 BEX1, BEX4, BEX2, 
NGFRAP1  
chr12 
12q12 
49,250,001 49,750,000 614.69 0.00087 ARF3, DDN, TUBA1B,  
TUBA1A, TUBA1C  
chr11 
11q13.1 
65,250,001 65,750,000 492.32 0.011 MALAT1, Hs.712678, 
Hs.732685, CFL1  
 
Analysis was performed using default parameters (see "Materials and Methods" section). Segments are sorted by 
decreasing expression value in the hippocampus transcriptome map. In the 'Map' mode, TRAM displays UniGene 
EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they have an expression value. For simplicity, 
some segments are not shown because they overlap with those highlighted in one of the listed regions. The complete 
results for these models are available as online supplementary material (see text). The segment location cytoband 
was derived from that of the first mapped gene within the segment. a Chromosome. b Segment Start/End: 
chromosomal coordinates for each segment. c Significantly over-/under-expressed genes as marked in the TRAM 
results. d Cytoband not available in Gene was derived from the UCSC Genome Browser (http://genome-
euro.ucsc.edu/cgi-bin/hgGateway).  
 
 
 At single gene level, the EST cluster Hs.732685 (mapping within the known locus MALAT1, 
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding), as shown by 
BLASTN analysis) (chr11) has the highest expression value (8,566.51), followed by the known 
genes CALM2 (5,801.15), TUBA1C (4,677.64) and TUBA1B (4,488.91), encoding respectively 
for calmodulin 2 (phosphorylase kinase, delta), tubulin, alpha 1c and tubulin, alpha 1b (Table 7). 
The EST cluster Hs.655406 (mapping within the known locus PCGF3, polycomb group ring 
finger 3) has the lowest expression value (6.74). Among the genes of chromome 21, the long 
intergenic non-protein coding RNA, LINC00114, has the highest expression value (2,304.90), 
followed by SOD1 (1,647.81) and OLIG1 (872.42) (Table 7). 
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Table 7 List of the five most over- and under-expressed genes (all significantly, with q<0.05, except genes with b 
note) in the hippocampus (pool 'F') transcriptome map.  
 
Gene name Value 'F' Location Data points  
'F' 
SD as % of 
expression 'F' 
Over-expressed genes 
Hs.732685a  8,566.51 11q13.1 24 35.69 
CALM2 5,801.15 2p21 32 48.89 
TUBA1C 4,677.64 12q13.12 40 37.64 
TUBA1B 4,488.91 12q13.12 77 44.32 
RPL41b  4,205.15 12q13 26 45.08 
Over-expressed chr21 genes 
LINC00114 2,304.90 21q22.2 11 51.35 
SOD1 1,647.81 21q22.11 41 28.92 
OLIG1 872.42 21q22.11 25 56.16 
TTC3 680.61 21q22.2 205 78.35 
APP 566.72 21q21.3 106 76.46 
Under-expressed genes 
Hs.655406b  6.74 4p16.3 5 31.25 
Hs.542157c 7.54 2p24.1 5 40.10 
LOC100505878 8.90 5q14.3 17 37.28 
Hs.559317c 9.14 2q24.1 24 35.20 
CSTF3-AS1 9.26 11p13 24 36.29 
Under-expressed chr21 genes 
LOC339622 11.39 21q21.1-q21.2 24 34.27 
Hs.434909b  12.65 21q22.12 17 26.44 
Hs.290805 12.87 21q21.1 24 49.36 
LINC00314 13.05 21q21.3 25 50.21 
Hs.723551b  13.15 21q22.11 24 40.58 
 
Value: mean gene expression value normalized across all the pool samples; Data poins: number of spots associated 
to an expression value for the locus; SD: standard deviation for the expression value expressed as a percentage of 
the mean. Over-expressed genes are sorted by decreasing gene expression value, under-expressed genes are sorted 
by increasing gene expression value. Full results are available as supplementary material (see text). a According to 
the criteria detailed in the Materials and Methods section, the segment window (12,500 bp) contains more than one 
gene, but the significance is assumed to remain because the expression value of this over- or under-expressed gene 
prevails over the others. b This gene is one of the five most over-/under-expressed ones, but the value is not 
statistically significant. This is either because this gene was present with other genes even in the 12,500 bp segment, 
and its expression value does not prevail over the others, or because the segment containing the gene does not fulfill 
criteria for local over-/under-expression, or because its expression value is not associated to at least 5 data points.c 
Cytoband not available in Gene was derived from the UCSC Genome Browser (http://genome-euro.ucsc.edu/cgi-
bin/hgGateway). 
 
 
 In the analysis of the hippocampus vs. whole brain transcriptome map, regional differential 
expression of pool 'F' (41 hippocampus samples) versus pool 'A' (60 brain samples) was 
investigated. There are no statistically significant over-/under-expressed segments. 
 At single gene level, an increase of more than 10 times was observed in all the first 10 loci 
(Supporting Information Table S3, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/, 
where the Pool 'F' here is named 'A' and the Pool 'A' here is named 'B'), including LINC00114 
and the known gene SLC44A4, encoding for solute carrier family 44, member 4, which have 
increases of 304.38 and 24.58 (Table 8), respectively. We also observed that in this range of 
expression ratio, two chr21 genes are included: LINC00114 (cited above) and AIRE, encoding 
for an autoimmune regulator, which has a 14.82-fold increase.  
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 Among the genes with the lowest 'F'/'A' expression ratio, a 50-fold decrease was observed 
for the uncharacterized locus, LOC613126, and for the known gene, LCE5A, encoding for late 
cornified envelope 5A (Table 8). 
 Among the chr21 genes, DNAJC28, encoding for DnaJ (Hsp40) homolog, subfamily C, 
member 28, has the lowest 'F'/'A' expression ratio (0.03), followed by two long non-coding 
RNAs, LINC00323 (0.12) and LINC00320 (0.16) (Table 8). 
 
Table 8 List of the five most over- or under-expressed genes (all significantly, with q<0.05, except genes with a 
note) in the hippocampus (pool 'F') vs. whole brain (pool 'A') transcriptome map.  
 
Gene name Value 'F' Value 'A' Ratio 
'F'/'A' 
Location Data 
points 
'F' 
Data 
points 
'A' 
SD as % of 
expression 
'F' 
SD as % of          
expression 
'A' 
Over-expressed genes     
LINC00114 2,304.90 7.57 304.38 21q22.2 11 14 51.35 31.53 
SLC44A4 269.98 10.98 24.58 6p21.3 80 74 261.98 41.67 
ACTA1 248.91 15.10 16.48 1q42.13 41 47 387.16 48.11 
IL10 151.36 9.42 16.07 1q31-q32 47 84 188.63 44.91 
ANKRD20A1 193.75 12.07 16.06 9q13 30 29 153.49 115.47 
Over-expressed chr21 genes 
LINC00114 2,304.90 7.57 304.38 21q22.2 11 14 51.35 31.53 
AIRE 351.73 23.74 14.82 21q22.3 52 62 202.59 66.93 
Hs.721038a 102.77 18.96 5.42 21q22.3 24 18 55.02 66.11 
Hs.385528b 82.10 17.36 4.73 21q22.2 17 18 46.17 38.78 
Hs.661896a 106.91 25.30 4.23 21q21.1 19 36 37.47 56.48 
Under-expressed genes     
LOC613126 14.89 651.08 0.02 7q21.2 17 21 22.79 250.64 
LCE5Aa 22.50 946.89 0.02 1q21.3 10 14 46.27 108.63 
DNAJC28 30.45 878.57 0.03 21q22.11 39 57 180.59 267.82 
GGT6 25.65 714.15 0.04 17p13.2 10 25 20.25 173.34 
ILDR1 22.35 544.13 0.04 3q13.33 58 58 39.07 350.19 
Under-expressed chr21 genes 
DNAJC28 30.45 878.57 0.03 21q22.11 39 57 180.59 267.82 
LINC00323 15.39 133.49 0.12 21q22.2 26 26 48.79 167.83 
LINC00320 59.71 379.16 0.16 21q21.1 49 43 70.95 139.33 
IFNAR1 52.06 148.85 0.35 21q22.11 89 102 59.67 484.24 
LOC101060027b 90.45 257.07 0.35 21q22.11 24 18 30.82 65.02 
 
Value: mean gene expression value normalized across all the pool samples; Data points: number of spots associated 
to an expression value for the locus; SD: standard deviation for the expression value expressed as a percentage of 
the mean. Over-expressed genes are sorted by decreasing gene expression ratio, under-expressed genes are sorted by 
increasing gene expression ratio. Full results are available as supplementary material (see text). a This gene is one of 
the five most over-/under-expressed ones, but the value is not statistically significant. This is either because this 
gene was present with other genes even in the 12,500 bp segment, and its expression value does not prevail over the 
others, or because the segment containing the gene does not fulfil criteria for local over-/underexpression, or 
because its expression value is not associated to at least 5 data points. b Cytoband not available in Gene was derived 
from the UCSC Genome Browser (http://genome-euro.ucsc.edu/cgi-bin/hgGateway).   
 
4.1.9 Male hippocampus vs. Female hippocampus transcriptome map analysis 
 
 The hippocampus samples for which the sex of the sample donor was available were 
grouped into two additional datasets: pool 'F.1' including 15 male samples and pool 'F.2' 
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including 14 female samples, and the corresponding transcriptome maps were generated and 
compared. 
 The gene expression value for each of the 26,045 loci of the male and female hippocampus 
transcriptome map (Supporting Information Table S4, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/, 
where the Pool 'F.1' here is named 'A.1' and the Pool 'F.2' here is named 'A.2') is available. The 
differential transcriptome map produced a gene expression ratio for each of the 26,045 shared loci 
(Supporting Information Table S4, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). 
 Results included 3 significantly over-expressed and 3 significantly under-expressed 
segments. The genome segment that has the highest statistically significant expression value is 
on chromosome Y (Yq11.21-q11.221), including the known genes TTTY15, USP9Y and DDX3Y 
encoding respectively for testis-specific transcript, Y-linked 15 (non-protein coding), ubiquitin 
specific peptidase 9, Y-linked and DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked (Table 9). 
 The genome segment that has the lowest statistically significant expression value is on 
chromosome X (Xq13.2), including the EST clusters Hs.720466 and Hs.648496 and the known 
genes XIST, JPX and FTX, encoding respectively for the X inactive specific transcript, the JPX 
transcript (XIST activator) and the FTX transcript (XIST regulator) (Table 9) (supplementary full 
results for transcriptome maps are available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/).  
  
Table 9 Genomic segments significantly over-/under-expressed in male hippocampus (pool 'F.1') vs. female 
hippocampus (pool 'F.2'). 
 
Chra and 
Location 
Segment 
Startb 
Segment 
Endb 
Value 
'F.1'/'F.2' 
q-value 
 
Genes in the 
segmentc 
 
Over-expressed segments 
chrY 
Yq11.21-
q11.221d 
14,750,001 15,250,000 2.54 0.000061 TTTY15, USP9Y, 
DDX3Y 
chrY 
Yq11.221 
22,250,001 22,750,000 2.25 0.000023 TTTY10, EIF1AY, 
Hs.670544 
Under-expressed segments 
chrX 
Xq13.2 
73,000,001 73,500,000 0.72 0.00000014 XIST, JPX, 
Hs.720466, 
Hs.648496, FTX, 
Hs.625698 
chr6 
6q25.3 
158,500,001 159,000,000 0.78 0.00029 Hs.633361, TULP4, 
TMEM181 
 
Analysis was performed using default parameters (see "Materials and Methods" section). Over-expressed segments 
are sorted by decreasing expression ratio, under-expressed segments are sorted by increasing expression ratio. In the 
'Map' mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they 
have an expression value. For simplicity, some segments are not shown because they overlap with those highlighted 
in one of the listed regions. The complete results for these models are available as online supplementary material 
(see text). a Chromosome. b Segment Start/End: chromosomal coordinates for each segment. c Significantly over-
/under-expressed genes as marked in the TRAM results. d Cytoband not available in Gene was derived from the 
UCSC Genome Browser (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
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 At single gene level, a more than ten-fold increase was observed in all the first 7 loci 
(Supporting Information Table S4, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). 
In particular, a more than 20-fold increase was observed for the known genes CKM (22.09) and 
ACTA1 (20.20), encoding respectively for creatine kinase, muscle, and for actin, alpha 1, skeletal 
muscle (Table 10).  
 Among the genes with the lowest 'F.1'/'F.2' expression ratio, an approximately 3-fold 
decrease was observed for example for the known genes HBG2 (0.30) and XIST (0.36), encoding 
respectively for the hemoglobin, gamma G, and for the X inactive specific transcript (Table 10). 
 
Table 10 List of the ten most over- or under-expressed genes (all significantly, with q<0.05 except the genes with a 
note) in male hippocampus (pool 'F.1') vs. female hippocampus (pool 'F.2').  
 
Gene name Value 
'F.1' 
Value 
'F.2' 
Ratio 
'F.1'/'F.2' 
Location Data 
points 
'F.1' 
Data 
points 
'F.2' 
SD as % of 
expression 
'F.1' 
SD as % of          
expression 
'F.2' 
Over-expressed genes 
CKM 387.51 17.55 22.09 19q13.32 15 14 247.78 30.96 
ACTA1 609.79 30.19 20.20 1q42.13 15 14 254.15 33.04 
RPS4Y1 370.50 20.97 17.67 Yp11.3 10 12 29.33 49.16 
MB 501.88 30.76 16.31 22q13.1 15 14 249.69 36.76 
MYL2 264.97 20.56 12.89 12q24.11 15 14 237.04 61.73 
MYH2 247.98 20.09 12.34 17p13.1 15 14 240.86 57.98 
TNNC2 363.55 31.10 11.69 20q12-
q13.11 
15 14 240.49 47.18 
TNNC1 109.26 12.16 8.99 3p21.1 15 14 219.80 34.82 
MYL1 176.50 21.52 8.20 2q33-q34 18 16 252.73 58.72 
MYLPF 216.10 32.82 6.58 16p11.2 15 14 218.34 76.14 
Under-expressed genes 
HBG2 81.26 270.10 0.30 11p15.5 19 22 67.38 175.46 
HBG1a 47.30 141.97 0.33 11p15.5 15 14 46.22 198.87 
XIST 215.35 606.58 0.36 Xq13.2 101 106 440.74 144.55 
RASEF 160.55 445.96 0.36 9q21.32 50 56 144.19 140.79 
FOLR1 287.61 717.29 0.40 11q13.3-
q14.1 
28 28 172.21 139.81 
Hs.594321a  278.32 688.73 0.40 4p16.3 7 10 41.83 48.67 
ANKRD36B 173.30 416.30 0.42 2q11.2 7 10 41.79 59.77 
Hs.655766 68.35 155.26 0.44 16p13.3 7 10 50.36 19.13 
Hs.744460 106.08 230.08 0.46 9q31.2 12 12 107.01 85.27 
LOC100996667b 58.82 122.18 0.48 9p12 7 10 50.50 49.53 
 
Value: mean gene expression value normalized across all the pool samples; Data points: number of spots associated 
to an expression value for the locus; SD: standard deviation for the expression value expressed as a percentage of 
the mean. Over-expressed genes are sorted by decreasing gene expression ratio, under-expressed genes are sorted by 
increasing gene expression ratio. Full results are available as supplementary material (see text). a This gene is one of 
the five most over-/under-expressed ones, but the value is not statistically significant. This is either because this 
gene was present with other genes even in the 12,500 bp segment, and its expression value does not prevail over the 
others, or because the segment containing the gene does not fulfil criteria for local over-/under-expression, or 
because its expression value is not associated to at least 5 data points. b Cytoband not available in Gene was derived 
from the UCSC Genome Browser (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
 
 Bivariate analysis of the statistical correlation between the gene expression values of the 
hippocampus transcriptome map in male and in female cells was performed (Figure 2). The 
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results showed a significant statistical correlation of data (r=0.98, p-value<0.0001) confirming 
the large overlapping of results between the two transcriptome maps, with the exception of 
single genes with a well-known sex-biased expression pattern. 
 
 
Figure 2 Bivariate analysis between the gene expression values of the hippocampus transcriptome map in male and 
in female cells (Supporting Information Table S4, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). 
The fit line is shown; Pearson correlation coefficient is 0.98 and p-value<0.0001. 
 
 
4.1.10 Heart and Heart vs. Pool of tissues minus heart transcriptome map analysis 
 
 In the heart transcriptome map analysis we check if the mean value provided by TRAM for 
the locus does not arise  from a small number of extreme values included in the whole 
expression values attributed to the locus which may either be from biological variability or 
technical artefacts of hybridization due to the different probes in the different experimental 
platforms. In any case this possibility occurs in a smaller fraction of the loci (for example, only 
3.8% of the loci has an SD>200 when expressed as % of the mean value, i.e. greater than twice 
the mean value). 
 Therefore, we decided to exclude from the results discussed in the manuscript those over- or 
under-expressed genes and segments containing genes whose expression values could be 
affected by a discrepancy between the values obtained with different probes assigned by the 
manufacturer to the same gene due to clear technical artefacts of hybridization. 
 In the analysis of the transcriptome map, 919,771 data points corresponding to 43,360 
mapped loci were included (Table III in the Data Supplement, it is available at: 
http://apollo11.isto.unibo.it/heart, where the Pool 'G' here is named 'A'; in the event of 
acceptance of the manuscript it will be available at: http://apollo11.isto.unibo.it/suppl/). 11,474 
data points of the map corresponded to 626 chr21 mapped loci. Results obtained by analysis 
included 36 significantly over-expressed segments.  
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 The genome segment that has the highest statistically significant expression value is on 
chromosome 1 (1p36) (Table 11), including the over-expressed known genes NPPA and NPPB 
encoding respectively for the natriuretic peptide A and B, and MFN2, encoding for mitofusin 2. 
 There are no significantly under-expressed segments. 
 
Table 11 The first five genomic segments significantly over-expressed in the whole heart (pool 'G') transcriptome 
map. 
 
Whole heart transcriptome map 
Chra and 
Location 
Segment 
Startb 
Segment 
Endb 
Value 
'G' 
q-value Genes in the segmentc 
Over-expressed segments 
chr1 
1p36 
11,750,001 12,250,000 677.02 0.0085 NPPA, NPPB, MFN2 
chr14 
14q11.2 
23,500,001 24,000,000 634.92 0.027 PSMB5, MYH6, MYH7 
chr18 
18p11.31 
3,000,001 3,500,000 585.88 0.0022 MYOM1, MYL12A, 
Hs.569882, MYL12B 
chr1 
1q43 
236,750,001 237,250,000 567.02 0.00046 ACTN2, Hs.601529, 
MT1HL1, RYR2 
chr11 
11q23.1 
111,750,001 112,250,000 513.29 0.0016 CRYAB, HSPB2, 
TIMM8B, SDHD, 
Hs.356270 
 
Analysis was performed using default parameters (see "Results" section). Segments are sorted by decreasing 
expression value in the heart transcriptome map. In the 'Map' mode, TRAM displays UniGene EST clusters (with 
the prefix "Hs." in the case of H. sapiens) only if they have an expression value. For simplicity, some segments are 
not shown because they overlap with those highlighted in one of the listed regions. The complete results for these 
models are available as online supplementary material (see text). a Chromosome. The segment location cytoband 
was derived from that of the first mapped gene within the segment.  b Segment Start/End: chromosomal coordinates 
for each segment. c Significantly over-/under-expressed genes as marked in the TRAM results.   
 
 
 At single gene level, the known gene MYL2, encoding for the myosin, light chain 2, 
regulatory, cardiac, slow protein, has the highest expression value (10,216.56), followed by the 
known genes MYH7 (8,725.76) and MB (8,283.87), encoding respectively for myosin, heavy 
chain 7, cardiac muscle, beta protein and the myoglobin (Table 12). The EST cluster Hs.738508 
has the lowest expression value (2.21).  
 Among the genes of chromosome 21, the known gene ATP5J, encoding for ATP synthase, 
H+ transporting, mitochondrial Fo complex, subunit F6, has the highest expression value 
(2,254.25), followed by ATP5O (2,205.50) and SOD1 (1,212.50), encoding respectively for ATP 
synthase, H+ transporting, mitochondrial F1 complex, O subunit and for superoxide dismutase 1, 
soluble (Table 12). The lowest expression value belongs to the EST cluster Hs.59471 (4.71) 
(Table 12). 
 
 
 
 
 
 
	  	   47	  	  	  	  
Table 12 List of the five most over- and under-expressed genes (all significantly, with q<0.05, except genes with a 
note) in the whole heart (pool 'G') transcriptome map.   
 
Whole heart transcriptome map 
Gene name Value 'G' Location Data points  
'G' 
SD as % of 
expression 'G' 
Over-expressed genes 
MYL2 10,216.56 12q24.11 33 41.46 
MYH7 8,725.76 14q12 20 63.16 
MB 8,283.87 22q13.1 39 59.23 
TCAPa  6,352.89 17q12 20 112.52 
NPPAa  6,332.35 1p36.21 18 77.72 
Over-expressed chr21 genes 
ATP5J 2,254.25 21q21.1 36 84.88 
ATP5O 2,205.50 21q22.11 34 72.59 
SOD1a  1,212.50 21q22.11 58 52.38 
Hs.129621a  1,128.12 21q22.3b 7 88.92 
Hs.664516a 773.63 21q22.11b 7 258.34 
Under-expressed genes 
Hs.738508a 2.21 8q24.12b 10 56.07 
C3orf80 2.57 3q25.33 8 39.74 
Hs.156135 2.58 1q32.1b 8 58.55 
Hs.644952a 2.72 6q23.3b 5 36.55 
Hs.637980a 2.82 11q13.4b 10 48.33 
Under-expressed chr21 genes 
Hs.59471a 4.71 21q22.12b 7 23.51 
Hs.596883a 4.84 21q22.3b 8 42.32 
Hs.665969a 4.93 21q22.3b 14 35.08 
Hs.661911a 4.93 21q22.3b 7 64.42 
Hs.603678 a 5.00 21q22.3b 8 57.32 
 
Value: mean gene expression value normalized across all the pool samples; Data points: number of spots associated 
to an expression value for the locus; 'SD': standard deviation for the expression value expressed as a percentage of 
the mean. Over-expressed genes are sorted by decreasing gene expression value, under-expressed genes are sorted 
by increasing gene expression value. Analysis was performed using default parameters (see "Results" section). Full 
results are available as supplemental data (see text). a This gene is one of the five most over-/under-expressed, but 
the value is not statistically significant. This is either because this gene was present with other genes even in the 
12,500 bp segment and its expression value does not prevail over the others, or because the segment containing the 
gene does not fulfil criteria for local over-/under-expression, or because its expression value is not associated to at 
least 5 data points. b Cytoband not available in Gene was derived from the UCSC Genome Browser (http://genome-
euro.ucsc.edu/cgi-bin/hgGateway).  
 
 
In the analysis of the heart vs. pool of tissues minus heart transcriptome map, regional 
differential expression of pool 'G' (32 heart samples) versus pool 'H' (629 samples) was 
investigated. Results obtained by analysis included 13 significantly over-/under-expressed 
segments: nine of them are over-expressed, four are under-expressed. The genome segment that 
has the highest statistically significant expression ratio is on chromosome 1 (1q43) (Table 13), 
including the over-expressed known genes ACTN2 and RYR2, encoding respectively for actinin, 
alpha 2 and ryanodine receptor 2 (cardiac), and the EST cluster Hs.601529. The genome 
segment that has the lowest statistically significant expression ratio is on chromosome 4 (4p21.1) 
(Table 13), including the under-expressed known genes: STATH, encoding for statherin, HTN3, 
encoding for histatin 3, HTN1, encoding for histatin 1, FDCSP, encoding for follicular dendritic 
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cell secreted protein, and SMR3B encoding for submaxillary gland androgen regulated protein 
3B. 
 
Table 13 The genomic segments significantly over-/under-expressed in the whole heart (pool 'G') vs. pool of tissues 
minus heart (pool 'H') differential transcriptome map. 
 
 
Analysis was performed using default parameters (see "Results" section). Over-expressed segments are sorted by 
decreasing 'G'/'H' ratio, under-expressed segments are sorted by increasing 'G'/'H' ratio. In the 'Map' mode, TRAM 
displays UniGene EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they have an expression 
value. For simplicity, some segments are not shown because they overlap with those highlighted in one of the listed 
regions. The complete results for these models are available as online supplemental data (see text). a Chromosome. 
The segment location cytoband was derived from that of the first mapped gene within the segment. b Segment 
Start/End: chromosomal coordinates for each segment. c Significantly over-/under-expressed genes as marked in the 
TRAM results.  
 
 
 At single gene level, an increase of more than 10 times was observed in all the first 129 loci, 
mostly including  known genes with known cardiac function (see Table 14 in the text and Table 
IV in the Data Supplement. The last is available at: http://apollo11.isto.unibo.it/heart, where the 
Pool 'G' here is named 'A' and the Pool 'H' here is named 'B'; in the event of acceptance of the 
manuscript it will be available at: http://apollo11.isto.unibo.it/suppl/will be available at: 
http://apollo11.isto.unibo.it/suppl/).  
 We also observed that in this range of expression ratio, one chr21 locus is included: the EST 
cluster Hs.664516 (18.28-fold increase) (Table 14).  
 Among the genes with the lowest 'G'/'H' expression ratio, a 100-fold decrease was observed 
for the EST cluster Hs.663101 and for the known gene ZG16B, encoding for zymogen granule 
protein 16B (Table 14). Among the chr21 genes, the known gene DSCR9, encoding for Down 
syndrome critical region 9 (non-protein coding) has the lowest 'G'/'H' expression ratio, preceded 
by three EST clusters (Table 14). 
Whole heart vs. Pool of tissues minus heart differential transcriptome map 
Chra and 
Location 
Segment 
Startb 
Segment 
Endb 
Value 
'G'/'H' 
q-value 
 
Genes in the segmentc 
 
Over-expressed segments 
chr1 
1q43 
236,750,001 237,250,000 15.78 0.00076 ACTN2, Hs.601529, 
RYR2 
chr1 
1p36 
11,750,001 12,250,000 14.41 0.0064 NPPA, NPPB, MFN2 
chr14 
14q12-q13 
34,000,001 34,500,000 4.22 0.00014 NPAS3, EGLN3, 
Hs.664985 
chr4 
4q35.1 
186,500,001 187,000,000 3.08 0.00027 SORBS2, Hs.481342, 
Hs.658732 
Under-expressed segments 
chr4 
4q21.1 
70,750,001 71,250,000 0.30 0.000026 STATH, HTN3, HTN1, 
FDCSP, SMR3B 
chr14 
14q32.13 
94,750,001 95,250,000 0.33 0.0029 SERPINA1, 
SERPINA11, 
SERPINA5 
chr8 
8p23.1 
6,750,001 7,250,000 0.34 0.00005 DEFA6, DEFA4, 
DEFA1, DEFA5 
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Table 14 List of the five most over- or under-expressed genes (all significantly, with q<0.05, except genes with a 
note) in the whole heart (pool 'G') vs. pool of tissue minus heart (pool 'H') differential transcriptome map.  
 
Whole heart vs. Pool of tissues minus heart differential transcriptome map 
Gene name Value 
'G' 
Value 
'H' 
Ratio 
'G'/'H' 
Location Data 
points 
'G' 
Data 
points 
'H' 
SD as % of 
expression 
'G' 
SD as % of          
expression 
'H' 
Over-expressed genes     
TNNI3a 4,648.05 23.33 199.26 19q13.4 26 568 76.26 207.39 
Hs.603146a b 1,745.82 10.13 172.32 16q24.2 7 73 263.69 78.91 
Hs.599556a b 1,666.76 10.62 156.91 9q22 7 73 263.38 87.26 
Hs.374521b 1,362.16 10.52 129.43 Xq13.1 7 73 263.11 56.11 
TNNT2 3,947.73 37.86 104.27 1q32 54 933 52.86 803.58 
Over-expressed chr21 genes 
Hs.664516a b 773.63 42.33 18.28 21q22.11 7 73 258.34 65.20 
ATP5O 2,205.50 382.56 5.77 21q22.11 34 1279 72.59 113.36 
UMODL1 25.68 6.71 3.83 21q22.3 23 335 102.67 112.05 
C21orf90a 82.59 22.84 3.62 21q22.3 25 720 411.67 69.30 
ATP5J 2,254.25 648.88 3.47 21q21.2 36 575 84.88 77.51 
Under-expressed genes     
Hs.663101a b 7.99 598.63 0.01 13q32.3 7 73 44.38 374.51 
ZG16B 10.54 708.46 0.01 16p13.3 21 416 70.61 316.85 
BPIFB1 6.89 456.21 0.02 20q11.21 25 462 87.51 401.41 
Hs.605373b 5.12 316.85 0.02 15q15-
q21.1 
7 73 46.73 383.85 
Hs.720020b 7.19 399.14 0.02 10q22.3 10 73 46.82 411.17 
Under-expressed chr21 genes 
Hs.721038a b 6.40 81.31 0.08 21q22.3 6 355 68.88 114.43 
Hs.663673a b 22.63 190.27 0.12 21q22.2 5 420 79.54 100.55 
Hs.709790a b 34.58 265.04 0.13 21q22.11 5 425 156.19 105.62 
DSCR9 5.39 38.12 0.14 21q22.13 24 405 77.30 80.44 
TMPRSS2 13.97 96.85 0.14 21q22.3 58 1821 90.39 328.48 
 
Value: mean gene expression value normalized across all the pool samples; Data points: number of spots associated 
to an expression value for the locus; SD: standard deviation for the expression value expressed as a percentage of 
the mean. Over-expressed genes are sorted by decreasing gene expression ratio, under-expressed genes are sorted by 
increasing gene expression ratio. Analysis was performed using default parameters (see "Results" section). Full 
results are available as supplemental data (see text). a This gene is one of the five most over-/under-expressed, but 
the value is not statistically significant. This is either because this gene was present with other genes even in the 
12,500 bp segment and its expression value does not prevail over the others, or because the segment containing the 
gene does not fulfil criteria for local over-/under-expression, or because its expression value is not associated to at 
least 5 data points. b Cytoband not available in Gene was derived from the UCSC Genome Browser (http://genome-
euro.ucsc.edu/cgi-bin/hgGateway).  
 
 
4.1.11 Gene expression level in the heart and association to cardiac mutant phenotypes 
  
 Differential expression data were available in the TRAM 'G'/'H' table for 101 potassium 
channel encoding genes (named by a KCN- root). The certain or suspected association to a 
cardiac phenotype has been recorded (Table V in the Data Supplement, it is available at: 
http://apollo11.isto.unibo.it/heart, where the Pool 'G' here is named 'A' and the Pool 'H' here is 
named 'B'; in the event of the acceptance of the manuscript it will be available at: 
http://apollo11.isto.unibo.it/suppl/). It may be observed a clear clustering of gene associated to 
multiple cardiac phenotypes, when mutated, in the group of genes with the higher heart/non-
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cardiac tissues expression ratio. In particular, following establishment of the arbitrary threshold 
of 1.5 ratio to define specific over-expression in the heart, 15 genes were expressed greater than 
1.5 folds in the heart in comparison with non-cardiac tissues and 86 were expressed lower than 
1.5 fold. Among the first group, 33.3% of the genes have been associated to known human 
arrhythmias (5 out of 15), but the association was seen only in 5.8% (5 out of 86) of the genes in 
the second group (p=0.006 by Fisher's exact test). A group of potassium receptor genes 
associated to non-cardiac, neurological phenotypes (KCNB1 and KCNA2, epileptic 
encephalopathy, early infantile; KCNMA1, generalized epilepsy and paroxysmal dyskinesia; 
KCNA1, episodic ataxia/myokymia syndrome) has been found in the lower range of heart/non-
cardiac tissues expression ratio (0.28-0.29). Searches in the previously reported quantitative 
transcriptome map for the human brain (Caracausi et al., 2014) revealed that these genes are 
instead actually over-expressed in the human brain in comparison to non-brain tissues, at a ratio 
of 3.2 (KCNB1), 2.8 (KCNA2), 2.2 (KCNA1) and 1.4 (KCNMA1). 
 
 
4.1.12 Validation of TRAM map results through Real-Time RT-PCR  
 
 In order to confirm the results of our meta-analysis study, we performed "Real Time" RT-
PCR experiments which are useful for validating the transcriptome maps of whole brain, 
cerebellum, cerebral cortex, hippocampus and whole heart. The primer pairs used to validate 
results are listed in Table 15. 
 
Table 15 Primer pairs used to validate TRAM Maps.  
 
Gene Symbol Gene Name RefSeq RNA 
GenBank 
Accession No. 
Primer pairs sequence 
(5´→  3´)a 
RT-PCR 
product size 
(base pair) 
BCYRN1 
 
 
TUBA1B 
 
 
SOD1 
 
 
BEX5 
 
 
RCAN1 
 
 
GPCPD1 
 
 
 
 
Brain cytoplasmic RNA 1 
 
 
Tubulin, alpha 1b 
 
 
Superoxide dismutase 1, 
soluble 
 
Brain expressed, X-linked 5 
 
 
Regulator of calcineurin 1 
 
 
Glycerophos-phocholine 
phosphodiesterase GDE1 
homolog (S. cerevisiae) 
 
 
NR_001568 
 
 
NM_006082 
 
 
NM_000454 
 
 
NM_001012978 
 
 
NM_004414 
 
 
NM_019593 
 
 
 
 
tagcgagaccccgttctccag 
gttgctttgagggaagttacgc 
 
cctcgactcttagcttgtcgg 
aggcagtagagctcccagcag 
 
tagcgagttatggcgacgaag 
ggtacagcctgctgtattatctc 
 
gtggtagaagctgacccctgag 
gctcctggtattcaccacctc 
 
ctggagcttcattgactgcgag 
gtgatgtccttgtcatacgtcc 
 
actcatggacctcagatctcg 
ggatcattggtatcatcaccc 
 
 
 
82 
 
 
159 
 
 
186 
 
 
226  
 
 
153 
 
 
174  
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OPRD1 
 
 
TBX18 
 
 
PABPN1L 
 
 
 
NPTX1 
 
 
NUAK1 
 
 
NTNG1 
 
 
ANKRD55 
 
 
GAPDH 
 
 
NCDN 
 
 
SERPFIN1 
 
 
 
 
INADL 
 
 
MYL2 
 
 
NDUFA4 
 
 
RYR2 
 
 
LRP5 
 
 
SVOP 
 
Opioid receptor, delta 1 
 
 
T-box 18 
 
 
Poly(A) binding protein, 
nuclear 1-like (cytoplasmic) 
 
 
Neuronal pentraxin 1 
 
 
NUAK family, SNF1-like 
kinase, 1 
 
Netrin G1 
 
 
Ankyrin repeat domain 55 
 
 
Glyceraldehyde-3-phosphate 
dehydrogenase 
 
Neurochondrin 
 
 
Serpin peptidase inhibitor, 
clade F (alpha-2 antiplasmin, 
pigment epithelium derived 
factor), member 1 
 
InaD-like (Drosophila) 
 
 
myosin, light chain 2, 
regulatory, cardiac, slow 
 
NDUFA4, mitochondrial 
complex associated 
 
ryanodine receptor 2 (cardiac) 
 
 
low density lipoprotein 
receptor-related protein 5 
 
SV2 related protein homolog 
(rat) 
NM_000911 
 
 
NM_001080508 
 
 
NM_001080487 
 
 
 
NM_002522 
 
 
NM_014840 
 
 
NM_001113226 
 
 
NM_024669 
 
 
NM_002046 
 
 
NM_001014839 
 
 
NM_002615 
 
 
 
 
NM_176877 
 
 
NM_000432 
 
 
NM_002489 
 
 
NM_001035 
 
 
NM_002335 
 
 
NM_018711 
ctgggcaacgtgcttgtcatg 
catcaggtacttggcactctg 
 
ctcgggggagacttggatgag 
ctgattctgataggcagtgacg 
 
aggagaaggtggaggctgacc 
gtccagagaacttgtcacacag 
 
 
gggcaaactttgcaatcgctc 
tctcctcggtgtcgttcctg 
 
tcaatgggagaccttaccgag 
tactctccgctgctgatttg 
 
gaaagtgaaactcgatcctccg 
ctcgcatcacactcattattgc 
 
ggcttgaaggctgtgtgagtc 
gcagcatttgtgtgtgttgaggc 
 
caacgaccactttgtcaagc 
ctgtgaggaggggagattca 
 
ctgccacatcttcctcaacctc 
ccagggtggccacattagcag 
 
ggctgtctccaacttcggcta 
cggtgaatgatggattctgttcg 
 
 
 
ctcacacttcagcagtccatc 
ggaaccatctgtgaacactaac 
 
gcgagtgaacgtgaaaaatgaag 
gaatggtttcctcagggtccg 
 
aacaaactgggtcccaatgatc 
ttgtgcggatgtggcttctgg 
 
gaaacagaacacacaggacagg 
gctggtcttcatactgtttccg 
 
cttcccgcacgagtatgtcag 
agctcatcatggactttccgc 
 
tgcatttgcgcccgtgtatag 
acctcgaacactgtcccgatg 
141  
 
 
247  
 
 
141  
 
 
 
193  
 
 
139  
 
 
102  
 
 
228  
 
 
214  
 
 
155  
 
 
150  
 
 
 
 
 117 
 
 
128 
 
 
151 
 
 
109 
 
 
116 
 
 
174 
 
a Top: forward primer; bottom: reverse primer (for each gene). 
 
 
 Using criteria as described in the "Material and Method" section above, we selected 9 genes 
from the adult brain transcriptome map: BCYRN1, TUBA1B, SOD1, BEX5, RCAN1, GPCPD1, 
OPRD1, TBX18 and PABPN1L. BEX5 gene was chosen as reference gene. The in vitro observed 
gene expression ratios between each target gene and the reference gene are provided in Table 16.  
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Table 16 Selected genes to validate in vitro through Real-Time RT-PCR the whole adult brain, cerebellum, cerebral 
cortex, hippocampus and heart transcriptome maps.  
 
Official Gene 
Symbol 
Official Gene Name EEV SD ER Ct 
mean 
OR 
Brain 
BCYRN1 Brain cytoplasmic RNA 1 7,875.54 13.02 12.80 18.67   14.22 
TUBA1B Tubulin, alpha 1b 4,876.25 55.86   8.00 19.63      7.31 
SOD1 Superoxide dismutase 1, 
soluble 
1,727.39 55.37   2.80 20.12      5.21 
BEX5 Brain expressed, X-linked 5 615.23 81.22   1.00 22.05      1.00 
RCAN1 Regulator of calcineurin 1 212.66 218.52   0.34 24.10      0.33 
GPCPD1 Glycerophosphocholine 
phosphodiesterase GDE1 
homolog (S. cerevisiae) 
63.29 92.61   0.10 26.08      0.084 
OPRD1 Opioid receptor, delta 1 27.07 217.68   0.044 29.69      0.0068 
TBX18 T-box18 9.65 61.70   0.015 29.92      0.0058 
PABPN1L Poly(A) binding protein, 
nuclear 1-like 
4.57 8.77   0.007 34.09      0.00032 
Cerebellum 
TUBA1B Tubulin, alpha 1b 2,991.80 35.16   7.05 20.26    20.53 
NPTX1 Neuronal pentraxin 1 1,081.87 86.51   2.55 22.53      4.26 
NUAK1 NUAK family, SNF1-like 
kinase, 1 
424.37 41.82   1.00 24.62      1.00 
RCAN1 Regulator of calcineurin 1  142.60 166.56   0.34 23.41      2.31 
GPCPD1 Glycerophosphocholine 
phosphodiesterase GDE1 
homolog (S. cerevisiae)  
 
167.03 95.59   0.39 
 
23.32      2.46 
NTNG1 Netrin G1 39.16 74.20   0.090 26.38      0.30 
ANKRD55 Ankyrin repeat domain 55 17.19 52.41   0.041 31.34      0.010 
TBX18 T-box 18 8.96 122.35   0.021 28.74      0.058 
Cerebral cortex 
TUBA1B Tubulin, alpha 1b 6,343.86 43.54   7.99 18.50   55.72 
GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase  
2,947.49 103.08   3.71 17.31 127.12 
NUAK1 NUAK family, SNF1-like 
kinase, 1 
793.97 62.54   1.00 24.30     1.00 
NCDN Neurochondrin 333.60 125.52   0.42 22.35     3.86 
SERPINF1 Serpin peptidase inhibitor, 
clade F (alpha-2 antiplasmin, 
pigment epithelium derived 
factor), member 1 
131.02 59.12   0.17 24.29     1.0070 
RCAN1 Regulator of calcineurin 1 81.21 90.00   0.10 24.00     1.23 
OPRD1 Opioid receptor, delta 1  42.71 80.72   0.13 27.77     0.090 
INADL InaD-like (Drosophila) 22.34 71.29   0.07 29.32     0.031 
Hippocampus 
TUBA1B Tubulin, alpha 1b 4,488.91 44.32   2.7 19.59     2.43 
SOD1 Superoxide dismutase 1 1,647.81 28.92   1 20.87     1 
NPTX1 Neuronal pentraxin 1 725.04 96.81   0.44 22.86     0.25 
NUAK1 NUAK family SNF1-like 
kinase 1 
522.06 110.21   0.32 24.44     0.084 
SERPINF1 Serpin peptidase inhibitor, 
clade F (alpha-2 antiplasmin, 
pigment epithelium derived 
factor), member 1 
255.58 283.85   0.16 24.36     0.089 
NTNG1 Netrin G1 54.11 91.87 0.033 26.27     0.024 
INADL InaD-like (Drosophila) 24.57 57.20 0.015 28.49     0.005 
Heart 
MYL2 myosin, light chain 2, 
regulatory, cardiac, slow 
10,216.56 41.46 28.34 16.25 111.43 
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NDUFA4 
 
NDUFA4, mitochondrial 
complex associated 
3,706.51 53.98 10.28 18.47   23.92 
RYR2 ryanodine receptor 2 
(cardiac) 
1,213.96 101.7 3.37 23.16     0.93 
SERPINF1 
 
Serpin peptidase inhibitor, 
clade F (alpha-2 antiplasmin, 
pigment epithelium derived 
factor), member 1 
360.44 66.62   1 23.05     1 
RCAN1 regulator of calcineurin 1 154.34 142.4 0.43 26.97     0.07 
LRP5 
 
low density lipoprotein 
receptor-related protein 5 
55.83 198.22 0.15 26.29     0.11 
SVOP SV2 related protein homolog 
(rat) 
19.86 58.48 0.06 32.49     0.0014 
 
In bold the gene chosen as reference, underlined genes having a high standard deviation for each map. From left to 
right: official gene symbol of selected gene; official full gene name; expected expression value (EEV), i.e. 
expression value as provided by TRAM software; standard deviation (SD) as percentage of expression; expected 
ratio (ER) between reference and target gene expression value; threshold cycle (Ct) provided by BioRad CFX 
Manager Software 2.1 manually positioning the threshold line; observed ratio (OR) determined between each target 
gene and the reference gene using the delta Ct (ΔCt) method, according to the formula: 2ΔCt= 2 Ctref - Cttarget. 
 
 
The correlation between the observed and expected gene expression ratios as calculated by 
bivariate analysis was statistically highly significant (Pearson correlation coefficient= 0.98 and 
p-value= 0) (Figure 3a). 
 
 
 
Figure 3 Bivariate analysis between observed (Real Time RT-PCR) and expected (TRAM) expression ratio in brain 
of selected genes (Table 16). a The fit line and a 95% bivariate normal density ellipse are shown; Pearson 
correlation coefficient is 0.98 and p-value<0.0001. b The fit line and a 95% bivariate normal density ellipse 
determined after the exclusion from the statistical analysis of those genes having a high standard deviation (SD as 
percentage of expression >95) of expected expression value (Table 16). This step did not affect the correlation 
between the two variables, indeed Pearson correlation coefficient is 0.98 and p-value 0.0001 
 
 
 From the whole cerebellum transcriptome map we selected the 7 genes: TUBA1B, NPTX1, 
NUAK1, RCAN1, GPCPD1, NTNG1, ANKRD55 and TBX18. NUAK1 gene was chosen as 
reference gene. We determined the in vitro observed expression ratio between each target gene 
and the reference gene (Table 16) as discussed above and we determined the correlation through 
a b 
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bivariate analysis. The result was again statistically highly significant (Pearson correlation 
coefficient=0.97 and p-value<0.0001) (Figure  4a). 
 
 
 
Figure 4 Bivariate analysis between observed (Real Time RT-PCR) and expected (TRAM) expression ratio in 
cerebellum of selected genes (Table 16). a The fit line and a 95% bivariate normal density ellipse are shown; 
Pearson correlation coefficient is 0.97 and p-value<0.0001. b The fit line and a 95% bivariate normal density ellipse 
determined after the exclusion from the statistical analysis of those genes having a high standard deviation (SD as 
percentage of expression >95) of expected expression value (Table 16). This step improved the correlation between 
the two variables, indeed Pearson correlation coefficient is 0.98 and p-value 0.0019. 
 
 
 From the whole cerebral cortex transcriptome map we selected the 8 genes: TUBA1B, 
GAPDH, NUAK1, NCDN, SERPINF1, RCAN1, OPRD1 and INADL. NUAK1 gene was chosen 
as reference gene. We determined the in vitro observed expression ratio between each target 
gene and the reference gene (Table 16) as discussed above and we performed the bivariate 
analysis between the expected and the observed ratios. The correlation between the two variables 
was not statistically significant (Figure 5a). When we attempted to exclude those genes that have 
an expected expression value with a high standard deviation (SD as percentage of Expression > 
95) from the statistical analysis, assuming that a high standard deviation implies a greater 
variability in the observed data, the correlation between the two variables became statistically 
highly significant (Pearson correlation coefficient=0.99 and p-value<0.0001) (Figure 5b). 
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Figure 5 Bivariate analysis between observed (Real Time RT-PCR) and expected (TRAM) expression ratio in 
cerebral cortex of selected genes (Table 16). a The fit line and a 95% bivariate normal density ellipse are shown. 
The correlation between the two variables was not statistically significant, the Pearson correlation coefficient is 0.65 
and p-value 0.0762. b The fit line and a 95% bivariate normal density ellipse determined after the exclusion from 
the statistical analysis of those genes having a high standard deviation (SD as percentage of expression >95) of 
expected expression value (Table 16). This step showed an increase of the correlation between the two variables, 
indeed the Pearson correlation coefficient is 0.99 and p-value<0.0001. 
 
 
 Applying this criterion to the previous statistical analysis, we observed that for the adult 
brain data there was no change (Figure 3b), for the whole cerebellum data occurred an increase 
of the Pearson correlation coefficient to 0.98, while the p-value became 0.0019 (Figure 4b). 
Despite these variations, all correlations remained significant. 
 We selected 7 genes from the hippocampus transcriptome map: TUBA1B, SOD1, NPTX1, 
NUAK1, SERPINF1, NTNG1, INADL. SOD1 gene was chosen as reference gene. The primer 
pairs used to validate results are listed in Table 15. The in vitro observed gene expression ratios 
between each target gene and the reference gene are provided in Table 16. The correlation 
between the observed and expected gene expression ratios as calculated by bivariate analysis 
was statistically highly significant: Pearson correlation coefficient is 0.99 and p-value<0.0001 
(Figure 6). 
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Figure 6 Bivariate analysis between observed (Real-Time RT-PCR) and expected (TRAM) expression ratios of 
selected genes in the hippocampus transcriptome map (Table 16). The fit line is shown; Pearson correlation 
coefficient is 0.99 and p-value<0.0001.  
 
 
 We selected 7 genes from the heart transcriptome map: MYL2, NDUFA4, RYR2, SERPINF1, 
RCAN1, LRP5, SVOP. SERPINF1 gene was chosen as reference gene. The primer pairs used to 
validate results are listed in Table 15. The in vitro observed gene expression ratios between each 
target gene and the reference gene are provided in Table 16. The correlation between the 
observed and expected gene expression ratios as calculated by bivariate analysis was statistically 
highly significant: Pearson correlation coefficient is 0.98 and p-value<0.0001 (Figure 7). 
 
 
 
Figure 7 Bivariate analysis between observed (Real-Time RT-PCR) and expected (TRAM) expression ratios of 
selected genes in the whole heart transcriptome map (Table 16). The fit line is shown; Pearson correlation 
coefficient is 0.98 and p-value<0.0001.  
 
 
4.1.13 Housekeeping gene search 
 
 In the pool of normal tissues minus brain transcriptome map, using the lower SD as a 
percentage of the mean value (≤30), two EST clusters (Hs.714416 and Hs.728191) and only one 
known gene (POM121C, encoding for the transmembrane nucleoporin C) were retrieved; while, 
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using the higher SD as a percentage of the mean value at ≤40, 29 genes common to all pool 
tissues fulfilled the selected criteria. By applying functional enrichment analysis with the 
"ToppGene Suite" Gene Ontology tool (Chen et al., 2009), we found that the statistically 
significant (p-value≤0.05) enriched function is structural constituent of ribosome (GO:0003735), 
associated to the RPS17L, MRPL18 and RPS18 genes. Ten out of 29 genes resulted "not found": 
they are the EST clusters.  
 In the adult brain, using the lower SD as a percentage of the mean value (≤30), one EST 
cluster (Hs.705664) and only one known gene (FUNDC1, encoding for an integral mitochondrial 
outer-membrane protein) were retrieved; while, using the higher SD as a percentage of the mean 
value at ≤40, 15 genes fulfilled the selected criteria. By applying functional enrichment analysis, 
we found that the statistically significant (p-value≤0.05) enriched function is unfolded protein 
binding (GO:0051082), associated to the PDRG1 and TTC1 genes. Six out of 15 genes resulted 
"not found": they are the EST clusters.  
 The same thing was done for the foetal brain transcriptome map. In this case, using the 
lower SD as a percentage of the mean value (≤30), 40 genes including some ribosomal proteins 
(MRPS24, MRPS35 and RPS18) were retrieved; while, using the higher SD as percentage of the 
mean value at ≤40, 229 genes came out by the selection. The statistically significant (p-
value≤0.05) enriched function is a structural constituent of ribosome (GO:0003735), associated 
to the MRPL18, RPL23, RPL4, RPS17L, MRPL51, RPS13, MRPL14, MRPS24, RPL24, RPS24, 
RPS18 and MRPL32 genes.  
 Analyzing common results among the three maps: RPS17L, encoding for S17-like ribosomal 
protein, is the only gene common to all three maps; the EST cluster Hs.714416 is common to the 
pool of tissues and adult brain transcriptome maps; PDRG1, encoding for p53 and DNA-damage 
regulated 1, TCEAL8, encoding for transcription elongation factor A (SII)-like 8, and TIMM9, 
encoding for translocase of inner mitochondrial membrane 9 homolog (yeast), are common to 
the foetal brain and brain transcriptome maps; ACTG1, encoding for actin, gamma 1, EMC4, 
encoding for ER membrane protein complex subunit 4, MRPL18, encoding for mitochondrial 
ribosomal protein L18, and YTHDF1, encoding for YTH domain family, member 1, are common 
to the pool of tissues and foetal brain transcriptome maps.  
 These results are provided as Supplementary Table 15, available at: http://apollo11.isto.unibo.it/suppl/2014_Caracausi/. 
 In the hippocampus transcriptome map, the search for housekeeping genes retrieved 241 
loci, including many known genes and uncharacterized loci (mostly EST clusters), fulfilling the 
selected criteria (Supporting Information Table S5, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). 
 Within this list, TBCB (tubulin folding cofactor B beta) was found to be the gene with the 
highest number of both data points (n=93) and samples (all 41 samples covered), suggesting the 
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reliability of its expression values (mean=570.15, SD expressed as a percentage of the 
mean=17.76). 
  By applying functional enrichment analysis we found that there are fifteen statistically 
significant (p-value≤0.05) enriched functions (Supporting Information Table S6, available at: 
http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). The first three are: RNA binding 
(GO:0003723), poly(A) RNA binding (GO:0044822) and oxidoreductase activity (GO:0016491) 
(Supporting Information Table S6, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). Seventy out of 241 
genes resulted "not found", they are: the EST clusters; an uncharecterized locus LOC100506365; 
two known genes, GTDC2 and NIM1, encoding respectively for protein O-linked mannose N-
acetylglucosaminyltransferase 2 (beta 1,4-) and for NIM1 serine/threonine protein kinase. 
 In the heart transcriptome map, the search for housekeeping genes with an SD as percentage 
of the mean value ≤30 retrieved 2 loci, including the known gene MRPL51, encoding for 
mitochondrial ribosomal protein L51, and the EST cluster Hs.465405, fulfilling the selected 
criteria (Table 17). The search for housekeeping genes with an SD as percentage of the mean 
value ≤40 retrieved 7 loci (Table 17). 
 
Table 17 Predicted housekeeping genes from the whole heart transcriptome maps using two different SD as 
percentage of the mean value (≤30 and ≤40).  
 
Gene name Value 'G' Chr Location Data 
points 
'G' 
SD as % of 
expression 
'G' 
Whole heart housekeeping genes having SD as % of the mean value ≤30 
Hs.465405a 121.91 chr1 1p36.13 19 22.92 
MRPL51 715.22 chr12 12p13.3-p13.1 18 27.31 
Whole heart housekeeping genes having SD as % of the mean value ≤40 
Hs.465405a 121.91 chr1 1p36.13 19 22.92 
MRPL51 715.22 chr12 12p13.3-p13.1 18 27.31 
RRAGC 126.38 chr1 1p34 32 33.07 
TRMT10C 103.35 chr3 3q12.3 119 37.41 
TRMT112 422.61 chr11 11q13.1 31 39.05 
ECHS1 764.25 chr10 10q26.2-q26.3 30 39.56 
PIK3C2B 106.77 chr1 1q32 35 39.70 
 
Genes are sorted in ascending order of SD as percentage of the mean value. a Cytoband not available in Gene was 
derived from the UCSC Genome Browser (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
 
4.2 DS AMKL transcriptome  
 
4.2.1 AMKL gene expression literature search 
  
 A general search using the acronym "AMKL" retrieved 157 articles, 6 of them describe gene 
expression profiling experiments (Klusmann et al., 2010a; Klusmann et al., 2010b; Lightfoot et 
al., 2004; McElwaine et al., 2004; Bourquin et al., 2006; Ge et al., 2006).  
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 No additional pertinent item was retrieved using the expression described in the Methods 
section and including the MeSH Term "Leukemia, Megakaryoblastic, Acute". 
  
4.2.2 AMKL gene expression database search 
 
 The Gene Expression Omnibus (GEO) (Barrett and Edgar, 2006) search allowed the 
retrievement of three additional works describing data possibly useful for meta-analysis (Yagi et 
al., 2003; Radtke et al., 2009; Kikushige et al., 2010). The lack of inclusion of these works in the 
literature search was due to failure of using the "AMKL" acronym and assigning the MeSH 
Term "Leukemia, Megakaryoblastic, Acute" during the PubMed indexing process (the more 
general term "Leukemia, Myeloid, Acute" was used). 
 The more general search using the expression "Down Syndrome"[MeSH] AND "Homo 
sapiens"[Organism] allowed the addition of one further work (Tomasson et al., 2008). This work 
analyzed several types of AML samples and did not explicitly mention AMKL or AML M7 in 
both PubMed and GEO databases. 
 No further pertinent works related to AMKL were identified by ArrayExpress database 
(Sarkans et al., 2005) search. 
 Several datasets for normal MK cells global gene expression profile fulfilling the selection 
criteria were obtained from the works (Nover-shtern et al., 2011) (GEO, 7 samples) and (Felli et 
al., 2010) (ArrayExpress, 1 sample), in addition to the 4 sample series identified in the first 
report of the TRAM software (Lenzi et al., 2011) and obtained from different works (Tenedini et 
al., 2004; Fuhrken et al., 2007; Giammona et al., 2006; Ferrari et al., 2007), for a total of 19 
datasets related to human normal MK cells. 
  
4.2.3 Dataset building 
 
 Of the 10 works related to DS or non-DS AMKL retrieved as above described, 7 were 
considered for the meta-analysis (Table 18). It was not possible to obtain raw data from the 
Authors of (Lightfoot  et al., 2004), while the only sample of AML M7 described in (Kikushige 
et al., 2010) was related to "Leukemic Stem Cells" cell type and the two AML M7 reported by 
Tomasson et al. (2008) were obtained from elderly patients. Data from (Ge te al., 2006) were 
kindly provided by Drs. Jeffrey Taub and Yubin Ge.  
 At the end, DS AMKL sample pool 'A' included 43 datasets, while non-DS AMKL sample 
pool 'B' was composed of 45 datasets. A TMD dataset pool 'C' was constructed starting from 20 
samples described in some of the DS AMKL related articles (Klusmann et al., 2010b; 
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McElwaine et al., 2004; Bourquin et al., 2006). Age and sex data were available for 29 out of 43 
DS AMKL patients (mean age: 20 months; 11 males and 18 females), for 26 out of 45 non-DS 
AMKL patients (mean age: 19 months; 19/7 males/females) and for 9 out of 20 TMD patients 
(mean age: 8 days; 7/2 males/females). GATA1 mutations giving rise to GATA1s were present in 
all DS AMKL and TMD samples, and not in non-DS AMKL samples, considering all samples 
for which this information was provided. Sample identifiers and main sample features are listed in 
Table 18 and Additional file 1 (available at: http://apollo11.isto.unibo.it/suppl). 
  Two pools were constructed from the normal MK related dataset selected: pool 'D' included 
all available MK samples, while pool 'E' was a subset including only CB-derived MK cells (Table 
18 and Additional file 1, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
 
Table 18. Main features of the samples used in TRAM analyses.  
Study ID 
 
Sample ID Sample type Platform Microarray Spots References 
Pool 'A' 
DS AMKL (25,955 mapped loci following analysis by TRAM) 
(n=43) 
A1...A3 
(n=3) 
GSM491372...4 BM 
Sorted leukemic 
blasts 
GPL570 Affymetrix  
U133 Plus 2.0 
54,675 Klusmann 
2010b 
A4...A25 
(n=22) 
GSM94245, 
GSM94272...92 
BM or PB GPL96 Affymetrix  
U133A 
22,283 Bourquin 
2006 
A26...A31 
(n=6) 
GSM417985...90 BM or PB 
Sorted leukemic 
blasts 
GPL570 Affymetrix  
U133 Plus 2.0 
54,675 Klusmann 
2010a 
A32...A38 
(n=7) 
E-MEXP-72* BMMC or PBMC A-AFFY-
33.adf.txt* 
Affymetrix  
U133A 
22,283 McElwaine 
2004 
A39...A43 
(n=5) 
/ BMMC or PBMC GPL96 Affymetrix  
U133A 
22,283 Ge  
2006 
Pool 'B'  
non-DS AMKL (26,045 mapped loci following analysis by TRAM) 
(n=45) 
B1-B2 
(n=2) 
GSM491370-1 BM 
Sorted leukemic 
blasts 
GPL570 Affymetrix  
U133 Plus 2.0 
54,675 Klusmann 
2010b 
B3...B23 
(n=21) 
GSM94221-4-5, 
GSM94227...32, 
GSM94234-5-7-
8, 
GSM94240-2-3-
8, 
GSM94256-9, 
GSM94261-2 
BM or PB GPL96 Affymetrix  
U133A 
22,283 Bourquin 
2006 
B24...B28 
(n=5) 
GSM39832-5, 
GSM39842-4, 
GSM39863 
PBMC or BMMC GPL8300 Affymetrix  
U95 Version 2 
12,625 Yagi 
2003 
B29...B35 
(n=7) 
GSM361502...4, 
GSM361506...8,  
GSM361510 
BM or PB GPL96 Affymetrix  
U133A 
22,283 Radtke 
2009 
B36...B40 
(n=5) 
GSM417991...5 BM or PB 
Sorted leukemic 
blasts 
GPL570 Affymetrix  
U133 Plus 2.0 
54,675 Klusmann 
2010b 
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B41...B45 
(n=5) 
/ BMMC or PBMC GPL96 Affymetrix  
U133A 
22,283 Ge  
2006 
Pool 'C'  
TMD (25,955 mapped loci following analysis by TRAM) 
(n=20) 
C1...C3 
(n=3) 
GSM491375...7 BM 
Sorted leukemic 
blasts 
GPL570 Affymetrix  
U133 Plus 2.0 
54,675 Klusmann 
2010b 
C4...C11 
(n=8) 
GSM94293...9 
GSM94300 
BM or PB GPL96 Affymetrix  
U133A 
22,283 Bourquin 
2006 
C12...C20 
(n=9) 
E-MEXP-72* BMMC or PBMC A-AFFY-
33.adf.txt* 
Affymetrix  
U133A 
22,283 McElwaine 
2004 
Pool 'D' 
MK (26,372 mapped loci following analysis by TRAM) 
(n=19) 
D1-D2 
(n=2) 
GSM321577-8 MK (BM) 
(subj=pool) 
GPL96 Affymetrix  
U133A 
22,283 Ferrari 
2007 
D3...D6 
(n=4) 
GSM112277-8, 
GSM112291-2 
MK (PB) (subj=1, 
rep. 1) 
GPL887 Agilent 1A 22,575 Giammona 
2006 
D7-D8 
(n=2) 
GSM15648, 
GSM8649 
MK (BM) (subj=6) GPL96 Affymetrix  
U133A 
22,283 Tenedini 
2004 
D9...D11 
(n=3) 
GSM88014-22-
34 
MK (PB) (subj=1) GPL887 Agilent 1A 22,575 Fuhrken 
2007 
D12...D18 
(n=7) 
GSM609746...52 CB GPL4685 Affymetrix  
HT-
HG_U133A 
22,944 Nover-
shtern 
2011 
D19 
(n=1) 
E-MEXP-2146* CB A-AFFY-
44.adf.txt 
Affymetrix  
U133 Plus 2.0 
54,675 Felli 
2010 
Pool 'E' = D12...D19 
CB MK (25,577 mapped loci following analysis by TRAM) 
(n=8) 
 
Samples selected for the meta-analysis of gene expression profiles in DS AMKL (pool 'A'), non-DS AMKL 
(pool 'B'), TMD (pool 'C'), and megakaryocytic cells (pool 'D' and 'E'). All Sample IDs and Platforms IDs are 
related to GEO database, other than codes marked with * (ArrayExpress database). Sample type: BM, bone 
marrow; PB, peripheral blood; BMMC, bone marrow mononuclear cells; PBMC, peripheral blood mononuclear 
cells; MK, megakaryocytic/megakaryoblast cells, obtained by in vitro differentiation of CD34+ cells; CD34+, 
undifferentiated CD34+ cells; BM, CB or PB: CD34+ cells derived from bone marrow, cord blood or peripheral 
blood, respectively. subj=number of subjects from which the sample was derived (in some cases, where 
subj=pool, the exact number of subjects included in a pool was not available). rep.=biological replicate. 
Microarray: U133A: Affymetrix Human Genome U133A Array; 1A: Agilent-012097 Human 1A Microarray 
(V2) G4110B; 22k A: Agilent Human oligo 22k A; HG-Focus: Affymetrix Human HG-Focus Target Array. 
Details about Sample identifiers and main sample features are listed in Additional file 1 (available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
 
 
4.2.4 Transcriptome differential maps 
 
 Datasets were loaded into TRAM and analyzed obtaining 8 tanscriptome maps: DS AMKL 
(pool 'A') vs. non-DS AMKL (pool 'B'); DS AMKL (pool 'A') vs. normal MK (pool 'D'); non-DS 
AMKL (pool 'B') vs. normal MK (pool 'D'); DS AMKL (pool 'A') vs. normal CB MK (pool 'E') 
cells; non-DS AMKL (pool 'B') vs. normal CB MK (pool 'E'); DS AMKL (pool 'A') vs. TMD 
(pool 'C'); TMD (pool 'C') vs. normal MK (pool 'D'); TMD (pool 'C') vs. normal CB MK (pool 
'E'). 
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 For each comparison between two cell types by TRAM, we describe below or in the 
corresponding Figures or Tables the total of data points analyzed for each cell type, i.e. gene 
expression values for all human mapped loci following intra- and inter-sample normalization 
(Lenzi et al., 2011); the number of loci for which the comparison between the two conditions 
was possible due to the presence of values for those loci in both sample pools considered; the 
number and the gene content of each genomic segment containing at least three over- or under-
expressed genes and found to be statistically significantly over- or under-expressed in the 
comparison between the two tissues. Each genomic segment was identified among the 12,373 
segments generated using the default window of 500,000 bp with a sliding window of 250,000 
bp and following removal of overlapping segments with similar gene content.  
 The description of the gene name corresponding to all gene symbols cited here in the text, 
Figures or Tables is given in the Additional file 2, available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/. 
We performed a PubMed search for the most relevant over- or under-expressed genes using gene 
symbol or gene description along with MeSH terms related to MK or MK progenitor cells, 
thrombopoiesis, AMKL, platelets.  
 Detailed results for each map are provided below, and are also available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/.  
 The absolute (not differential) expression values and maps for each cell type (not compared 
to another cell type) are also available in the complete sets of results at available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/, but are not discussed here because they include 
typical housekeeping genes whose over-expression is no longer evident when compensated by 
the corresponding housekeeping genes in the compared cell type. 
  
4.2.5 Transcriptome map comparison of DS AMKL vs. non-DS AMKL 
 
 We first analyzed regional differential expression of pool 'A' (43 DS AMKL samples) versus 
pool 'B' (45 non-DS AMKL samples) (Table 18). A total of 1,061,761 data points from the pool 
'A' and 1,084,700 data points from the pool 'B' were included in the analysis. An 'A'/'B' ratio 
value was determinable for 25,954 loci having values both in 'A' and 'B' pools (Additional file 3, 
available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). The main results are shown in 
Figure 8.  
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Figure 8 Main results of DS-AMKL vs. MK, DS AMKL vs. non-DS AMKL, non-DS AMKL vs. MK comparisons. 
For each comparison the number of loci analyzed, the most over- or under-expressed segments and single genes, and 
the highest and lowest median expression ratios for all the genes located in the same chromosome are indicated. 
 
 
 Results obtained by the analysis included 3 significantly non-overlapped over-expressed 
segments (Table 19). The highest expression ratio between DS AMKL and non-DS AMKL 
(3.27) was observed in a segment on chromosome 15 (15q21.2), including the known gene HDC 
(encoding for histidine decarboxylase, which converts L-histidine to histamine). The second 
segment with the highest expression was located on chromosome 4 (4q31.1) and contained over-
expressed genes such as GYPE, GYPB and GYPA, encoding for glycophorin E, B and A (MNS 
blood group) respectively. The third over-expressed segment spans the cluster of apolipoprotein 
encoding genes on chromosome 19 (19q13.2). 
 
 
 
 
 
 
 
 
 
 
 
DS AMKL 
Pool 'A'   n=43 
Data n=1,061,761  
non-DS AMKL 
Pool 'B'   n=45 
Data n=1,084,700 
 
'A'/'B' comparison   Loci n=25,954 
 
Region           'A'/'B’  Genes 
 
Segments 
15q21.2           3.274  HDC 
  4q31.1           2.214  GYPE GYPB GYPA 
19q13.2           1.575  APOE APOC1 APOC2 
 
Single Genes 
          23.860  SLITRK6 
          17.097  HDC 
            0.046  SPINK2  
            0.040  RPS12 
 
Genes of a chromosome 
chr22             0.928   
chrY             0.762 
 
chr21 Gene 
            6.187  ADAMTS1     
'A'/'D' comparison  Loci n=25,800 
 
Region         'A'/'D’       Genes 
 
Segments 
  3p26.2       20.808      LRRN1 
  1q23         18.066      FAM78B 
15q26.2       14.726      NR2F2-AS1 
  4q12           0.454      PF4 PPBP CXCL3 
  4q32.1         0.130      GUCYA3 GUCYB3 
 
Single Genes 
        58.885      TMEM241 
        50.759      CMBL 
          0.002      LBX1   
          0.002      TSPAN10 
 
Genes of a chromosome 
chr21           1.754 
chrX           1.172 
MK 
Pool 'D'   n=19 
Data n=411,381 
'B'/'D' comparison  Loci n=25,819 
 
Region   'B'/'D’   Genes 
 
Segments 
15q26.2  22.295   NR2F2-AS1 
  4q13       0.385   PF4V1 PF4 
    PPBP CXCL3 
 
 
Single Genes 
  156.443  TMEM241 
  122.994  CDYL2 
        0.003  TSPAN10 
         0.002  MAP3K10 
          0.001  LBX1   
 
Genes of a chromosome 
chr21         1.768 
chrX         1.236 
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Table 19 Genomic segments significantly over- or under-expressed in the DS AMKL vs. non-DS AMKL 
differential transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'A'/'B' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr15 
15q21.2 
50,250,001 50,750,000 3.27 0.00233 HDC, Hs.656448, Hs.660869d  
chr4 
4q31.1 
144,750,001 145,250,000 2.21 0.00024 GYPE, GYPB, GYPA 
chr19 
19q13.2 
45,000,001 45,500,000 1.58 0.00461 APOE, APOC1, APOC2 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. non-DS AMKL (pool 'B'). Analysis was 
performed using default parameters (see Methods section). Segments are sorted by decreasing 'A'/'B' ratio. In the 
"Map" mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of Homo sapiens) only if 
they have an expression value. Some segments are not shown for simplicity because they are over-lapping with 
those highlighted in one of the listed regions. The complete results for these models are available as on line 
additional material. a Chr: chromosome. The segment location cytoband was derived from that of the first mapped 
gene within the segment. b Segment Start/End: chromosomal coordinates for each segment. c Significantly over-
/under-expressed genes as marked in the TRAM results. dThis UniGene cluster contains EST with at least one Alu 
sequence, according to Repeat Masker (http://www.repeatmasker.org/). For this reason, it can not be excluded that 
its over-expression is related to unspecific hybridization by Alu-containg probes. 
 
 
 At single gene level, a fold increase higher than 5 was observed in all of the first 20 genes 
with the greatest expression ratios of DS AMKL vs. non-DS AMKL samples (Table 20 and 
Additional file 3, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). In 
particular, a 24-fold increase was observed for SLITRK6 gene, encoding for a membrane protein 
to date described as similar to receptor for BDNF (brain-derived neurotrophic factor) and 
predominantly expressed in neural tissues. Among the genes with the lower 'A'/'B' expression 
ratios a 169.5-fold decrease was observed for a UniGene EST cluster, Hs.355689.  
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Table 20 List of the five most over- or under-expressed genes (all significantly, with q<0.05) in the DS AMKL vs. 
non-DS AMKL transcriptome map. 
 
Gene Value 
'A' 
Value 
'B' 
'A'/'B' 
Ratio 
Location Data points SD SD 
'A' 'B' 'A' 'B' 
Over-expressed genes 
SLITRK6 465.5 19.5 23.860 13q31.1 27 21 113.0 79.6 
HDC 1,119.4 65.5 17.097 15q21-q22 36 45 98.8 249.4 
ZNF587B  615.0 39.3 15.643 19q13.43b 43 40 427.6 32.2 
SOSTDC1 111.7 8.6 12.957 7p21.1 43 45 176.5 108.4 
LOC100287628a 1,381.3 107.7 12.820 16p13.2 9 7 80.2 56.8 
Under-expressed genes 
Hs.587427 a 19.8 407.8 0.049 7p15.2 18 14 28.9 353.3 
SPINK2 13.1 285.1 0.046 4q12 36 45 81.8 115.0 
Hs.602709 a 15.8 370.2 0.043 11q13.2b 9 7 33.1 256.9 
RPS12 20.7 519.1 0.040 6q23.2 43 50 113.7 213.0 
Hs.355689 a 3.7 624.4 0.006 18q11.2b 9 7 47.3 168.4 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. non-DS AMKL (pool 'B'). Value: mean gene 
expression value normalized across all the pool samples; Data points: number of spots associated to an expression 
value for the locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results 
available as additional material (see text). a The segment window contains more than one gene, but the significance 
is assumed to be maintained because the expression value of this over- or under-expressed gene prevails over the 
others. b Cytoband not available in Gene was derived from the UCSC Genome Browser (University of California 
Santa Cruz (UCSC) Genome Browser. (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
 
 At chromosomal level, we calculated (in the TRAM "Chr" table) the median 'A'/'B' 
expression ratio for all the genes located in the same chromosome. The highest ratios were near 
to 1 (0.93 for chr22, 0.92 for chrX and chr21, 0.91 for chr19); other values were in the range 
from 0.90 (chr17 and chr12) to 0.76 (chrY). 
 We performed two additional transcriptome maps to investigate specifically sex-biased gene 
expression patterns (data not shown, results may be regenerated by the user by 
excluding/including or reimporting samples on the basis of data provided in Additional file 1, 
available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/): in particular, we compared male 
(pool 'A.1', n=11) vs. female DS AMKL cells (pool 'A.2', n=18). These datasets are derived from 
the samples for which the knowledge about the sex of the sample donor was available. The 
results showed a significant statistical correlation of data between male and female gene 
expression data (r=0.99, p-value<0.0001), showing a large overlap of results between the two 
transcriptome maps, with the exception of single genes with a well known sex-biased expression 
pattern. For example, XIST, which is specifically activated in female cells to start the X-
inactivation process, turns out to be the most differentially expressed gene between female 
(value=402.60) and male (value=12.20) DS AMKL cells (ratio=33). 
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4.2.6 Transcriptome map comparison of DS AMKL or non-DS AMKL vs. normal MK  
 
 Regional differential expression of pool 'A' (43 DS AMKL samples) or pool 'B' (45 non-DS 
AMKL samples) versus pool 'D' (19 normal MK cell samples, 411,381 data points) (Table 18) 
was investigated. An 'A'/'D' ratio value was determinable for 25,800 loci (Additional file 4, 
available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). The main results are shown in 
Figure 8. 
 For what DS AMKL samples are concerned, results included 5 significantly differentially 
expressed segments in DS AMKL cells, 3 over- and 2 under-expressed (Table 21). The highest 
expression ratio (20.81) between DS AMKL cells and normal MK was observed in the segment 
at coordinates 3,500,001-4,000,000 on chromosome 3, including the known gene LRRN1, 
encoding for a type I transmembrane protein. The second segment with highest expression ratio 
(18.07) was located on chromosome 1 (1q23) and contained FAM78B (family with sequence 
similarity 78, member B). The third segment was on chromosome 15 and included NR2F2-AS1, 
a non-coding RNA. The first significantly under-expressed segment (4q32.1) includes genes 
encoding for subunits of soluble guanylate cyclase (GUCY1A3 and GUCY1B3), while the second 
spans the cluster of MK specific genes located on chromosome 4 (4q12-q21). 
 
Table 21 Genomic segments significantly over- or under-expressed in the DS AMKL vs. MK differential 
transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'A'/'D' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr3 
p26.2 
3,500,001 4,000,000 20.81 0.00006 Hs.241414,  LRRN1, Hs.128128 
chr1 
1q23 
166,000,001 166,500,000 18.07 0.00004 Hs.22930, FAM78B, Hs.662048 
chr15 
15q26.2 
96,750,001 97,250,000 14.73 0.00001 Hs.677040, Hs.661950, NR2F2-AS1, 
Hs.592015 
Under-expressed segments 
chr4 
4q12-q21 
74,750,001 75,250,000 0.45 
 
0.00079 
 
PF4,  PPBP, CXCL3 
chr4 
4q32.1 
156,250,001 156,750,000 0.13 
 
0.00012 
 
GUCY1A3, Hs.612374, GUCY1B3 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. MK (pool 'D'). Analysis was performed using 
default parameters (see Methods section). Segments are sorted by decreasing 'A'/'D' ratio. In the "Map" mode, 
TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of Homo sapiens) only if they have an 
expression value. Some segments are not shown for simplicity because they are over-lapping with those highlighted 
in one of the listed regions. The complete results for these models are available as on line additional material. a Chr: 
chromosome. The segment location cytoband was derived from that of the first mapped gene within the segment. b 
Segment Start/End: chromosomal coordinates for each segment. c Significantly over-/under-expressed genes as 
marked in the TRAM results.  
 
 
 At single gene level, a fold increase higher than 18 was observed in all of the first 20 genes 
with the greatest expression ratios of DS AMKL vs. MK samples (Table 22 and Additional file 
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4, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). In particular, a 59-
fold increase was observed for TMEM241, encoding a transmembrane protein of unknown 
function. Among the genes with the lowest 'A'/'D' expression ratio a 589.7-fold decrease was 
observed for TSPAN10, encoding for tetraspanin 10. 
 
Table 22 List of the five most over- or under-expressed genes (all significantly, with q<0.05) in the DS AMKL vs. 
MK transcriptome map.  
 
Gene Value 
'A' 
Value 
'D' 
'A'/'D' 
Ratio 
Location Data points SD SD 
'A' 'D' 'A' 'D' 
Over-expressed genes 
TMEM241 1,036.6 17.6 58.885 18q11.2 18 8 57.7 115.8 
CMBL 592.4 11.7 50.759 5p15.2 27 8 142.0 30.1 
IFI27 467.8 11.6 40.474 14q32 36 82 90.0 27.6 
CSRNP1 640.6 16.8 38.023 3p22 9 8 41.3 138.3 
PTGS2 2,205.0 59.2 37.276 1q25.2 q25.3 63 20 156.4 131.6 
APOC2ab 431.7 11.7 37.044 19q13.2 54 28 81.4 41.6 
SLITRK6b 465.5 13.3 35.057 13q31.1 27 10 113.0 95.6 
Under-expressed genes 
MAP3K10 5.4 2,352.3 0.002 19q13.2 36 19 47.4 135.1 
DRD4 5.0 2,327.6 0.002 11p15.5 36 19 51.3 135.2 
DLGAP3 4.8 2,297.9 0.002 1p35.3-p34.1 9 7 40.8 37.6 
LBX1 2.7 1,358.5 0.002 10q24 36 19 46.4 152.6 
TSPAN10a 7.9 4,674.7 0.002 17q25.3 9 8 55.0 46.0 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. MK (pool 'D'). Value: mean gene expression 
value normalized across all the pool samples; Data points: number of spots associated to an expression value for the 
locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results available as 
additional material (see text). a The segment window contains more than one gene, but the significance is assumed 
to be maintained because the expression value of this over- or under-expressed gene prevails over the others.  
b This gene, exceeding the limit of five genes for each list, has been shown for its relevance in the Discussion, being 
recurrent in other comparisons. 
 
 
 At chromosomal level, the highest ratio was observed for chr21 (1.75), the lowest for chrX 
(1.17), other values were in the range from 1.68 (chrY) to a value of 1.23 for chr17. 
 Regarding the non-DS AMKL samples, results obtained by default analysis and derived 
from 'B'/'D' expression ratio for 25,819 loci included one significantly over- and one 
significantly under-expressed segment (Table 23). The highest expression ratio (22.30) between 
non-DS AMKL and normal MK was observed in the same segment on chr15, significantly over-
expressed also in the DS AMKL transcriptome map. This segment was the only significantly 
over-expressed one in this comparison. Similarly, the only significantly under-expressed 
segment includes the cluster of MK specific genes on chromosome 4 also found to be under-
expressed in DS AMKL samples (Table 21). 
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Table 23 Genomic segments significantly over- or under-expressed in the non-DS AMKL vs. MK differential 
transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'B'/'D' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr15 
15q26.2 
96,750,001 97,250,000 22.30 <0.00001 Hs.677040, Hs.661950, NR2F2-AS1,  
Hs.592015 
Under-expressed segments 
chr4 
4q13-q21 
74,500,001 75,000,000 0.39 
 
0.00009 
 
PF4V1, PF4, PPBP, CXCL3 
 
Data refer to the following comparisons: non-DS AMKL (pool 'B') vs. MK (pool 'D'). Analysis was performed using 
default parameters (see Methods section). Segments are sorted by decreasing 'B'/'D' ratio. In the "Map" mode, 
TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of Homo sapiens) only if they have an 
expression value. Some segments are not shown for simplicity because they are over-lapping with those highlighted 
in one of the listed regions. The complete results for these models are available as on line additional material. a Chr: 
chromosome. The segment location cytoband was derived from that of the first mapped gene within the segment. b 
Segment Start/End: chromosomal coordinates for each segment. c Significantly over-/under-expressed genes as 
marked in the TRAM results.  
 
 
 At single gene level, a fold increase higher than 31 was observed in all of the first 20 genes 
with the greatest expression ratios of non-DS AMKL vs. MK samples (Table 24 and Additional 
file 5, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). In particular, a 
156-fold increase was observed for TMEM241. Overall, there was a remarkable overlap between 
the most over- (TMEM241, CMBL, ZNF445, SPRR4) and under-expressed (PF4V1, FLJ22184, 
FSIP2, PPP1R3B, HIST3H3, PIF1, SPSB4, ILDR1, MAP3K10, DRD4, LBX1, TSPAN10) genes 
in DS and in non-DS AMKL samples (Additional files 4 and 6, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
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Table 24 List of the five most over- or under-expressed genes (all significantly, with q<0.05) in the non-DS AMKL 
vs. MK transcriptome map.  
 
Gene Value 
'B' 
Value 
'D' 
'B'/'D' 
Ratio 
Location Data points SD SD 
'B' 'D' 'B' 'D' 
Over-expressed genes 
TMEM241 2,754.1 17.6 156.443 18q11.2 14 8 89.9 115.8 
CDYL2 1,613.5 13.1 122.994 16q23.2 7 8 128.9 69.8 
MPV17L 1,857.8 24.4 76.280 16p13.11 7 8 119.5 65.0 
ATP6V0D2 836.7 11.9 70.488 8q21.3b 21 10 169.4 82.9 
CMBL 757.9 11.7 64.938 5p15.2 21 8 176.2 30.1 
Under-expressed genes 
ILDR1 13.7 4,333.8 0.003 3q13.33 14 9 98.4 63.3 
HIST3H3 3.9 1,313.0 0.003 1q42 40 19 78.0 137.9 
TSPAN10a 12.1 4,674.7 0.003 17q25.3 7 8 88.1 46.0 
MAP3K10 3.9 2,352.3 0.002 19q13.2 45 19 40.1 135.1 
LBX1 2.0 1,358.5 0.001 10q24 45 19 85.7 152.6 
 
Data refer to the following comparisons: non-DS AMKL (pool 'B') vs. MK (pool 'D'). Value: mean gene expression 
value normalized across all the pool samples; Data points: number of spots associated to an expression value for the 
locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results available as 
additional material (see text). a The segment window contains more than one gene, but the significance is assumed 
to be maintained because the expression value of this over- or under-expressed gene prevails over the others. b 
Cytoband not available in Gene was derived from the UCSC Genome Browser (University of California Santa Cruz 
(UCSC) Genome Browser. (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
 
 At chromosomal level, looking at the median 'B'/'D' expression ratio for the genes located in 
the same chromosome, the highest ratio was observed for chr21 (1.77) and chrY (1.73), followed 
by chr13 (1.71) and chr10 (1.59); other values were in the range from 1.58 (chr20), with a value 
of 1.24 for chrX. 
 
4.2.7 Transcriptome map comparison of DS AMKL or non DS-AMKL vs. normal CB MK 
 
 Regional differential expression of pool 'A' (43 DS AMKL samples) or pool 'B' (45 non-DS 
AMKL samples) versus pool 'E' (8 normal cord-blood (CB)-derived MK cell samples, 191,798 
data points) (Table 18) was investigated. The main results are shown in Figure 9. 
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Figure 9 Main results of DS AMKL vs. CB MK and non-DS AMKL vs. CB MK comparisons. For each comparison 
the number of loci analyzed, the most over- or under-expressed segments and single genes, and the highest and 
lowest median expression ratios for all the genes located in the same chromosome are indicated. 
 
 
 For what DS AMKL samples are concerned, results derived from 'A'/'E' expression ratio for 
25,540 loci (Additional file 6, available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/) 
included 1 significantly over- and 3 under-expressed segments in DS AMKL cells (Table 25). A 
remarkable expression ratio (80.36) between DS AMKL cells and normal CB MK was observed 
for a segment on chromosome 3 (3q22.1), including collagen-encoding COL6A5 and COL6A6 
known loci. The three significantly under-expressed segments included the region on 
chromosome 4 (4q12-q21) with PF4, PPBP and CXCL3 loci implied in MK differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
DS AMKL 
Pool 'A'   n=43 
Data n=1,061,761  
non-DS AMKL 
Pool 'B'   n=45 
Data n=1,084,700 
 
'A'/'E' comparison   Loci n=25,540 
 
Region        'A'/'E’          Genes 
 
Segments 
3q22.1        80.362  COL6A5 COL6A6 
7q11.23         0.482  GSAP PTPN12 
4q12          0.371  PF4 PPBP CXCL3 
4q32.1          0.122  MAP9 GUCYA3 GUCYB3 
 
Single Genes 
      45.063  PTPRO 
       43.477  APOC2 
         0.018  GNG11  
                     0.018  RPS12   
          0.018  OLFM4 
 
Genes of a chromosome 
chr21          2.082 
chrX          1.366 
CB MK 
Pool 'E'   n=8 
Data n=191,798 
'B'/'E' comparison   Loci n=25,546 
 
Region         'B'/'E’  Genes 
 
Segments 
  3q22.1     116.132  COL6A5 COL6A6 
 11p15         50.979  OR10A5 OR10A4 
   4q12           0.423  PF4 PPBP CXCL5 CXCL3 
 
 
Single Genes 
         33.831  PTPRO 
         23.511  CES3 
           0.023  SPTLC3   
                       0.020  SPATA1   
            0.020  OLFM4 
 
Genes of a chromosome 
chrY           2.511 
chrX           1.464 
	  	   71	  	  	  	  
Table 25. Genomic segments significantly over- or under-expressed in the DS AMKL vs. normal CB MK 
differential transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'A'/'E' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr3 
3q22.1 
130,000,001 130,500,000 80.36 0.00015 COL6A5, COL6A6, Hs.596805 
Under-expressed segments 
chr7 
7q11.23 
77,000,001 77,500,000 0.48 0.00117 GSAP, PTPN12, Hs.720279 
chr4 
4q12-q21 
74,750,001 75,250,000 0.37 
 
 0.00119 
 
PF4, PPBP, CXCL3 
chr4 
4q32.1 
156,250,001 156,750,000 0.12 
 
 0.00000 
 
MAP9, GUCY1A3, Hs.612374, GUCY1B3 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. normal CB MK (pool 'E'). Analysis was 
performed using default parameters (see Methods section). Segments are sorted by decreasing 'A'/'E' ratio. In the 
"Map" mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of Homo sapiens) only if 
they have an expression value. Some segments are not shown for simplicity because they are over-lapping with 
those highlighted in one of the listed regions. The complete results for these models are available as on line 
additional material. a Chr: chromosome. The segment location cytoband was derived from that of the first mapped 
gene within the segment. b Segment Start/End: chromosomal coordinates for each segment. c Significantly over-
/under-expressed genes as marked in the TRAM results.  
 
 
 At single gene level, a fold increase higher than 15.7 was observed in all of the first 20 
genes with the greatest expression ratios of DS AMKL cells vs. CB MK (Table 26 and 
Additional file 6, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/ - where 
Pool 'D' here is named 'A' and Pool 'H' here is named 'B'). In particular, a 45-fold increase was 
observed for the tyrosine phosphatase receptor gene (PTPRO), known to be involved in 
megakaryocytopoiesis. 
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Table 26. List of the five most over- or under-expressed genes (all significantly, with q<0.05) in the DS AMKL vs. 
normal CB MK differential transcriptome map. 
 
Gene Value 
'A' 
Value 
'E' 
Ratio 
'A'/'E' 
 
Location Data Points SD SD 
'A' 'E' 'A' 'E' 
Over-expressed genes 
PTPRO 679.7 15.1 45.063 12p13-p12 81 9 133.0 60.8 
APOC2a 431.7 9.9 43.477 19q13.2 54 10 81.4 43.4 
IFI27 467.8 11.5 40.742 14q32 36 8 90.0 57.1 
HDC 1,119.4 34.2 32.716 15q21-q22 36 8 98.8 168.1 
VIPR2a b 346.2 13.5 25.582 7q36.3 115 23 334.8 49.3 
Under-expressed genes 
CDKL1 4.6 174.3 0.027 14q21.3 45 9 65.3 99.0 
ASAP2 19.1 734.1 0.026 2p24 36 8 95.4 67.3 
GNG11 18.9 1,042.3 0.018 7q21 36 8 119.7 81.2 
RPS12 20.7 1,157.2 0.018 6q23.2 43 15 113.7 112.4 
OLFM4 8.9 499.3 0.018 13q14.3 36 7 83.9 121.5 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. normal CB MK (pool 'E'). Value: mean gene 
expression value normalized across all the pool samples; Data points: number of spots associated to an expression 
value for the locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results 
available as additional material (see text). a The segment window contains more than one gene, but the significance 
is assumed to be maintained because the expression value of this over- or under-expressed gene prevails over the 
others. b This gene is one of the five most over-expressed ones, but the value is not statistically significant due to the 
presence of a lot of loci associated with less than 5 data points in the CB MK integrated dataset. 
 
 
 At chromosomal level, the highest ratio was observed for chr21 (2.08), followed by chrY 
(1.89); other values were in the range from 1.84 (chr22) to 1.37 (chrX). 
 Regarding the non-DS AMKL samples, results derived from 'B'/'E' expression ratio (for 
25,546 loci) included 2 significantly over- and 1 under-expressed segments in non-DS AMKL 
(Table 27). A remarkable expression ratio between non-DS AMKL and normal CB MK (116.13) 
was observed in the same segment on chromosome 3 (3q22.1), including collagen-encoding 
COL6A5 and COL6A6 known loci that was observed in DS AMKL samples. The second 
segment was specific of non-DS AMKL samples and included the two olfactive receptor genes 
OR10A5 and OR10A4. The only significantly under-expressed segment included the region on 
chromosome 4 (4q12-q21) highly enriched in MK-specific loci (PF4, PPBP, CXCL5 and 
CXCL3) as in the case of DS AMKL samples, and was extended to PF4V1 locus.  
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Table 27. Genomic segments significantly over- or under-expressed in the non-DS AMKL vs. normal CB MK 
differential transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'B'/'E' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr3 
3q22.1 
130,000,001 130,500,000 116.13 0.00030 COL6A5, COL6A6, Hs.596805 
chr11 
11p15 
6,750,001 7,250,000 50.98 0.00117 OR10A5, OR10A4, LOC100506238 
Under-expressed segments 
chr4 
4q12-q21 
74,750,001 75,250,000 0.42 
 
0.00003 
 
PF4, PPBP, CXCL5, CXCL3 
 
Data refer to the following comparisons: non-DS AMKL (pool 'B') vs. normal CB MK (pool 'E'). Analysis was 
performed using default parameters (see Methods section). Segments are sorted by decreasing 'B'/'E' ratio. In the 
"Map" mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they 
have an expression value. Some segments are not shown for simplicity because they are over-lapping with those 
highlighted in one of the listed regions. The complete results for this model are available as on line additional 
material. a Chr: chromosome. The segment location cytoband was derived from that of the first mapped gene within 
the segment. b Segment Start/End: chromosomal coordinates for each segment. c Significantly over-/under-expressed 
genes as marked in the TRAM results.  
 
 
 At single gene level, a fold increase higher than 14.7 was observed in all of the first 20 
genes with the greatest expression ratios of non-DS AMKL vs. CB MK samples (Table 28 and 
Additional file 7, the last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). In 
particular, a 33.8-fold increase was observed for PTPRO, encoding a tyrosine phosphatase 
receptor. Overall, there was some overlapping between the most over- and under-expressed 
genes in DS and in non-DS AMKL samples (Additional files 6 and 7, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
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Table 28 List of the five most over- or under-expressed genes (all significantly, with q<0.05) in the non-DS AMKL 
vs. normal CB MK differential transcriptome map. 
 
Gene Value 
'B' 
Value 
'E' 
Ratio 
'B'/'E' 
Location Data Points SD SD 
'B' 'E' 'B' 'E' 
Over-expressed genes 
PTPROb 510.3 15.1 33.831 12p13-p12 97 9 137.8 60.8 
CES3b 287.4 12.2 23.511 16q22.1 47 9 335.8 73.8 
SCD5a b 544.7 27.2 19.992 4q21.22 61 18 290.3 73.9 
TOP3Ba b 150.2 7.5 19.922 22q11.22 60 14 431.8 19.7 
MT1Ea b 237.1 11.9 19.899 16q13 45 8 92.5 27.3 
Under-expressed genes 
Hs.23729a 2.3 85.1 0.027 1p13.2c 40 8 121.0 89.5 
PDE6C 2.2 88.2 0.025 10q24 45 8 112.9 105.9 
SPTLC3 4.8 203.7 0.023 20p12.1 47 9 86.5 110.7 
SPATA1 7.0 356.2 0.020 1p22.3 40 7 127.4 77.9 
OLFM4 9.7 499.3 0.020 13q14.3 45 7 105.1 121.5 
 
Data refer to the following comparisons: non-DS AMKL (pool 'B') vs. normal CB MK (pool 'E'). Value: mean gene 
expression value normalized across all the pool samples; Data points: number of spots associated to an expression 
value for the locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results 
available as additional material (see text). a The segment window contains more than one gene, but the significance 
is assumed to be maintained because the expression value of this over- or under-expressed gene prevails over the 
others. b This gene is one of the five most over-expressed ones, but the value is not statistically significant due to the 
presence of a lot of loci associated with less than 5 data points in the CB MK integrated dataset. c Cytoband not 
available in Gene was derived from the UCSC Genome Browser (University of California Santa Cruz (UCSC) 
Genome Browser. (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
 At chromosomal level, regarding the median 'B'/'E' expression ratio for the genes located in 
the same chromosome, the highest ratio was observed for chrY (2.51), followed by chr21 (2.19); 
other values were in the range from 2.03 (chr20) to 1.46 (chrX). 
    
4.2.8 Transcriptome map comparison of DS AMKL vs. TMD 
 
 Regional differential expression of pool 'A' (43 DS AMKL samples) versus pool 'C' (20 
TMD samples, 398,162 data points) (Table 18) was investigated. The main results are shown in 
Figure 10. 
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Figure 10 Main results of DS AMKL vs. TMD, TMD vs. MK, TMD vs. CB MK comparisons. For each comparison 
the number of loci analyzed, the most over- or under-expressed segments and single genes, and the highest and 
lowest median expression ratios for all the genes located in the same chromosome are indicated. 
 
 Results obtained by default analysis and derived from 'A'/'C' expression ratio for 25,955 loci 
(Additional file 8, it is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/) included 2 
significantly over-expressed segments in DS AMKL (Table 29). The highest expression ratio 
(2.20) between DS AMKL and TMD was observed in a segment on chromosome 2 (2q31.3), 
including the known gene ITGA4, encoding an alpha 4 chain of integrin protein and CERKL, a 
gene responsible for retinitis pigmentosa and involved in the protection of cells from apoptosis 
induced by oxidative stress (Repeat Masker (http://www.repeatmasker.org/). The second 
segment with the highest expression ratio (1.40) was located on chromosome 8 (8q21.3) and 
contained the NECAB1 and OTUD6B genes, encoding for neuronal Ca(2+)-binding protein and 
the deubiquitinating enzyme, respectively. 
 
 
 
 
 
 
 
 
 
DS AMKL 
Pool 'A'   n=43 
Data n=1,061,761  
'C'/'D' ratio   Loci n=25,800 
 
Region       'C'/'D’      Genes 
 
Segments 
  3p26.2     27.995      LRRN1 
15q26.2     19.859      NR2F2-AS1 
 
Single Genes 
                126.356      TMEM241 
      91.126      CMBL 
        0.004      HIST3H3 
                    0.003      LBX1   
         0.003      MAP3K10 
 
Genes of a chromosome 
chrY         2.096 
chrX         1.327 
TMD 
Pool 'C'   n=20 
Data n=398,162 
'C'/'E' ratio   Loci n=25,540 
 
Region     'C'/'E’      Genes 
 
Segments 
3q22.1     75.968     COL6A5 COL6A6 
 
 
Single Genes 
    44.869     CGA 
    34.680     PTPRO 
      0.032     RHOBTB1   
                  0.030     RPS12   
       0.020     OLFM4 
 
Genes of a chromosome 
chr21       2.397 
chrX       1.529 
 
'A'/'C' ratio   Loci n=25,955 
 
Region    'A'/'C’     Genes 
 
Segments 
2q31.3     2.203     ITGA4 CERKL 
8q21.3     1.403     NECAB1 OTUD6B 
 
Single Genes 
 15.498     ZNF587B 
 13.431     IFI27 
  12.036     SLITRK6 
                0.203     SLFNL1   
     0.081     KIAA2022 
 
Genes of a chromosome 
chr14     0.868 
chrY     0.736 
CB MK 
Pool 'E'   n=8 
Data n=191,798 
MK 
Pool 'D'   n=19 
Data n=411,381 
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Table 29 Genomic segments significantly over- or under-expressed in the DS AMKL vs. TMD differential 
transcriptome map. 
 
Chra 
and 
Location 
Segment 
Startb 
Segment 
Endb 
'A'/'C' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr2 
2q31.3 
182,000,001 182,500,000 2.20 0.00045 ITGA4, CERKL, Hs.72981 
chr8 
8q21.3 
91,750,001 92,250,000 1.40 0.00051 NECAB1, LOC100127983, OTUD6B 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. TMD (pool 'C'). Segments are sorted by 
increasing 'A'/'C'.  In the "Map" mode, TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of 
H. sapiens) only if they have an expression value. Some segments are not shown for simplicity because they are 
over-lapping with those highlighted in one of the listed regions. The complete results for this model are available as 
on line additional material. a Chr: chromosome. The segment location cytoband was derived from that of the first 
mapped gene within the segment. b Segment Start/End: chromosomal coordinates for each segment. c Significantly 
over-/under-expressed genes as marked in the TRAM results.  
 
 
 At single gene level, a fold increase ranged from 15.5 to 3.5 for the first 20 genes with the 
greatest expression ratios of DS AMKL vs. TMD samples (Table 30 and Additional file 8, the 
last is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). The highest fold increases 
were observed for the ZNF587B (15.5) and IFI27 (13.4) genes, encoding for a zinc finger protein 
and the interferon alpha-inducible protein 27, respectively. The lowest 'A'/'C' expression ratios 
were observed for KIAA2022 (10-fold decrease) and SLFNL1 (5- fold decrease) genes. 
 
Table 30 List of the five genes most over- or under-expressed (all significantly, with q<0.05) in the DS AMKL vs. 
TMD differential transcriptome map. 
 
 
Data refer to the following comparisons: DS AMKL (pool 'A') vs. TMD (pool 'C'). Value: mean gene expression 
value normalized across all the pool samples; Data points: number of spots associated to an expression value for the 
locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results available as 
additional material (see text).aThe segment window contains more than one gene, but the significance is assumed to 
be maintained because the expression value of this over- or under-expressed gene prevails over the others. 
bCytoband not available in Gene was derived from the UCSC Genome Browser (University of California Santa Cruz 
(UCSC) Genome Browser. (http://genome-euro.ucsc.edu/cgi-bin/hgGateway). 
 
Gene Value 
'A' 
Value 
'C' 
Ratio 
'A'/'C' 
Location Data 
Points 
SD SD 
'A' 'C' 'A' 'C' 
Over-expressed genes 
ZNF587B 615.0 39.7 15.498 19q13.43b 43 20 427.6 20.9 
IFI27 467.8 34.8 13.431 14q32 36 11 90.0 91.4 
SLITRK6 465.5 38.7 12.036 13q31.1 27 9 113.0 84.5 
BST2a 117.6 14.8 7.967 19p13.1 36 11 260.0 98.8 
ZNF521 143.0 19.6 7.309 18q11.2 18 6 113.5 58.6 
Under-expressed genes 
ALS2CR12 4.2 15.8 0.268 2q33.1 18 6 80.3 103.2 
GBP5 11.6 43.8 0.266 1p22.2 18 6 75.7 110.6 
GHRH 14.7 67.1 0.219 20q11.2 43 20 97.7 257.0 
SLFNL1a 18.9 92.9 0.203 1p34.2 18 6 90.3 122.1 
KIAA2022 24.3 297.9 0.081 Xq13.3 27 9 52.2 260.9 
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 At chromosomal level, the highest ratio was observed for chr14 (0.87, followed by 0.86 for 
chr5, chr21, chr8, chr12 and chr16), the lowest for chrY (0.74). 
 
4.2.9 Transcriptome map comparison of TMD vs. normal MK or CB MK cells 
 
 Regional differential expression of pool 'C' (20 TMD samples) versus pool 'D' (19 MK 
samples) or 'E' (8 CB MK samples) (Table 18) was investigated. The main results are shown in 
Figure 10. 
 For what MK samples are concerned, results obtained by default analysis and derived from 
'C'/'D' expression ratios for 25,800 loci (Additional file 9, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/) included 2 significantly over-expressed 
segments in TMD cells (Table 31). 
 
Table 31 Genomic segments significantly over- or under-expressed in the TMD vs. normal MK differential 
transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'C'/'D' 
Ratio 
q-value Genes in the segmentc 
Over-expressed segments 
chr3 
3p26.2 
 
3,500,001 4,000,000 28.00 0.00006 Hs.241414,d  LRRN1, Hs.128128 
chr15 
15q26.2 
96,750,001 97,250,000 19.86 0.00000 Hs.677040,d Hs.661950,d NR2F2-AS1, Hs.592015 
 
Data refer to the following comparisons: TMD (pool 'C')  vs. normal MK (pool 'D'). Analysis was performed using 
default parameters (see Methods section). Segments are sorted by increasing 'C'/'D' ratio. In the "Map" mode, 
TRAM displays UniGene EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they have an 
expression value. Some segments are not shown for simplicity because they are over-lapping with those highlighted 
in one of the listed regions. The complete results for this model are available as on line additional material. 
a Chr: chromosome. The segment location cytoband was derived from that of the first mapped gene within the 
segment. b Segment Start/End: chromosomal coordinates for each segment. c c Significantly over-/under-expressed 
genes as marked in the TRAM results. d This UniGene cluster contains EST with at least one Alu sequence, 
according to Repeat Masker (http://www.repeatmasker.org/). For this reason, it can not be excluded that its over-
expression is related to unspecific hybridization by Alu-containg probes. 
 
 
 The highest expression ratio (28.0) between TMD and normal MK was observed in a 
segment on chromosome 3 including the known gene LRRN1, already observed as over-
expressed in comparison of DS AMKL vs. normal MK (Table 21). The second segment with the 
highest expression ratio (19.9) was located on chromosome 15, and contained the locus NR2F2-
AS1, encoding for an antisense mRNA, already observed as over-expressed in comparison of DS 
AMKL and non-DS AMKL vs. normal MK (Table 21 and 23). 
 At single gene level, fold-increase was higher than 16.5 for the first 20 genes with the 
greatest expression ratios (Table 32 and Additional file 9, the last is available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/), with the highest fold increases for TMEM241 
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(126.4) and the cysteine hydrolase gene (CMBL) (91.1). The lowest 'C'/'D' expression ratios were 
observed for a member of the serine/threonine kinase family (MAP3K10) and the homeobox 
gene (LBX1) (both with 333-fold decrease) .  
 At chromosomal level, the highest ratio was observed for chrY (2.1) and chr21 (1.93), 
followed by chr13 (1.71), the lowest for chrX (1.33). 
 
Table 32 List of the five genes most over- or under-expressed (all significantly, with q<0.05) in the TMD vs. 
normal MK differential transcriptome map. 
 
Gene Value 
'C' 
Value 
'D' 
Ratio 
'C'/'D' 
Location Data 
Points 
SD SD 
'C' 'D' 'C' 'D' 
Over-expressed genes 
TMEM241 2,224.4 17.6 126.356 18q11.2 6 8 57.1 115.8 
CMBL 1,063.5 11.7 91.126 5p15.2 9 8 168.8 30.1 
PTGS2 2,256.4 59.2 38.145 1q25.2-q25.3 20 20 147.6 131.6 
CGA 360.6 10.0 36.238 6q12-q21 14 19 159.7 27.3 
TMEFF2 755.1 22.5 33.605 2q32.3 9 9 190.3 44.3 
Under-expressed genes 
ILDR1 18.3 4,333.8 0.004 3q13.33 6 9 58.9 63.3 
DRD4 9.3 2,327.6 0.004 11p15.5 11 19 52.3 135.2 
HIST3H3 5.2 1,313.0 0.004 1q42 11 19 36.2 137.9 
LBX1 4.3 1,358.5 0.003 10q24 11 19 26.6 152.6 
MAP3K10 7.4 2,352.3 0.003 19q13.2 11 19 28.8 135.1 
 
Data refer to the following comparisons: TMD (pool 'C') vs. normal MK (pool 'D'). Value: mean gene expression 
value normalized across all the pool samples; Data points: number of spots associated to an expression value for the 
locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results available as 
additional material (see text).  
 
 
 As far as the comparison of TMD with CB MK samples is concerned, results derived from 
the 'C'/'E' expression ratio for 25,540 loci (Additional file 10, available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/) included only 1 significantly over-expressed 
segment in TMD cells (Table 33). The segment with a significant high expression ratio (76.0) 
between TMD and normal CB MK cells was on chromosome 3 (3q22.1), including the known 
genes COL6A5 and COL6A6 and already observed as over-expressed in DS as well in non-DS 
AMKL samples in comparison with CB MK samples. 
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Table 33 Genomic segments significantly over- or under-expressed in the TMD vs. normal CB MK differential 
transcriptome map. 
 
Chr and 
Locationa 
Segment 
Startb 
Segment 
Endb 
'C'/'E' 
Ratio 
q-value Genes in the segmentc 
chr3 
3q22.1 
130,000,001 130,500,000 75.97 0.00015 COL6A5, COL6A6, Hs.596805   
 
Data refer to the following comparisons: TMD (pool 'C') vs. normal CB MK (pool 'E'). Analysis was performed 
using default parameters (see Methods section). Segments are sorted by 'C'/'E' ratio. In the "Map" mode, TRAM 
displays UniGene EST clusters (with the prefix "Hs." in the case of H. sapiens) only if they have an expression 
value. Some segments are not shown for simplicity because they are over-lapping with those highlighted in one of 
the listed regions. The complete results for this model are available as additional material on line. a Chr: 
chromosome. The segment location cytoband was derived from that of the first mapped gene within the segment.b 
Segment Start/End: chromosomal coordinates for each segment. c Significantly over-/under-expressed genes as 
marked in the TRAM results.  
 
 
 At single gene level, a fold increase ranged from 44.9 to 15.1 for the first 20 genes with the 
greatest expression ratios (Table 34 and Additional file 10, the last is available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). The highest fold increases were observed for 
CGA (44.9), encoding for the alpha chain of the glycoprotein hormones and PTPRO (34.7), as 
already observed in non-DS AMKL vs. CB MK comparison. The lowest 'C'/'E' expression ratio 
was observed for OLFM4 (1:50 fold decrease), encoding olfactomedin 4, an antiapoptotic factor 
that promotes tumor growth. 
 At chromosomal level, the highest ratio was observed for chr21 (2.40), followed by chrY 
(2.37) and chr20 (2.13), the lowest for chrX (1.53). 
 
Table 34 List of the five genes most over- or under-expressed (all significantly, with q<0.05) in the TMD vs. 
normal CB MK differential transcriptome map. 
 
Gene Value 
'C' 
Value 
'E' 
Ratio 
'C'/'E' 
Location Data 
Points 
SD SD 
'C' 'E' 'C' 'E' 
Over-expressed genes 
CGA 360.6 8.0 44.869 6q12-q21 14 8 159.7 39.9 
PTPROb 523.1 15.1 34.680 12p13-p12 25 9 116.8 60.8 
CLCA1b 319.2 9.9 32.380 1p22.3 20 8 116.7 17.5 
APOC2a b 301.6 9.9 30.372 19q13.2 17 10 66.6 43.4 
HDC a b 918.0 34.2 26.830 15q21-q22 11 8 59.9 168.1 
Under-expressed genes 
CDKL1 5.9 174.3 0.034 14q21.3 14 9 82.0 99.0 
GNG11 34.3 1,042.3 0.033 7q21 11 8 80.1 81.2 
RHOBTB1 7.7 241.3 0.032 10q21.2 20 8 49.7 97.4 
RPS12 34.6 1,157.2 0.030 6q23.2 20 15 77.4 112.4 
OLFM4 10.0 499.3 0.020 13q14.3 11 7 56.0 121.5 
 
Data refer to the following comparisons: TMD (pool 'C') vs. normal CB MK (pool 'E'). Value: mean gene 
expression value normalized across all the pool samples; Data points: number of spots associated to an expression 
value for the locus; SD: standard deviation for the expression value expressed as percentage of the mean. Full results 
available as additional material (see text).a The segment window contains more than one gene, but the significance is 
assumed to be maintained because the expression value of this over- or under-expressed gene prevails over the 
others. b This gene is one of the five most over-expressed ones, but the value is not statistically significant due to the 
presence of a lot of loci associated with less than 5 data points in the CB MK integrated dataset.  
	  	  80	   	  	  	  
4.2.10 Comparison with previously published data 
 
 As a result of the analysis above described, a reference integrated map for the expression of 
about 26,000 mapped sequences (~75% known genes and ~25% expression sequence tags - 
ESTs) was de facto generated for five cell types (DS AMKL cells, non-DS AMKL cells, TMD 
cells, MK and CB MK). This gave us the opportunity to compare our data with the expression 
values of specific known genes from previously published works about the considered cell types. 
 Following analysis of the main literature about AMKL, we selected 38 genes of interest and 
have tabulated their expression values desumed from our 9 differential maps, comparing these 
values to the ones previously described in different experimental settings (Table 35).  
 The wide agreement of expression ratio values for specific genes between our data, 
generated by systematic meta-analysis of hundred of thousands of gene expression values from 
any gene expression profile available, and the data obtained by different marker-specific 
methods in published quantitative studies, is relevant for the validation of our maps that may so 
be used for exploring any other expression ratio in the considered biological conditions. 
 
Table 35 Comparison with previously published data.  
 
Gene Location References 'A'/'B'  'A'/'D'  'B'/'D' 'A'/'E' 'B'/'E' 'A'/'C' 'C'/'D' 'C'/'E' 
MK Markers          
BST2 19p13.11 Ge 2006 0.53 5.36 10.07 7.21 13.56 7.97 0.67 0.91 
GATA1 Xp11.23 
Bourquin 2006 
Khan 2011 
Melemed 1997 
3.39 1.45 0.43 1.97 0.58 1.19 1.22 1.66 
GP1BA 17p13.2 Fuhrken 2007 0.46  0.07 0.14 0.25 0.53 0.81 0.08 0.30 
HBG1  11p15.5 Bourquin 2006 2.36 1.40 0.59 1.07 0.45 0.78 1.79 1.37 
HBG2 11p15.5 Bourquin 2006 2.47 1.31 0.53 1.06 0.43 0.71 1.84 1.48 
ITGA2B 17q21.32 Ge 2006 0.82 0.63 0.77 1.52 1.84 1.05 0.60 1.44 
ITGB3 17q21.32 Ge 2006 0.75 0.08 0.10 0.10 0.13 0.65 0.12 0.15 
PF4 4q12-q21 Lenzi 2011 0.90 0.06 0.06 0.11 0.12 0.44 0.13 0.25 
PPBP 4q12-q13 Lenzi 2011 1.45 0.10 0.07 0.13 0.09 0.28 0.34 0.44 
TAL1 1p32 Ge 2006 0.85 0.19 0.22 0.16 0.19 1.05 0.18 0.16 
Chr21 Genes          
ADAMTS1 21q21.2 Strippoli 2013 6.19 7.02 1.14 7.14 1.15 1.82 3.85 3.91 
BACH1  21q22.11  Bourquin 2006 1.86 1.44 0.77 1.04 0.56 1.55 0.93 0.67 
DYRK1A 21q22.13 Herrera 1998 1.61 0.87 0.54 0.63 0.39 1.14 0.77 0.55 
ERG 21q22.3 Bourquin 2006 Klusmann 2010b 0.68 3.47 5.12 3.10 4.57 1.42 2.44 2.18 
ETS2 21q22.2 Bourquin 2006 Klusmann 2010b 0.93 1.11 1.20 1.39 1.49 0.73 1.52 1.90 
GABPA 21q21.3  Bourquin 2006 Klusmann 2010b 1.39 2.45 1.76 1.52 1.10 1.55 1.58 0.98 
RUNX1 21q22.3 Bourquin 2006 Klusmann 2010b 0.71 1.08 1.51 0.84 1.18 1.06 1.01 0.80 
SOD1 21q22.11 Tonelli 2000 1.88 1.52 0.81 2.78 1.48 1.52 1.00 1.84 
SON 21q22.11 Bourquin 2006 1.28 1.39 1.08 1.03 0.80 1.44 0.96 0.71 
Other genes 
APOC1 19q13.2 Bourquin 2006 4.37 10.04 2.30 16.26 3.72 1.79 5.63 9.11 
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Ge 2006  
Lightfoot 2004 
APOC2 19q13.2 Bourquin 2006 4.36 37.04 8.49 43.48 9.96 1.43 25.88 30.37 
APOE 19q13.2 Bourquin 2006 Ge 2006 2.18 3.57 1.64 3.24 1.48 1.56 2.30 2.08 
CDA  1p36.2-p35 Ge 2006 0.39 0.40 1.03 0.88 2.24 0.88 0.46 1.00 
DICER1 14q32.13 Klusmann 2010b 0.80 0.41 0.51 0.27 0.34 0.99 0.41 0.27 
FCER1A  1q23 Bourquin 2006 Ge 2006 6.32 4.28 0.68 8.86 1.40 1.32 3.25 6.72 
GYPA 4q31.21 Ge 2006 3.40 1.56 0.46 0.89 0.26 1.19 1.31 0.75 
GYPB 4q31.21 Ge 2006 2.81 1.28 0.46 0.89 0.31 1.27 1.01 0.70 
GYPE 4q31.1 Ge 2006 2.07 1.63 0.79 1.71 0.82 1.72 0.95 0.99 
HDC 15q21-q22 Bourquin 2006 Ge 2006 17.10 9.95 0.58 32.72 1.91 1.22 8.16 26.83 
IGF1R 15q26.3 Klusmann 2010a 0.76 1.18 1.55 0.94 1.24 1.21 0.98 0.78 
ITGAL 16p11.2 Taniguchi 1999 0.79 0.21 0.26 0.09 0.11 1.02 0.20 0.09 
KIT 4q11-q12 Bourquin 2006  1.66 3.34 2.01 3.08 1.85 1.22 2.74 2.53 
MPL 1p34 Gear and Camerini 2003 1.11 0.31 0.28 0.22 0.20 1.23 0.25 0.18 
MTOR 1p36.22 Klusmann 2010a 0.87 1.57 1.82 1.94 2.24 0.89 1.76 2.17 
MYCN 2p24.3 McElwaine 2004 0.35 1.00 2.87 0.77 2.19 0.34 2.99 2.28 
PRAME 22q11.22 McElwaine 2004 1.60 11.59 7.24 15.61 9.76 4.18 2.77 3.73 
SMOX 20p13 Ge 2006 1.37 0.76 0.55 1.02 0.75 0.79 0.96 1.30 
ST18 8q11.23 Klusmann 2010b 0.90 0.74 0.82 0.74 0.82 0.78 0.96 0.95 
 
Expression values of genes known for their role in MK differentiation and DS or non-DS AMKL development in 
each of the eight comparisons: DS AMKL (pool 'A') vs. non-DS AMKL (pool 'B'); DS AMKL (pool 'A') vs. normal 
MK (pool 'D'); non-DS AMKL (pool 'B') vs. normal MK (pool 'D'); DS AMKL (pool 'A') vs. normal CB MK (pool 
'E') cells; non-DS AMKL (pool 'B') vs. normal CB MK (pool 'E'); DS AMKL (pool 'A') vs. TMD (pool 'C'); TMD 
(pool 'C') vs. normal MK (pool 'D'); TMD (pool 'C') vs. normal CB MK (pool 'E'). Data extracted from the full 
tables showing expression values and their ratio for about 17-26,000 loci for each comparison. In bold: expression 
ratio values are consistent with data available in the literature (see references indicated). The other values are 
reported for completeness. Descriptions of the gene symbols are given in Additional file 2 (available at: 
http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
 
 
4.3 HR-DSCR on human chromosome 21 and gene hunting 
 
4.3.1 HR-DSCR computational biology analysis  
 
 BLASTX research did not find a significant similarity with the amino acid sequences known 
in the region between 37,929,000-37,975,000 bp. Comparing the sequence of interest with the 
EST sequences cataloged in the GenBank  database, there was no evidence of the presence of 
EST sequences matching the HR-DSCR. 
 The FGENESH program shows the presence of a putative gene on the complementary 
strand consisting of 7 exons. The predicted amino acid sequence does not have homology with 
the amino acid sequences of known proteins, neither human nor of other organisms. Having 
found no prediction about the presence of genes encoding for protein on the reference filament, 
we focused on the research of transcripts with regulatory function. The miRBase (Kozomara and 
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Griffiths-Jones, 2014) analysis of the region NC_000021.9 between 37,959,229-37,963,130 
confirmed a significant homology between a stretch of about 100 bp and the known miRNA: 
hsa-mir-1273a (Figure 11). 
     
 
 
 
Figure 11 miRBase analysis of the 1,000 bp sequence on the NC_000021.9 between 37,959,001-37,960,000 bp. 
 
4.3.2 Putative miRNA1 molecular analysis  
 
4.3.2.1 Northern Blot (miRNA1 probe) 
 
 The labelling of the miRNA1 probe, used for hybridization on the MTN2 filter, was 
measured at the beta-counter, which took over a radioactivity of 1,093,898 counts per minute 
(cpm) in 1 µL. After the hybridization step, we proceeded with the exposure of the filter 
autoradiographically and subsequently developed in the darkroom. The development of the 
autoradiographic sheet made clearly visible two bands at the same height but in two different 
tissues, such as heart and skeletal muscle (Figure 12). 
 We measured the distance between the visible bands on the sheet and the loading wells and 
we reported the measurements in logarithmic scale on graph paper. Taking advantage of the 
straight line for the MTN2 filter, according to the method described in the Materials and 
Methods section, it was possible to convert the distance in millimeters in the number of 
nucleotides. Both bands correspond to a transcript of approximately 13.5 Kb (Figure 12). 
               1  2  3 4 5 6 7 8 9 10 11 12 
 
 
Figure 12 Autoradiographic sheet developed after 100 h of exposure to the commercial filter MTN2 hybridized 
with the probe for the putative miRNA1. Lane 2: total RNA of heart; lane 3: total RNA of skeletal muscle. In the 
other lanes the following total RNA are present: 1) brain, 4) colon, 5) thymus, 6) spleen, 7) kidney, 8) liver, 9) 
intestine, 10) placenta, 11) lung, 12) peripheral blood leukocytes. 
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 Exposure to the phosphor screen was acquired at PhosphorImager. The result was the same 
as the autoradiographic sheet (Figure 13). 
  
 
 
Figure 13 Capturing of PhosphorImager of phosphor screen after 24 hours of exposure to the commercial filter 
MTN2 hybridized with the probe for putative miRNA1. 
 
 
 Exposure to the phosphor screen was also performed after washing the filter necessary to 
remove the probe remained linked. The acquisition at the PhosphorImager showed that the 
washing is successful since the hybridization signal of the probe was no longer visible. 
 
4.3.2.2 Northern Blot (pri-miRNA1 probe) 
 
 Following the result described above we have designed a probe specific for a region longer 
than the previous examined. This probe is complementary to the sequence of the primary form of 
the putative miRNA1 and within the limits 37,959,623-37,959,673. The labelling of the pri-
miRNA1 probe, used for hybridization on the MTN2 filter, was measured at the beta-counter, 
which took over a radioactivity of 525,219 counts per minute (cpm) in 1 µL. After the 
hybridization step, we proceeded with the exposure of the filter to the autoradiographic sheet 
subsequently developed in the darkroom. The development of the autoradiographic sheet made 
clearly visible two bands at the same height (13.5 Kb) of those obtained in the first hybridization 
with the miRNA1 probe, in the same tissues such as heart and skeletal muscle (Figure 14).  
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  1   2   3   4   5  6  7  8  9  10 11 12 
 
 
Figure 14 Autoradiographic sheet developed after 72 h of exposure to the commercial MTN2 filter hybridized with 
the pri-miRNA1 probe. The hybridization signals are in lanes 2 and 3 and correspond, respectively, to total RNA of 
heart and skeletal muscle. 
 
4.3.3 DSCR4 locus genomic organization 
 
 The analysis on UCSC Genome Browser of the DSCR4 locus found the presence of a EST 
sequence aligned in part to the HR-DSCR with the identification code CB993317.  
We performed an analysis using the software NCBI Splign (http://www.ncbi.nlm.nih.gov/sutils/splign/) of 
this EST to identify possible splicing site against the entire genomic sequence of human 
chromosome 21. We obtained the alignment of EST to 4 exons which identify a new isoform of 
the gene DSCR4 not described. This isoform, referred to conventionally as DSCR4.2, has exons 
1 (E1) and 2 (E2) in common with the isoform 1, while differs for the lack of exon 3 (E3) and 
having the last two exons in 3' end, which are then classified as exon 4 (E4) and exon 5 (E5) 
(Figure 15). 
   
 
 
Figure 15 Genomic organization of locus DSCR4. Explanation in the text. 
 
 
 The data recorded in the NCBI database of the EST CB993317 show that it was identified 
from a cDNA library made from placental tissue. To confirm the genomic organization of the 
identified transcript, the relative electropherogram was obtained through the database UniGene 
(http://www.ncbi.nlm.nih.gov/unigene). 
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 The study of this circuit detects an excellent quality of sequencing, allowing the unequivocal 
confirmation of the two splice junctions E2-E4 and E4-E5 (Figure 16). 
                                                                            
 
 
Figure 16 Electropherogram of the EST sequence CB993317 illustrating the 6 bases just before and after the 
splicing sites E2-E4 (left) and E4-E5 (right).                                
 
 
 The exact boundaries of the exons (E) and introns (I) of the specific isoform 2 are given in 
Table 36. It is inferred that the overall extension of the DSCR4 locus is of 169,936 bp, due in 
particular to the addition of a very long intron. Compared to the previous estimate of 67,350 bp, 
the new model of the locus DSCR4 is increased by 102,586 bp. 
 
 Beginning End Dimensions 
bp 
Beginning 
CDS 
End 
CDS 
CDS 
bp 
DSCR4.2 E1 38,121,360 38,121,128 232 38,121,255 38,121,128 127 
DSCR4.2 I1 38,121,127 38,120,409 718    
DSCR4.2 E2 38,120,408 38,120,307 101 38,120,408 38,120,307 101 
DSCR4.2 I2 38,120,306 37,953,006 167,000    
DSCR4.2 E4 37,953,005 37,952,821 184 37,953,005 37,952,852 153 
DSCR4.2 I3 37,952,820 37,951,702 1,118    
DSCR4.2 E5 37,951,701 37,951,425 276    
 
Table 36. Exons and introns coordinates of the isoform DSCR4.2 (based on GenBank sequence NC_000021.9). 
     bp= base pairs; CDS= coding DNA sequence. 
 
 It is therefore legitimate to reconstruct the overall sequence of the new transcript identified, 
leading to the prediction of a sequence coding for a protein, in particular for a polypeptide of 127 
amino acids (Figure 17). 
  1 MSLIILTRDDEPRIFTPDSDAASPALHSTSPLPDPASASPLHREEKILPKVCNIVSCLSF 
 61 SLPASPTDSGLASPTIIRDPVASKSQLELSSRPAKTEPRAWSAQFGRCSAQPQPQVDFLP 
121 AENTCSG 
 
Figure 17 Sequence of the predicted amino acid product of DSCR4.2 transcript. The specific amino acids of this 
isoform are shown in blue. 
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 The systematic search of homology with other proteins using PSI-BLAST is not allowed to 
highlight any significant similarity to any polypeptide or known protein family, nor to functional 
domains. The polypeptide is identical to DSCR4 for the first 77 amino acids, then by departing 
from DSCR4 in the carboxyl-terminal region of the sequence. 
 
4.3.4 HRDSCR1 Locus  
 
 The results described above allow to identify and provide an initial description of a new 
complex locus contained in the HR-DSCR, which is conventionally called here HRDSCR1. The 
structure of this locus is derived from the demonstration that the stretch of about 100 bases 
identified as putative miRNA is actually transcribed and included in a long transcript of 
approximately 13 kb expressed in skeletal muscle and human heart. In addition, the bases present 
on the complementary strand are expressed as part of a large intron, which we identified as 
belonging to a new isoform of RNA transcribed from the known locus DSCR4 (Figure 18). 
 
 
Figure 18 Representation of the region of human chromosome 21 containing the two loci HRDSCR1 and DSCR4 
which have an opposite orientation. On strand 5'-3' we find the locus HRDSCR1 and on the complementary strand 
the locus DSCR4. Highlighted the region common to the two loci containing on the strand 5'-3' the putative 
miRNA1 precursor form. 
 
 
 From these data we can deduce that the 37.9 Mb region included in the HR-DSCR is not 
intergenic, as one might assume from current maps of human chromosome 21, but is transcribed 
and constitutes a new human locus. This locus appears bidirectionally transcribed leading to the 
formation of two partially overlapping transcripts at the level of the region of the putative 
miRNA1. 
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Chapter 5 
 
Discussion and conclusions 
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5.1 Systematic meta-analysis of gene expression profiles of normal human tissues  
 
 In this work we proposed an integrated model of the human transcriptome of the whole 
brain (adult and foetal) and three of the brain regions severely affected in Down syndrome (DS), 
such as the cerebellum, cerebral cortex and hippocampus (Haydar and Reeves, 2012), and of the 
whole heart. 
 TRAM software allowed us to integrate data from different sources, including data from 
different microarray experiments, also performed on different platforms through a method of 
intra-sample and inter-sample normalization (quantile scaled normalization). We used a set with 
a relevant number of samples to create a quantitative transcriptome reference map for each of 
tissues and organs. This map allowed us to identify critical genome regions which are 
over/under-expressed in normal brain and heart and are typical of these tissues compared to the 
pool of all the other human tissues. It also allowed us to assign a linear reference expression 
value to each locus. 
 
5.1.1 Whole normal human brain transcriptome map  
 
 The adult brain transcriptome map showed the highest expression value of a segment on 
chromosome 12, including the known genes TUBA1A, TUBA1B and TUBA1C (Baumann et al., 
1996; Okumura et al., 2013). This finding appears to be an evident genetic correlate of the well 
known main structural characteristic of the nervous system functional unit, the neuron. The 
cytoskeleton is most responsible for the neuron shape and function, it consists of microtubules 
and the expression of tubulins is typically used as a marker of neural differentiation. The alpha 
and beta tubulins represent the major components of microtubules. The analysis at single gene 
level showed that the first over-expressed gene is BCYRN1, while TUBA1B is the second. 
BCYRN1 encodes a small neural non-messenger RNA, the sequence contains a 5´ portion 
homologous to the Alu Lm (left-hand Alu monomer) and seems to have a regulative function 
(Wang et al., 2002; Mus et al., 2007). This RNA probably belongs to the subfamily of Alu-
elements over-represented in the transcriptome of brain tissue (Faulkner et al., 2009; Xu et al., 
2010). As pointed out by Lejeune (1988), some studies supported the hypothesis that deficiency 
in the neurotubule network could be associated with mental disorder (Nunez, 1985). The 
relationship between some mental disorders and increased levels of BCYRN1 was demonstrated. 
Its over-dosage seems to be associated with the increase of the cytoskeleton fibres causing a 
blockage in transport of the RNA within the cell due to the fibre overcrowding (Mus et al., 
2007). Among chr21 genes, SOD1, APP and DNAJC28 have the highest expression values. A 
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preclinical research study conducted on mice used both SOD1 and APP as therapeutic targets in 
support of the hypothesis of the over-dosage effect of chr21 genes in the pathogenesis of Down 
syndrome (Costa and Scott-McKean, 2013). The DNAJC28 gene has not yet been characterized 
and its function could be interesting to investigate.  
 To highlight the brain-specific gene expression profile, a comparison pool composed of 622 
datasets derived from 53 different human tissues or organs has been accurately assembled. 
Spinal cord samples (n=24) have been included in this pool, considering the distinctive 
anatomical and functional features of the brain and spinal cord, and the extensive overlapping of 
results when the spinal cord samples are included in or removed from the non-brain sample pool. 
 When we compare the adult brain gene expression with the pool of tissues minus brain gene 
expression, the highest statistically significant expression value is attributed to a segment on 
chromosome 5, including the known genes GABRA6, GABRA1 and GABRG2 encoding for 
subunits of the GABAergic receptor, one of the major inhibitory receptors in mammalian brain. 
An altered expression of GABA receptors is typical in the brains of subjects with autism and 
Fragile X syndrome, another common form of inherited mental retardation (D’Hulst et al., 2006; 
Fatemi et al., 2009). The significantly under-expressed segment is on chromosome 2 and 
contains REG1B, REG1A and REG3A genes, encoding for proteins secreted by the pancreas 
(Sanchez et al., 2001; Zhou et al., 2010; Christa et al., 1996). These data allow the affordable 
identification of genes expressed specifically in the brain and not in other tissues.  
 At single gene level, ANKRD30B is over-expressed in the adult brain compared to the pool 
of non-brain tissues. It is also known as the NY-BR-1.1 gene, a homologous gene of NY-BR-1, 
with which it shares 54 % of amino acids, but unlike NY-BR-1 gene expressed in breast and 
testis, it is also expressed in the brain. The ankyrin proteins carry out a wide variety of biological 
activities, they have a repeat motif recognized in more than 400 proteins, including cyclin-
dependent kinase inhibitors, transcriptional regulators, cytoskeletal organizers, developmental 
regulators, and toxins (Jäger  et al., 2001). 
 Among chr21 genes, DNAJC28, LINC00320, LINC00323, OLIG1 and OLIG2 are over-
expressed. OLIG1 and OLIG2 are known to have the function of transcription factors in 
oligodendrocytes, cells that perform the main function of myelination of neurons in the central 
nervous system. A recent study suggested a link between the over-dosage of OLIG2 in trisomy 
21 and the reduced brain size in affected individuals (Lu et al., 2012). Instead, LINC00320 and 
LINC00323 are non-coding sequences that may have a regulatory role and that seem to have a 
fundamental role in the adult brain because they maintain a low expression value in the foetal 
brain transcriptome map. Their function could be interesting to investigate.  
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 The foetal brain transcriptome map, as the adult brain transcriptome map, showed the 
highest expression value of the segment on chromosome 12, including the known genes 
TUBA1A, TUBA1B and TUBA1C. It is interesting to note that at two very different 
developmental stages of the human brain, the same chromosomal segment (12q13.12) is over-
expressed. At single gene level, TUBA1B has the highest expression value. Among the genes of 
chr21, DNAJC28, followed by SOD1 (1,657.36) and ATP5O are over-expressed. In this case we 
note the same DNAJC28 and SOD1 expression patterns between adult and foetal brain, while it 
is interesting to note that ATP5O is over-expressed. 
 Comparison between the foetal brain and the adult brain transcriptome map showed the 
highest expression value of a segment on chromosome 8, including the known gene BHLHE22 
and the uncharacterized loci, LOC100130155 and Hs.388788. BHLHE22 gene encodes for a 
transcription factor that regulates cell fate determination, proliferation, and differentiation (Xu et 
al., 2002). It seems to be involved in neuronal development rather than in the functions 
performed by the adult brain. LOC100130155 and Hs.388788 are loci which have not yet been 
characterized but are probably fundamental in brain development.  
 At single gene level there is a high expression ratio for TMSB15A gene and for DCX gene, 
which have an increase of 63.15 times and of 42.79 times, respectively. The former is involved 
in cellular motility (Bao et al., 1996; Gu et al., 2008). Its expression profile was analyzed in 
normal and pathological tissues (Yokoyama et al., 1996) and it was considered a neuroblastoma 
specific gene. The derivation of neuroblastome from neuroblasts or nerve undifferentiated cells 
allows us to draw the further conclusion that neuroblastoma specific genes might include genes 
that are especially expressed in the developing nervous system. The DCX gene is involved in 
neuronal migration during development by regulating the organization and stability of 
microtubules (Fung et al., 2011; Bechstedt and Brouhard, 2012). It was demonstrated that DCX 
mutations are associated with disorders caused by an abnormal migration of neurons during 
development (Hehr et al., 2007). The low expression ratio of LINC00320 could be significant of 
the regulatory role played by this locus in the adult brain only. This information favours the 
hypothesis that the foetal brain transcriptome map can be used as a reference for the rapid 
identification of genes involved in the development of the central nervous system. 
 We noted that many differences exist between the gene expression patterns of the adult and 
foetal brain, indeed many adult brain genes are not yet active at such an early phase of 
development as the foetal stage, while many foetal brain genes which are less active in the adult 
brain are possibly those involved in brain development. 
 The experimental screening was performed on the adult brain transcriptome map through a 
"Real-Time" RT-PCR experiment using 9 genes selected from the brain TRAM map (see 
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"Materials and Methods"). One of these genes is chosen as reference, according to its medium-
high expression value among the 9 genes selected. The observed and expected expression ratios 
are listed in Table 16. It is interesting to note that the correlation between the values calculated 
by TRAM using 60 normal human brains and an experimental comparison using independent 
samples is maintained through several orders of magnitude and from the lowest to the highest 
values.  
 The significant correlation indicates that the alternative method of sample collection – a 
different tissue source of the sample and the different post-mortem interval of tissue retrievement 
– was neutralized by the high number of samples. In fact, as regards the post-mortem interval 
(PMI), it was proven that undegraded mRNA may be isolated from most brain regions many 
hours postmortem (up to 30 hours), so the PMI is not actually predictive of mRNA integrity 
(Ervin et al., 2007).  
 Although there are studies showing a sex-biased brain gene expression (e.g., Trabzuni et al., 
2013), it was also proven that gender does not have a significant influence on the observed gene 
expression changes, at least when a significant number of samples is available for study 
(Lockstone et al., 2007). Following the observation by Trabzuni and coll. (2013) that a minority 
of genes (2.6%) presents sex-biased expression level in specific brain subregions, it is expected 
that differential gene expression analysis between male and female whole brains affects a small 
number of genes. Table 5 shows the first ten over-/under-expressed genes identified by our 
analysis. For several of them we have found literature evidence about their relationship with 
gender (e.g., DRD4 (Vawter et al., 2004; Dmitrieva et al., 2011), FTHL17 (Wang et al., 2001), 
XIST (Brown et al., 1992). DRD4 gene, encoding for D4 subtype of the dopamine receptor, 
seems to be involved in the difference in the number of dompaminergic neuron between males 
and females (Vawter et al., 2004). DRD4 gene has been extensively studied for its possible 
association with increased vulnerability to antisocial and impulsive behaviour, including 
behaviour recurrent in males and not in females (e.g., Dmitrieva et al., 2011). FTHL17 gene, 
encoding for ferritin, heavy polypeptide-like 17, was described as a typical example of X-linked 
genes expressed only in male germ cells (Wang et al., 2001). It could be interesting to 
investigate its linkage with brain tissue. XIST gene, encoding for X inactive specific transcript 
(non-protein coding) (Brown et al., 1992) has the lowest expression ratio between male and 
female brain in the differential transcriptome map, demonstrating that it is a gene typically 
expressed in females. These results are a confirmation of the reliability of the data produced by 
our map. 
 For the others genes shown in Table 5, it would be interesting to investigate their 
relationship with gender, in particular for the neuronal gene NPAS4, encoding for neuronal PAS 
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domain protein 4 and seeming to be involved in the transcriptional regulation of some neural 
genes in the brain (Ooe et al., 2004), and for CCL3, IL1B and CCL4 genes encoding respectively 
for chemokine (C-C motif) ligand 3, interleukin 1, beta and chemokine (C-C motif) ligand 4, all 
three of which are involved in immune system responce (Guo et al., 2003; Zunszain et al., 2012). 
 In summary, the high correlation (r=0.94, data not shown) between the male- and female-
derived gene expression values support the utility of a human brain map as a general standard 
reference, while the creation of differential expression maps comparing male- and female-
derived samples remains feasible using our approach, and may highlight sex-biased differences 
for specific genes, whether they are located on the sex chromosomes or not. 
 The experimental validation of our map allows us to consider all the other intervening 
values among the points we selected as bona fide values, thus for the first time providing a 
complete and quantitative representation of the reference expression values for 39,250 mapped 
and 26,026 unmapped transcripts of the normal human brain.  
 The initial analysis of the biological meaning of these data clearly shows a relationship of 
our findings with what is already known about genes which have either a relevant function or are 
almost silenced in the brain. While the correlation between the values obtained by meta-analysis 
of multiple gene profiling datasets and independent samples assayed by a different method 
(Real-Time RT-PCR) is excellent, some remaining differences may easily be attributed to the 
physiological biological differences among the samples, as well as to experimental error. In 
some cases, specific differences in the method of analysis can explain the variability of the 
expression value. For instance, BCYRN1 contains a 5´ portion homologous to the Alu Lm, and 
the corresponding array probe (37 bp) recognizes this domain. So it is possible that, in addition 
to BCYRN1, other members of this family of interspersed repetitive DNA (Martignetti and 
Brosius, 1993) hybridized to the probe. This could explain a hybridization signal higher than that 
observed, indeed the observed gene expression relative to the reference gene is 7.11 by RT-PCR 
and 12.8 by meta-analysis of cDNA hybridization microarrays. 
 
5.1.2 Cerebellum transcriptome map 
 
 The cerebellum transcriptome map showed the highest expression value of a segment on 
chromosome 11 containing an EST cluster and the long non-coding RNA (ncRNA), MALAT1 
(Kryger et al., 2012). This ncRNA is very abundant in neurons where it controls the expression 
of a subset of genes significantly involved in nuclear and synapse function and regulates 
synaptogenesis (Bernard et al., 2010). At single gene level BCYRN1 is over-expressed as in the 
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whole brain, while among chr21 genes, DNAJC28 and SOD1 remain the genes with the highest 
statistically significant expression values. 
 When we compare the cerebellum gene expression map with the adult brain gene expression 
map, the highest value is attributed to CBLN3. It is a new member of the precerebellin family 
coding for a neuropeptide detected in the granule neurons of cerebellum that, together with 
CBLN1, regulate synapse integrity and plasticity in Purkinje cells (Iijima et al., 2007). The 
lowest expression value is attributed to NRGN. This gene has specific functions in the cerebral 
cortex (Li et al., 2003), it is a target of thyroid hormone and in hypothyroidism conditions suffers 
an altered control of expression which causes mental disorder during development (Shen et al., 
2012). The experimental validation of the expected data was made on 8 genes of the whole 
cerebellum transcriptome map, again finding a higly significant statistical correlation. We noted 
that the observed expression ratios of RCAN1 and GPCPD1 indicate their over-expression in 
comparison with the reference gene instead of being under-expressed as the data anticipated. 
This result could be due to a SD as a percentage of expression calculated by TRAM >95 for 
RCAN1 and GPCPD1. A high SD could explain the significant distance between expected and in 
vitro observed results, indeed the exclusion of RCAN1 and GPCPD1 from the statistical analysis 
determines the increase of the statistical correlation from 0.96 to 0.97. 
 
5.1.3 Cerebral cortex transcriptome map  
 
 In the cerebral cortex TRAM map the significantly over-expressed segment is again on 
chromosome 12, including the over-expressed known genes TUBA1A, TUBA1B and TUBA1C. 
At single gene level, the EST cluster Hs.732685 is the first over-expressed locus, followed by 
TUBA1B. Among chr21 genes OLIG1, PCP4 and SOD1 have the highest statistically significant 
expression values. PCP4 is known to be highly expressed in the brain, primarily in the Purkinje 
cells, a class of GABAergic neurons located in the cerebellar cortex (OMIM entry #601629).  
 When we compare the cerebral cortex gene expression with the adult brain gene expression, 
the over-expression of the KRTAP13-2 gene encoding for a protein associated to keratin, is 
interesting. In contrast, DNAJC28 and LINC00320 are under-expressed: the only time this 
happens to DNAJC28 in our maps. The experimental validation of the expected data was made 
on 8 genes of the whole cerebral cortex transcriptome map. The gene expression value as 
calculated by TRAM for GAPDH, NCDN and RCAN1 was not observed. The first two have a SD 
as a percentage of expression calculated by TRAM >95, while the third has a SD of 90 %. The 
statistical correlation between expected and observed ratios is not significant. To improve the 
correlation, we excluded those genes with a SD as percentage of expression value >95 from the 
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statistical analysis and, in fact, after this selection, the correlation became highly significant. 
 Applying the same criterion to the previous maps which were experimentally screened, the 
correlation remained the same in the whole brain transcriptome map (Figure 3b), whereas it 
further increased in the whole cerebellum transcriptome map (Figure 4b). That the significance 
was maintained confirms the theory that our maps could be used as a reference for expression 
studies performed on whole brain.  
 
5.1.4 Hippocampus transcriptome map 
  
The hippocampus transcriptome map showed the highest expression value of a segment 
on chromosome 12 (12q13.12) (Table 6), including the over-expressed known genes TUBA1A, 
TUBA1B and TUBA1C. The over-expression of this segment was already found in the whole 
brain transcriptome map (Caracausi et al., 2014). It describes the main structural feature of the 
nervous system functional unit, the neuron, characterized by the preponderant extension of the 
neurotubules of its cytoskeleton. This segment returns as the fourth over-expressed, including 
two other genes: ARF3 and DDN. It is worth the presence, together with the tubulin genes, of the 
DDN gene encoding for a protein which interacts with the cytoskeleton components and seems 
to modulate the structure of the postsynaptic cytoskeleton (Kremerskothen et al., 2006). The 
second over-expressed segment is on chr8 (8p21.2) (Table 6), including the known genes 
BNIP3L, PNMA2 and DPYSL2. This genome region was found to have links with the severe 
mental disorder schizophrenia (SZ) (Fallin et al., 2011). This is a gene-rich region which 
includes 32 annotated genes, among them the strongest statistical evidence of association with 
SZ is for DPYSL2 (Fallin et al., 2011). In mammals, DPYSL2 is required to induce axonal 
outgrowth, maintaining neuronal polarity and promoting microtubule assembly in hippocampal 
neurons. It has been implicated in multiple neurological disorders associated with impaired 
neuronal plasticity and neurodegeneration (Czech et al., 2004; Williamson et al., 2011).  
 A segment representation of the genome could help to identify chromatin domains whose 
genes are encoding for proteins interacting with each other or belonging to the same cell 
pathway. This is the case of the over-expressed segment on chrX, including the genes of the 
BEX (brain-expressed X-linked) family: BEX1, BEX2 and NGFRAP1 (Table 6), which are 
known to be involved in the same neuronal signaling pathway (Naderi et al., 2007).  
 At single gene level, the over-expression of an EST cluster, Hs.732685 (mapping within the 
known locus MALAT1, as showed in the Results section), and of the known gene CALM2 
followed by TUBA1C and TUBA1B emerges (Table 7). CALM2 is an intracellular Ca2+-binding 
protein found mainly in the central nervous system (Shirasaki et al., 2006). It mediates many 
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physiological functions in response to changes in the intracellular Ca2+ concentration, such as 
neuronal cell death due to Ca2+ overload in neurons after excitotoxic insult. It was reported that 
calmodulin antagonists protect hippocampal CA1 neurons against hypoxia and attenuate brain 
damage after transient focal ischemia (Sun et al., 1997; Sato et al., 2003). TUBA1A, TUBA1B 
and TUBA1C are among the first ten over-expressed genes of the hippocampus transcriptome 
map. Alpha and beta tubulins are typically used as markers of neural differentiation (Kumar et 
al., 2010; Okumura et al., 2013). They are needed for neurotubule network assembling, which is 
fundamental for neuron shape and function and seems to be disturbed in some mental disorders 
(Lejeune, 1988; Baumann et al., 1996). 
 Due to the fact that the hippocampus is one of the main brain sub-regions which is severely 
affected in DS (Bartesaghi et al., 2011), particular attention was paid to the expression of chr21 
genes in this brain region. Among the chr21 genes, the over-expression of SOD1 and OLIG1 
emerges (Table 7). They typically have a high expression pattern in the whole brain (Caracausi 
et al., 2014). Ahead of them, the long intergenic non-protein coding RNA, LINC00114, also 
known as C21orf24, is over-expressed. It was previously identified following a study of detailed 
annotation of a genomic DNA region (21q22.2-q22.3) on human chromosome 21 (Owczarek et 
al., 2004). The characterization of C21orf24 identified six different mRNA alternative splice 
forms, and the failure to identify any significant open reading frames in all the alternative splice 
forms suggests that it should be classified as a gene for non-coding RNAs (Owczarek et al., 
2004). The LINC00114 sequence turns out to be identical to the C21orf24 isoform 3, as shown 
by a BLASTN analysis. The relational database at the core of the TRAM software allowed us to 
track the probes for LINC00114 used by the microarray platforms included in our analysis, and 
showed that they actually are identical to C21orf24 isoform 6. We tried to clone this sequence 
and found that it is not over-expressed as it appears to be from the microarray hybridization 
signal (data unshown). We did not find repeated sequences in the region recognized by the 
probes, so this finding remains unexplained. 
 The differential transcriptome map obtained by the comparison of the hippocampus vs. the 
whole brain transcriptome map again showed, at single gene level, the over-expression of the 
chr21 locus, LINC00114, suggesting a typical hippocampal function. Among the other over-
expressed genes there are SLC44A4 and IL10 genes (Table 8). SLC44A4 belongs to a new 
family of choline transporters, the choline transporter-like proteins (CTL1-5). A recent study 
showed its functional linkage to acetylcholine synthesis and secretion in non-neuronal cells 
(Song et al., 2013), even if our data show its exact over-expression in the brain sub-region. 
Interleukin-10 (IL-10) is a cytokine with anti-inflammatory properties which negatively 
modulates proinflammatory cascades at multiple levels in the central nervous system. Cytokines 
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are involved in bidirectional signaling between the central nervous system and the peripheral 
immune system, and play a role in cognitive processes. Cytokines also take part in the regulation 
of neurogenesis: the proliferation of new neurons which is crucial for hippocampal functions 
such as learning and memory (Arisi, 2014). 
 Emerging as one of the most expressed chr21 genes is the AIRE gene (Table 8), encoding 
for an autoimmune regulator performing a fundamental function in the thymus. Its expression 
was studied in DS individuals whose immune phenotype is characterized by thymus hypotrophy 
(Lima et al., 2011). It is under-expressed in DS individuals compared to normal individuals, 
probably due to a down-regulation of this gene among the chr21 genes as an effect of the 
genomic-dosage imbalance (Prandini et al., 2007).  
 Analysis of the differential transcriptome map also allowed us to identify the genes with a 
low expression level in the hippocampus, which probably do not have a typical function in this 
brain structure when compared to the whole organ. For example, the under-expression of 
DNAJC28 gene (Table 8), previously found to be a typical brain gene compared to a pool of non-
brain tissues (Caracausi et al., 2014), may imply that the hippocampus is not the cerebral sub-
region in which it performs its function. In addition, this gene has a high expression level in the 
foetal brain and in the cerebellum vs. whole brain but, in the cerebral cortex only, it has a 50-fold 
decrease (Caracausi et al., 2014). These data confirm that the brain is a very complex organ and 
that a reference transcriptome map of its sub-regions is necessary in order to piece together how 
they individually function. 
 Studies showing a sex-biased brain gene expression (Trabzuni et al., 2013) led us to 
investigate whether gender has a significant influence on the hippocampus gene expression 
profile observed in our analysis. We performed an additional differential transcriptome map to 
investigate specifically sex-biased gene expression patterns.  
 The relationship between gene expression profile and gender was found for the genes 
included in the genomic segments which were significantly over-/under-expressed in the 
differential transcriptome map. The first over-expressed segment is on chrY (Table 9) and 
includes TTTY15, USP9Y and DDX3Y, all encoding for products involved in spermatogenesis 
and having at single gene level an expression ratio higher than 2. The first under-expressed 
segment is on chromosome X and includes the known genes XIST, JPX and FTX. All deriving 
products are involved in the chrX inactivation process and their expression ratio is lower than 
one. XIST in particular has a 2.8-fold decrease, confirming that it is a typically expressed gene in 
females. These results are an additional confirmation of the reliability of the data produced by 
our map.  
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 At single gene level, the highest expression ratios were observed for genes that have a 
typical function in the muscles (Table 10). The sex-biased expression of these genes suggests 
that they could behave like tissue-indipendent gender-specific transcripts (Staedtler et al., 2013). 
 To be sure that gender did not lead to a significant global gene expression variation, we 
performed a statistical bivariate analysis between male and female gene expression values. This 
showed a significant correlation of data (r=0.98, p-value<0.0001) (Figure 2), probably because, 
when a great number of samples (n=41) is available, the numerous demographic differences do 
not affect this kind of analysis (Lockstone et al., 2007). In agreement with a recent study by 
Trabzuni et al. (2013) showing that a small number of genes (2.6%) presents sex-biased 
expression levels in specific brain sub-regions, we noted that XIST – specifically activated in 
female cells to start the X-inactivation process – is the most differentially expressed chrX gene 
in female (value=606.58) and male (value=215.35) hippocampus (ratio=2.8). In contrast, genes 
located in the pseudoautosomal region of chrX – which are known to escape X-dosage 
compensation and to be represented in two active copies in both female and male cells – appear 
to be expressed at very similar levels (for example, ratio=1.23 for ASMT and ratio=1.16 for 
ARSD). 
 To prove the reliability of the hippocampus transcriptome map generated by TRAM 
software, we performed an experimental validation of the obtained data. The significant 
correlation between the expected and observed data (r=0.99, p-value<0.0001) (Figure 6) allows 
us to consider all the other intervening values among the points we selected as bona fide values, 
thus for the first time providing a reliable and quantitative representation of the reference 
expression values for 30,739 mapped transcripts of the normal human hippocampus.  
 Initial analysis of the biological meaning of these data clearly shows a relationship of our 
findings with what is already known about genes which have either a relevant function or are 
almost silenced in the hippocampus.  
 While the correlation between the values obtained by meta-analysis of multiple gene 
profiling datasets and independent samples assayed by a different method (Real-Time RT-PCR) 
is excellent, some differences between the two types of data are not to be excluded, due to the 
physiological and biological differences among the samples, experimental errors during 
microarray analysis, or differences in the method of analysis.  
 The availability of the systematic and detailed expression map presented here for the 
hippocampus represented an excellent occasion to investigate, among many features of the 
transcriptome, the suitability of individual genes as the best stable reference genes for data 
normalization in gene expression studies. This is because they fulfill criteria including a widely 
diffused, constant and high expression (Casadei et al., 2011). The results offer a selection of 
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many known genes and uncharacterized loci, mostly EST clusters (Supporting Information Table 
S5, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). We would like to enfasize 
that TBCB is the best gene at behaving like a housekeeping gene (Supporting Information Table 
S5, available at: http://apollo11.isto.unibo.it/suppl/2015_Caracausi/). It encodes for a tubulin 
cofactor which is fundamental for the polymerization of microtubules, the main components of 
which are over-expressed in our transcriptome map. It is also involved in microglial cytoskeletal 
changes during microglia transition in response to injury or pathogen invasion of the central 
nervous system (Fanarraga et al., 2009). 
Until now, no study had been carried out by relating such a large number of samples, 
integrating data from several experiments conducted on different platforms, and providing 
information about 39,250 loci in the adult brain map, about 38,163 loci in the cerebellum map, 
about 27,504 loci in the cerebral cortex map and about 30,739 loci in the hippocampus map. The 
new TRAM version issued includes updated gene tables of Entrez Gene and UniGene, 
improving gene localization data and parsing. It solves the problem of many aliases of each 
gene, allowing the correct assignment of each probe to the loci for known transcripts and EST 
clusters. The EST clusters and the uncharacterized loci mentioned in our work would be 
interesting to investigate. Their localization was derived from UCSC “ESTs” track in the UCSC 
Genome Browser (Kuhn  et al., 2009), which was also imported and processed during the TRAM 
set-up (Lenzi et al., 2011).  
 There are several databases and atlases of brain gene expression with specific features 
publicly available online, for example GeneCards (Safran et al., 2010), Allen Atlas (Hawrylycz 
et al., 2012) and BrainSpan Atlases (http://www.brainspan.org/). GeneCards is an integrated 
database that provides genomic, transcriptomic, proteomic, genetic, clinical, and functional 
information on human genes. However, it provides transcriptomic information that comes from a 
limited number of hybridization experiments performed only on the Affymetrix GeneChip HG-
U95 set. Furthermore, this database does not give information about uncharacterized loci, such 
as EST clusters. Allen Brain Atlas is a transcriptional atlas of the adult human brain comprising 
microarray profiling performed on macrodissected and on laser microdissected brain regions. It 
provides expression data on brain specific regions. It provides a very useful amount of data for 
the experimenter but remains incomplete when searching for data derived from whole tissue and 
from a large number of samples. Furthermore, the number of loci and the number of 
hybridizations per single locus are lower than those analyzed by TRAM software. This is 
confirmed by the data attributed to SOD1 expression in the brain. Although it is possible to see 
the expression of SOD1 for each macrodissected brain region, it is not possible to have a 
reference expression value for the entire tissue. The hybridization signal is only provided by two 
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probes which are both from the same platform, whereas the one provided by our transcriptome 
map was obtained from the normalization of 96 data point expression values and 9 different 
platforms. The TRAM data for BCYRN1, the gene with the highest expression value in the brain, 
is not searchable in the Allen Atlas, probably due to the low number of genes about which it 
gives information, and the same goes for clusters of EST. The different type of data does not 
allow us to make a comparison between the expression values provided by TRAM and those 
provided by the Allen Atlas. BrainSpan Atlas is an atlas of spatio-temporal gene expression 
profiles obtained by RNA sequencing and exon-array performed on macrodissected tissues at 
different stages of human development. Neither of these atlases corresponds with our goal of 
determining the whole brain gene expression profile using a wide range of data to provide a 
normalized reference expression value for each human transcript, with the chance of integrating 
them even if they come from multiple experiments carried out on different platforms (Lenzi et 
al., 2011). 
 The availability of the systematic and detailed expression maps presented here for several 
human tissues represented an excellent occasion to investigate, among many features of the 
transcriptome, the suitability of individual genes as the best ones for selection as reference genes 
in gene expression studies. This is because they fulfil criteria including a widely diffused, 
constant and high expression. The results consist of many known genes and uncharacterized loci, 
mostly EST clusters. The enhanced function is related to the known genes of each group. It is 
interesting to note that the non-brain tissue pool and the foetal brain share the same enriched 
function, i.e. structural constituent of ribosome (GO:0003735), a function associated with genes 
that result constitutively expressed in the cells although it is not associated with the same genes. 
Furthermore, the enriched function of the adult brain is unfolded protein binding (GO:0051082). 
We analyzed only these maps to verify if the housekeeping genes shared among the pool of 53 
tissues are also present in the whole adult and foetal brain.  
 Finally, it would be interesting to investigate the role of certain ncRNAs emerging from our 
analysis when the corresponding probes were present on the experimental platform.  
 Our maps can provide a useful and ready reference benchmark to test hypotheses about 
localized gene expression levels of human transcripts in the brain and in three brain subregions 
such as the cerebellum, the cerbral cortex, and the hippocampus, regions severely affected in ID. 
These data could also contribute to a better understanding on a regional (chromosomal) basis of 
the chr21 gene expression (Strippoli et al., 2013). Its over-expression in trisomy 21 is associated 
with the most common form of constitutional ID. 
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 The transcriptome maps can easily be extended to many other tissues and pathological 
conditions to obtain a quantitative dissection of regional gene expression levels within a certain 
tissue, or of differential expression between two biological conditions. 
 
5.1.5 Whole heart transcriptome map 
 
The quantitative transcriptome reference map of the whole normal human heart provided 
a reference typical value of expression for each the 43,360 known, mapped and 22,976 
uncharacterized (unmapped) transcripts.  
The heart transcriptome map showed the highest expression value of a segment on chr1 
(1p36) and includes the over-expressed known genes NPPA, NPPB and MFN2 encoding 
respectively for natriuretic peptide A, natriuretic peptide B and mitofusin 2 (Table 11). NPPA 
and NPPB belongs to the natriuretic peptide family and are synthesized as precursor proteins 
which undergo intracellular modification (cleavage events) to produce cardiac hormones 
involved in the cardiovascular homeostasis. Both are expressed in cardiac tissue and are used as 
diagnostic tools in cardiovascular disease (de Lemos et al., 2003; Song et al., 2005). MFN2 is a 
mitochondrial membrane protein, whose expression levels are used as a diagnostic tool for 
severe cardiovascular diseases as vascular proliferative disorders (Sorianello et al., 2012). 
Remarkably, genes encoding products with very different functions (endocrine and 
mytochondrial, respectively) result as belonging to the same cluster expressed at very high levels 
in the heart. The second over-expressed segment is on chr14 (14q11.2) (Table 11) and includes 
the over-expressed known genes: PSMB5, encoding for subunit beta 5 of the proteasome 20S, 
MYH6, encoding for myosin, heavy chain 6, cardiac muscle, alpha, MYH7, encoding for myosin, 
heavy chain 7, cardiac muscle, beta. It is well known that the MYH6 map  ~4kb downstream of  
MYH7 (Matsuoka et al., 1989) and their expression and relative abundance of the proteins are 
correlated to the contractile velocity of cardiac muscle (Nakao et al., 1997). Both have been 
previously studied for their involvement in heart disease (Posch  et al., 2011), with the 
conclusion that they are involved in different forms of congenital heart disease, both in 
association with mutation in the cardiac muscle actin gene (ACTC1) (Budde et al., 2007; 
Monserrat et al., 2007; Granados-Riveron et al., 2010). 
At the single gene level, the over-expression of genes encoding for proteins involved in 
typical cardiac tissue structure and function emerge (Table 12). Cardiac muscle, although 
structurally and functionally similar to skeletal muscle, has some special features: a larger 
diameter of cardiac fibres necessary for the relatively high concentrations of stored cytosolic 
Ca2+, independent of extracellular supply; due to specialized groups of cells called pacemakers, 
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cardiac muscle is able to initiate its own contraction and rhythm without the requirement of 
external stimulation from motor neurons in order to contract; finally, myocardial cells are short, 
branched and interconnected with adjacent cells by gap junctions or electrical synapses (Davison 
et al., 2000). All these features enable a large mass of cardiac myocytes to contract 
autonomously as single cell block. The cardiac muscle fibres have a high aerobic oxidative 
capacity, and they consist of a great number of mitochondria and aerobic respiratory enzymes 
(Davison et al., 2000). The high demand of oxygen is also reflected in high levels of myoglobin 
and a richer capillary supply (Gray and Standring, 2005). Recent developments in genetic 
investigations and molecular analysis have greatly increased our understanding of the 
mechanisms involved during the process of muscle contraction. These mechanisms are well 
represented in the quantitative map of the heart transcriptome that we have obtained in that genes 
expressed at the highest levels are implied in the key structural and functional cardiac pathways, 
both considering the heart in itself as well as in comparison with non-cardiac tissues. This also 
suggests that other genes with less characterized roles in the heart but with a relevant expression 
in this organ may have critical functions for cardiac molecular physiopathology. In particular, 
the known genes with the highest levels of expression are: MYL2 (expression value=10,216.56), 
MYH7 (expression value=8,725.76) and MB (expression value=8,283.87) (Table 12), clearly 
associated to the contractile apparatus and the oxygen supply to it. They are followed by other 
genes involved in the main function of cardiac cells as TCAP (expression value=6,352.89), 
encoding for the protein involved in the titin linkage to Z-disc of sarcomer, NPPA (expression 
value=6,332.35), cited above, the gene for the cardiac muscle actin, ACTC1 (expression 
value=5,779.15), and genes encoding for the three closely associated proteins of the troponin 
complex, i.e. troponin C (calcium binding), TNNC1 (expression value=5,550.96), troponin I 
(inhibition of tropomyosin binding), TNNI3 (expression value=4,648.05), and troponin T 
(tropomyosin binding), TNNT2 (expression value=3,947.73) (Table III in the Data Supplement, 
it is available at: http://apollo11.isto.unibo.it/heart, in the event of acceptance of the manuscript 
it will be available at: http://apollo11.isto.unibo.it/suppl/it will be available at: 
http://apollo11.isto.unibo.it/suppl/). They encode for troponin proteins exclusively expressed in 
the cardiac muscle tissue distributed along the length of the thin filament and together with the 
tromyosin, TPM1 (gene expression value=1,778.49) (Table III in the Data Supplement, it is 
available at: http://apollo11.isto.unibo.it/heart, in the event of acceptance of the manuscript it 
will be available at: http://apollo11.isto.unibo.it/suppl/) undertakes the control of initiation, 
inhibition and speed of contraction of  skeletal and cardiac muscle (Davison et al., 2000). TPM1 
is one of the four known tropomyosin genes predominantly expressed in the heart (Davison et 
al., 2000), unlike the other isoforms (TPM2, TPM3 and TPM4) which have a lower expression 
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level in cardiac tissue (Table III in the Data Supplement, it is available at: 
http://apollo11.isto.unibo.it/heart, in the event of acceptance of the manuscript it will be 
available at: http://apollo11.isto.unibo.it/suppl/), as was already known (Davison et al., 2000). A 
high level of expression was also observed for  TTN (expression value=1,794.78), which 
completes the list of the genes encoding the main sarcomeric proteins. Being closely associated 
with the myosin thick filament, it is elastic and changes length as the sarcomer contracts and 
relaxes (Alberts et al., 2007). This quantitative representation of gene expression in the human 
heart, obtained without any a priori specific assumption and fully coherent with established 
biological knowledge about cardiac structure/function, seems to visualize at the molecular level 
the classical description of the basic histology of cardiac tissue. 
Due to the fact that the heart is one of the organs principally involved in the typical 
symptoms of DS (Strippoli et al., 2013), particular attention was paid to the expression in the 
transcriptome map of chr21 genes, which were actually revealed to be over-expressed in 
transcriptome maps generated by TRAM when comparing diploid and trisomic blood cells 
(Pelleri et al. 2014). Among the first five chr21 genes, ATP5J and ATP5O, encoding for 
mitochondrial protein involved in the cell respiratory chain, are over-expressed, followed by 
SOD1 (Table 12). 
 It is interesting to check if our transriptome model is coherent at a quantitative level with the 
ratio of gene products found at precise relative amounts in the heart. We will illustrate two 
typical examples: sarcomere structural proteins and proteins involved in the production of 
energy. 
 The sarcomere is a unique example in biology of a sub-molecular structure that has 
exceptional stability and organisation due to hundreds of molecules gathered among them. It is 
limited by two Z-discs, and consists of thin and thick filaments. The thin and thick filaments are 
the most important elements for the execution of the contraction cycle. The thick filaments 
consist mainly of myosin and myosin binding protein as MyBP-C. The thin filaments consist of 
cardiac actin, α-tropomyosin and C-, Ι- and Τ- troponins. The Z-disc, which separates myofibrils 
in sarcomeres, is the site that binds the thin filaments through alpha-actinin and the beta-subunits 
of CapZ protein and the giant protein, titin, through the T-cap (Sarantitis et al., 2012). Some of 
these proteins are described to interact among them with an expectable, if not accurate, 
stoichiometric ratio (Davison et al., 2000; Sarantitis et al., 2012). For instance, the C-, I- and T-
troponins associate with each other to form the troponin complex in a stoichiometry of 1:1:1. We 
observed if there was a correlation between this stoichiometry and our whole normal human 
heart transcriptome map gene expression level among the specific cardiac troponin (TNNC1, 
TNNI3 and TNNT2), and we found a ratio of 1.19:1 between TNNC1 (expression 
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value=5,550.97) and TNNI3 (expression value=4,648.05) genes, 1.18:1 between TNNI3 and 
TNNT2 (expression value=3,947.73), and 1.41:1 between TNNC1 and TNNT2, suggesting that in 
this case, as it is often supposed, the main regulatory mechanisms controlling the amount of the 
protein are localized at the very initial step of gene expression. These observations confirm 
similar findings such as the coexpression at high and similar levels of hemoglobin A and B genes 
(HBA and HBB) in the blood (Piovesan et al., 2013).  
 Similarly, subunits ATP5J and ATP5O are known to be part of the same respiratory chain 
complex being present in equivalent amount. At the mRNA level, our map assigns the 
expression values to the relative encoding genes of 2,254.25 and 2,205.50, respectively, thus 
showing a 1.02:1 ratio fully consistent with the stoichiometry of their assembly in the 
mitochondrial ATP synthase complex (Kane and Van Eyk 2009). 
 However, the correspondence between transcripts and protein levels may not be granted as a 
rule, due to the mechanisms of post-transcriptional regulation of each gene (Denti et al., 2013) 
and also to the fact that proteins may belong to different omo- or etero-polymeric complexes 
with different stoichiometry.  
To highlight the heart-specific gene expression profile, a comparison pool composed of 629 
datasets derived from 53 different human tissues or organs has been accurately assembled. 
 The differential transcriptome map obtained by the comparison of the whole heart vs. the 
pool of tissues minus heart transcriptome map showed the over-expression of a segment on chr1 
(Table 13) including the known genes for ACTN2 and RYR2: the first is known to help the 
anchoring of the myofibrillar actin filaments to the Z disc of muscle cells (skeletal, cardiac) 
(Ribeiro et al., 2014) and the second is involved in the cardiac muscle excitation-contraction 
coupling, supplying calcium to the cardiac tissue (Liu et al., 2015b). Another segment on chr1 is 
over-expressed (Table 13), as in the single transcriptome map of the organ, and it includes the 
known genes: NPPA, NPPB, MFN2 and seems to be one of those chromatin domains with a 
typical expression pattern in the cardiac tissue.  
 If we observe the first five under-expressed genome segments (Table 13): the segment on 
chr14 (14q32.13) including the cluster of genes encoding for members of the serpin peptidase 
inhibitor (SERPINA1, SERPINA11, SERPINA5) (Heit et al., 2013), and the segment on chr 8 
(8p23.1), including the cluster of genes encoding for defensin protein (DEFA6, DEFA4, DEFA1, 
DEFA5) (Chapnik et al., 2012) involved in the host defence's immune system, emerge. Each of 
them seems to be chromatin domain including genes which have no function typical of cardiac 
tissue.  
 At single gene level the over-expression of troponin I type 3 (TNNI3) gene followed by 
troponin T type 2 (TNNT2) gene emerges (Table 14). The first is the actin-binding subunit, the 
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second is the tropomyosin-binding subunit of the troponin complex of the cardiac muscle (Solaro 
et al., 2013). Increased activity of these genes is known to cause hypertrophic cardiomiopathy 
(HCM) (Solaro et al., 2013). Mutations in genes encoding for sarcomeric proteins, as myosin, 
troponin and tropomyosin, are inherited mutations which can result in serious heart disease and 
are the main cause of HCM (Davison et al., 2000; Alberts et al, 2007). The same thing was 
observed for the nine genes encoding for myosin chain which have an expression ratio >2 in the 
differential transcriptome map (data unshown, see Supplementary TRAM file, it is available at: 
http://apollo11.isto.unibo.it/heart, in the event of acceptance of the manuscript it will be 
available at: http://apollo11.isto.unibo.it/suppl/). Four of them, if they undergo a heterozygous or 
omozygous missense mutation, cause severe cardiac defects and diseases. They encode for: 
MYH6 myosin, heavy chain 6, cardiac muscle, alpha (Carniel et al., 2005; Ching et al., 2005; 
Holm et al., 2011), MYL3 myosin, light chain 3, alkali, ventricular, skeletal, slow (Caleshu et 
al., 2011), MYH7 myosin, heavy chain 7, cardiac muscle, beta (Kamisago et al., 2000; Klaassen 
et al., 2008; Armel and Leinwand, 2009; Das et al., 2014), and MYL2 myosin, light chain 2, 
regulatory, cardiac, slow (Grey et al., 2005).  
 The interesting finding that a differential expression level in the heart for a structural heart 
protein encoding gene is highly predictive of cardiomyopathy (hypertrophic or dilated) or other 
structural heart defects led us to formulate the more generalized hypothesis that members of a 
gene family with a cellular function common to many cell types (e.g., potassium channels) but 
expressed at high levels in a specific tissue in comparison with other tissues may be 
systematically associated to functional disease in that tissue when mutated. We show here that 
among 101 potassium channel encoding genes, those expressed at a ratio >1.5 in the heart/non-
cardiac tissues differential transcriptome map are significantly associated to human arrythmias. 
Instead, at the bottom of the gene list ordered by decreasing ratio values we note channels under-
expressed in the heart, but known to be over-expressed in the brain in similar brain/non-brain 
tissues ratio values that are associated to neurologic phenotypes (Table V in the Data 
Supplement, it is available at: http://apollo11.isto.unibo.it/heart, in the event of acceptance of the 
manuscript it will be available at: http://apollo11.isto.unibo.it/suppl/). Remarkably, this is the 
first demonstration to our knowledge that quantitative expression values may be systematically 
used as clues to anticipate that effects of mutations that will most likely affect a given human 
tissue, so that the map described here could support further searching for a heart disease gene. 
This also opens the way to more generalized studies aimed at establishing this type of correlation 
for all the human genes and tissues and all the phenotypes described in humans. A study of this 
type has recently been published for the mouse (Liao and Weng, 2015): by analysing mRNA 
expression data derived from different methods together with phenotype data of mouse mutants, 
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it was shown that despite the presence of widespread ectopic transcription, gene expression and 
mutant phenotypes remain associated, particularly for tissue-specific genes, genes expressed at 
high level or genes expressed at early developmental stages. Our generation of quantitative, 
reference standard transcriptome maps for different human organs and tissues (here, and REFS 
TRAM Brain/Hyppo/AMKL), comparable because they are normalized around the mean and by 
scaled quantiles (Lenzi et al., 2011), could greatly facilitate a similar task for all human genes 
and tissues, along with the availability of the OMIM database containing systematic data about 
mutant human phenotypes. 
  Among the first five over-expressed chr21 genes of the differential transcriptome map, the 
over-expression of the genes for the mitochondrial proteins ATP5O and ATP5J return (Ronn et 
al., 2009; Zhu et al., 2013), in support to the significant role of mitochondria in the essential 
function played by the cardiac tissue (Table 14).  
 The differential transcriptome map results confirm that the heart specific expression pattern 
is quantitatively centred on sarcomeric and mitochondrial genes, in full agreement with its 
structure and energy-dependent contractile functions, as well as on hormonal peptide encoding 
genes, reflecting its well-known endocrine function (Ogawa and de Bold, 2014). 
 To prove the reliability of the heart transcriptome map generated by TRAM software, we 
performed an experimental validation of the obtained data. The significant correlation between 
the expected and observed data (r=0.98, p-value<0.0001) (Figure 7) allows us to consider all the 
other intervening values among the points we selected as bona fide values, thus for the first time 
providing a reliable and quantitative representation of the reference expression values for 43,360 
mapped transcripts of the normal human heart.  
 Initial analysis of the biological meaning of these data clearly shows a relationship of our 
findings with what is already known about genes which have either a relevant function or are 
almost silenced in the heart.  
 The high significant correlation allowed us to consider each expression value as a reference 
expression value for a list of 43,360 known, mapped and 22,976 uncharacterized (unmapped) 
transcripts of the whole normal human heart, and confirmed that TRAM could be used to 
generate an atlas of the transcriptome of all kinds of biological conditions. 
 The availability of the systematic and detailed expression map presented here for the heart 
represented an excellent occasion to investigate, among many features of the transcriptome, the 
suitability of individual genes as the best stable reference genes for data normalization in gene 
expression studies. This is because they fulfill criteria including a widely diffused, constant and 
high expression (Casadei et al., 2011).  
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 The best gene at behaving like a housekeeping in the heart is MRPL51 (Table 17), encoding 
for mitochondrial ribosomal protein L51. The recurrent over-expression of mitochondrial protein 
is due to the typical structure of the cardiac cell, whose large volume proportion is occupied by 
mitochondria (Gray and Standring, 2005). 
In our work about a quantitative reference global portrait of gene expression in the 
normal human heart we demonstrate the very high expression of the sarcomeric genes commonly 
described in the contractile system of the heart, we identify genes expressed especially in the 
heart vs. all other non-cardiac tissues, and we provide a list of genes with a great range of 
reference expression values, which could be used to infer a very high rate of information about 
the whole normal human heart.  
  To date researchers find much difficulty in analysing the results of gene expression studies 
due to difficulty in obtaining healthy cardiac muscle data and setting a control group to contrast 
the results. As a consequence, human studies of gene expression in cardiac muscle were limited. 
The great majority of studies are done in small groups of a particular gene or genes separately 
and exposed to a certain stimulus (Costa and Franco, 2015).  
 All produced data support the utility of the human heart map as a general standard reference 
and of the differential maps as tools to highlight differences for specific genes.  
This kind of study could be applied to analyse the transcriptional profile of different biological 
conditions, for example of diseased myocardium, allowing the discovery of new biomarkers and 
the understanding of the mechanisms underlying pathophysiology (Liu et al., 2015a). 
 
5.2 DS AMKL transcriptome 
 
We also have presented here a comprehensive analysis of transcriptome in human DS 
AMKL cells. Integration of data from different sources, including data obtained from different 
Authors using a variety of platforms, was made possible by a recent approach described by us 
for creation and analysis of transcriptome maps (Ge et al., 2006). While most approaches are 
aimed to separate gene expression profiles related to the same biological source in subclasses, 
the TRAM tool provides means to integrate and summarize a pool of samples of the same 
biological origin leading to a global picture of gene expression for that condition. Moreover, 
TRAM identifies critical genomic regions and genes with significant differential expressions 
between two biological conditions. 
 Several Authors have determined gene expression profiles for DS or non-DS AMKL 
samples or have explicitly compared these two leukemic conditions. However, due to the rarity 
of the M7 subtype of leukemia and the need to limit the analysis to pediatric age because DS 
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AMKL occurs almost exclusively in children, these studies were typically limited to small group 
of samples. In addition, most platforms used in the microarray studies are affected by omissions 
or errors in mapping a certain percentage of probes to specific loci in the genome. In our 
analysis, the use of theversion of the TRAM software, TRAM 1.1, allowed us to map thousands 
of previously uncharacterized microarray probes and to avoid the errors in probe assignment to 
human loci often present in the data supplied by the manufacturer along with the platforms. 
 A systematic comparison of AMKL originated from trisomy 21 cells versus non-trisomy 21 
cells should highlight specific mechanisms (Caldwell et al., 2013) related to the presence of an 
extra copy of chr21 in DS children developing AMKL. Moreover, we presented a comparison 
with normal MK cells that has never been performed in other analyses about AMKL. Our global 
quantitative models of the transcriptome in the AMKL cells could also be useful to test 
hypotheses for correlations between any parameter associated to the condition (e.g., specific 
mutations or phenotype aspects) and specific changes in gene expression. 
 Our results, obtained in an integrated and open setting without any a priori assumption, 
show several previously unidentified aspects regarding specificity of AMKL originated by 
trisomy 21 cells.  
 First, there are only a few genomic regions significantly over- or under-expressed when 
comparing DS versus non-DS AMKL samples. This finding suggests that transcriptome maps of 
these two conditions are similar while on the other hand allows to focus to a small set of regions 
that appears to be critical in order to differentiate these disease conditions. Relevant differences 
regarding genes were reported in Table 19 (genomic segments) and Table 20 (single genes), with 
potential implications for the identification of diagnostic or therapeutic targets. There are three 
main regions over-expressed in DS AMKL vs. non-DS AMKL (Table 19). The first one 
(15q21.2) contains HDC gene, whose mRNA is translated in the enzyme converting L-histidine 
to histamine produced by only a few cell types (Roela et al., 2007); HDC mRNA increase has 
been shown to be associated to basophilic rather than to MK differentiation of pluripotent 
hematopoietic cells (Malinge et al., 2012). These observations led to the discovery of a skewing 
toward a potential basophilic differentiation for DS AMKL not highlighted in the original works 
from which the data were derived. Supporting this hypothesis, FCER1A mRNA, encoding the 
alpha subunit of the high-affinity IgE receptor, the initiator of the allergic response and strongly 
typical of basophilic differentiation, is 6.3 times over-expressed (the 8th most over-expressed 
known gene) in DS vs. non-DS AMKL, reinforcing the notion that in DS AMKL but not in non-
DS AMKL the leukemic dedifferentiation involved the possibility of redirection toward 
basophilic differentiation. Remarkably, in (Taub et al., 1999) is demonstrated by an electron 
microscopy analysis that AMKL blast cells from children with DS may contain basophil-like 
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granules which were almost totally absent in blasts from children with non-DS AMKL or adults 
with AMKL, so that our data allows to the visualization of the molecular correlation at the level 
of the whole transcriptome of a morphological feature observed more than 20 years ago. Two 
other genomic regions are over-expressed in DS vs. non-DS AMKL blasts. The first is the region 
of glycophorins genes (GYPE, GYPA, GYPB) on chr4, erythroid surface markers (Boztug et al., 
2013): this reinforces the concept of a disturbance of multilineage myeloid hematopoiesis in DS 
AMKL and has been observed by flow cytometry in the non-neoplastic hematopoiesis itself in 
trisomy 21 (Kaushansky, 2005). The other is the region of apolipoproteins genes (APOC1, 
APOC2, APOE) on chr19 that has been described as a signature of progression from TMD to DS 
AMKL in a gene expression profile (Lightfoot et al., 2004), it was not possible to include this in 
our analysis), further underlining its specificity for DS vs. non-DS MK blast cells.  
 When grouping expression values by chromosome, the chromosome with the greatest global 
RNA output was chr21 in both TMD and DS-AMKL vs. normal CB MK; we observed the same 
result in both DS and non-DS AMKL vs. normal MK comparisons. These data suggest that over-
expression of chr21 genes is a key factor in AMKL development. In particular, ADAMTS1, 
encoding a protease known to inhibit angiogenesis (Caracausi et al., 2014) is the most over-
expressed chr21 gene in DS vs. non-DS AMKL comparison. It is interesting to notice that this 
gene has been correlated to pediatric leukemias (ALL and DS-AML) (Strippoli et al., 2013; 
Melgarejo et al., 2010) but its exact role in leukemogenesis is still to be discovered. Our 
quantitative approach summarizing all values for each locus may clearly highlight mean 
expression ratio near to 1.5:1 for several chr21 genes when comparing DS AMKL vs. non-DS 
AMKL. This observation is consistent with the presence of an additional copy of the considered 
genes in trisomic cells. For example, GABPA expression presents a ratio close to 1.5:1 expected 
in trisomy of chr21, as well as other chr21 genes (DYRK1A, SON, BACH1) (Table 35). Even 
relatively small but significant differences (around 1.5-fold) in expression of numerous genes 
likely produce an aggregate effect, as observed in (Dy et al., 1999), where the same genes seem 
to be candidates to explain the impact of trisomy 21 in hematopoiesis abnormalities. For this 
reason it could be interesting to start from significant and robustus meta-analysis data to plan 
functional approaches in the future. Moreover, our data are consistent with the previous 
observation that RUNX1, ERG and ETS2 oncogenes, although located on chr21, are not over-
expressed in DS vs. non-DS AMKL (Bourquin et al., 2006; Klusmann et al., 2010b). It has also 
been recently demonstrated that they are not located on a chr21 duplicated minimal region in two 
cases of AML of M0 subtype (FAB classification) (Eguchi et al., 1992). As regard oncogenes, if 
chr21 oncogenes cited above appear not to be over-expressed in DS AMKL, TRIB1 (chr8) may 
be a novel important oncogene for DS AMKL and its mutation is an earlier genetic event in 
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leukemogenesis (Nakahata and Okumura, 1994). In particular, it has been shown that a mutation 
of TRIB1 (Nakahata and Okumura, 1994), a myeloid oncogene whose protein product is able to 
enhance ERK phosphorylation and to promote degradation of C/EBP family transcription 
factors, is a gain-of-function mutation remaining in leukocytes of the remission stage in which 
GATA1 mutation disappeared. Our results show a mean value of 1.40 for the human TRIB1 
expression ratio between DS and non-DS AMKL samples, with a higher over-expression 
observed when comparing leukemic samples to normal MK (ratio 3.15 for DS AMKL and 2.26 
for non-DS AMKL). 
 Although the expression of chr21 genes as a whole, or of some individual chr21 genes, may 
be coherent with the 3:2 gene expression ratio model in the comparison between trisomic and 
euploid cells, we note that discrepancies from this ideal model seen in our data for some of the 
comparisons we have made (Figures 8, 9 and 10) may be ascribed to the complexity of gene 
regulation in the aneuploid state (Maclean et al., 2012; Reynolds et al., 2010), to individual 
variability (Chang et al., 2010) as well as to the general dysregulation typical of the neoplastic 
state for which specific cell types we analyze is concerned. 
 Additional biologically relevant findings came from comparison of each type of 
megakaryoblastic leukemic condition with normal MK cells. Due to the role of the 
microenvironment in the hemopoiesis, including hemopoiesis in DS (Chou et al., 2012), it is 
expected that DS MK would present growth alterations due to trisomy 21 in both hemopoietic 
and microenvironment cells. From this point of view, DS MK cells would be the ideal control for 
the progression of a trisomic cell toward TMD and AMKL, however no gene expression profile 
dataset was available for this cell type. We propose here a biological model of the transcriptome 
depicting progressive changes from normal MK to TMD and then to DS AMKL, able to 
underline both shared and unique transcriptome map patterns for DS and non-DS variants of 
AMKL (Figure 19).  
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Figure 19 Biological model of the transcriptome depicting progressive changes from MK to TMD then to DS 
AMKL. Downward pointing arrow indicates the repression of genes involved in MK differentiation; upward 
pointing arrow indicates the over-expression of potential molecular markers of progression to AMKL. Value: mean 
gene expression value normalized across all the pool samples. §Observed both in DS and non-DS AMKL. 
 
 
 Noteworthy, the genomic segment on chr4 known to contain a cluster of genes highly 
specific for MK differentiation (Canzonetta et al., 2012; Lenzi et al., 2011), was the highest 
significantly under-expressed segment in both DS and non-DS AMKL in comparison with 
normal MK. In particular, the more strongly under-expressed region 4q12-q21 contains a cluster 
of genes, including PF4 (encoding for the platelet factor 4, a main component of platelet alpha 
granules) (Antonarakis et al., 2004; Prandini et al., 2007; Yokoyama et al., 2012), and PPBP 
(encoding for beta-thromboglobulin) (Canzonetta et al., 2012), that are the most up-regulated 
transcripts in the megakaryocytic differentiation from CD34+ hematopoietic progenitors (Lenzi 
et al., 2011). This finding highlights a common final outcome of the block of MK cells 
differentiation in both DS and non-DS AMKL. It should be underlined that this result came from 
systematic ab initio analysis of more than 12,000 segments on the human genome including 
about 26,000 mapped loci, thus highlighting that this region critical for the MK differentiation is 
actually the more repressed in absolute when comparing transcriptome maps of AMKL (DS or 
non-DS) and normal MK cells.  
MK   TMD  DS AMKL  
4q12-q21 
4q13-q21 
(PF4,PPBP)§   
MAP3K10§ 
MPL§ 
Block of 
MK 
differentiation 
TMEM241§ 
Marker of 
progression 
to AMKL 
APOC2 
ZNF587B 
Markers of 
progression 
to DS AMKL 
 
Gene   Value   Value    Value    Value 
    MK    TMD         non-DS AMKL      DS AMKL
          
PF4   4,817.62    625.49   302.55   273.32  
PPBP   3,031.70           1,040.40   203.69   294.75 
MAP3K10  2,352.30        7.40       3.90       5.40 
MPL      229.71      58.49     64.78     71.78 
TMEM241       17.60           2,224.41           2,754.07            1,036.63 
APOC2       11.65    301.59     98.95   431.71 
ZNF587B       28.82      39.68     39.32   615.04  
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 In addition, the most under-expressed gene in TMD blasts when compared to normal MK 
cells is MAP3K10, encoding an activity of mitogen-activated protein kinase kinase kinase 
(MAPKKK). It is known that the mitogen-activated protein kinase (MAPK) pathway is involved 
in and is sufficient for megakaryocytic differentiation (Deutsch et al., 2005; Roberts and Izraeli, 
2014). MAPK activity is present in several tens of human proteins, and we have identified the 
member MAP3K10 as the critically repressed gene in the block of MK differentiation in the 
development of leukemia with MK features in that it appears down-regulated 300-fold in TMD 
cells and 500-fold in both DS and non-DS AMKL compared with normal MK samples. Finally, 
transcript for MPL, the receptor of thrombopoietin which is the primary regulator of normal 
thrombopoiesis (the formation of platelets) (Tunnacliffe et al., 1992; Gear and Camerini, 2003; 
Antonarakis et al., 2004), is decreased by ~70% in either TMD, DS and non-DS AMKL cells vs. 
normal MK cells. 
 An exceedingly high over-expression of the gene located on chromosome 18 and encoding 
for the uncharacterized membrane protein TMEM241 has been found in both DS (59-fold) and 
non-DS (156-fold) AMKL cells vs. normal MK. Although this probe was not present in all 
considered experimental platforms, its extreme differential expression makes it a candidate for 
further studies as a marker of progression from normal MK to AMKL blasts, also due to its 126-
fold over-expression in TMD vs. MK cells.  
 Moreover, we identified several signatures of progression specifically to DS-AMKL. 
Remarkably, segments and genes up- or down-regulated in TMD in comparison with normal MK 
cells were highly similar to those specifically found in DS AMKL, underlining striking 
similarities between TMD and DS AMKL at the level of the whole transcriptome (already noted 
in (McElwaine et al., 2004), in their smaller set). On the other hand, a direct comparison between 
TMD and DS AMKL shows specific potential markers of progression to DS AMKL. As cited 
above, apolipoproteins genes (APOC1, APOC2, APOE) have been described as a signature of 
progression from TMD to DS AMKL (Lightfoot et al., 2004) and it is interesting to notice that 
APOC2 is among the 20 most expressed genes in the comparison between TMD and MK (25.88-
fold increase), showing a progressive increase of expression from normal MK to TMD and then 
to DS AMKL. In our analysis, ZNF587B appears to be the most discriminant marker between 
TMD and DS AMKL. Again, this observation offers the opportunity to integrate and discuss 
single genes and pathways previously described as abnormally expressed in DS or non-DS 
AMKL (Table 35). For example, the PRAME gene, encoding for a tumor antigen (McElwaine et 
al., 2004) was identified as a specific marker for DS AMKL blasts (n=7), with no expression in 
TMD (n=9). While our meta-analysis on PRAME expression data points (36 for DS AMKL and 
11 for TMD) confirmed a clear over-expression of PRAME in DS AMKL (4.2-fold increase, 
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(Table 35)), it was not the most discriminant marker, that was exactly ZNF587B, while PRAME 
was the 33rd out of 25,955 transcripts ordered by decreasing DS AMKL vs. TMD expression 
ratio (Additional file 8, it is available at: http://apollo11.isto.unibo.it/suppl/2014_Pelleri/). 
 Finally, since leukemias in infants or young children originate from fetal hematopoietic cells 
(Klusmann et al., 2010a; Klusmann et al., 2010b; Chou et al., 2008; Tunstall-Pedoe et al., 2008) 
and the progenitors (fetal/neonatal MKP) are present in the cord blood (Olson et al., 1992; Liu 
and Sola-Visner, 2011), comparisons with CB MK cells have been also performed. Data from 
DS and non-DS AMKL vs. CB MK comparisons confirmed the repression of the clusters of 
genes expressed in MK. The over-expression of a region with collagen genes emerge both in DS 
and non-DS AMKL as well as that of the single gene PTPRO (Table 26 and 28), encoding for a 
tyrosine phosphatase receptor known to be involved in megakaryocytopoiesis and whose mRNA 
targeting by antisense oligonucleotides results in inhibited MK progenitor proliferation 
(Slungaard, 2005). On the other hand, the difference between DS and non-DS AMKL vs. CB 
MK is shown by the over-expression of the two olfactive receptor genes OR10A5 and OR10A4 
(Table 26 and 28) only in non-DS derived cells.  
 The analysis of enrichment in specific gene functions using the tool FuncAssociate, for the 
100 most over- or under-expressed genes in the comparison of DS vs. non-DS AMKL and of 
both of them vs. MK cells gave no significant results, other than a significant enrichment in 
genes involved in sequence-specific DNA-binding in non-DS AMKL vs. MK cells (data not 
shown), highlighting the relevance of remodeling the transcription factor network in leukemia. 
 Our results provide a systematic meta-analysis using any available gene expression profile 
dataset related to AMKL in pediatric age. These allow to identify more general trends and to 
produce a highly coherent view of the transcriptome depicting progressive changes from MK to 
TMD and then to DS AMKL. We believe that the originality of our results is due to several 
concurrent original features of the TRAM 1.1 platform. Advantages and relevant differences are: 
integration of the largest possible number of samples; integrated analysis of the largest possible 
number of genes (the integration of different platforms led us to assess expression ratio for about 
26,000 loci, quantitating almost 4,000 genes in addition to the widely used platform U133A 
when used alone); absence of a priori filtering (in several works, this led to actual analysis of less 
than 50% of the genes present on the experimental platform); characterization at regional/map 
level in the study of gene expression (usually absent in the works from which data were 
obtained), relevant with regard to the study of an aneuploidy such as trisomy 21. 
 These results provide a new integrated model of the whole human transcriptome in DS and 
non DS AMKL, TMD and normal human MK cells, providing hints about pathophysiology of 
AMKL and also being useful to highlight possible clinical markers. 
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5.3 HR-DSCR on human chromosome 21 and gene hunting 
 
 A computational and molecular biology analysis of the HR-DSCR (Pelleri et al., 2016) was 
performed. This region of 34-kb was identified after a systematic reanalysis and comparison of 
all known and reported cases of PT21, enriched with analysis of Hsa21 CNVs in healthy 
subjects. Its duplication is shared by all the subjects with DS and is not present in all the subjects 
without DS. The main result discussed in the work of Pelleri and coll. (2016) is that, combining 
and comparing data which allow inclusion and exclusion of delimited Hsa21 stretches in the 
critical region for DS basic features, a very restricted region may be identified on Hsa21 within 
the traditional DSCR, confirming and further narrowing it to an unprecedented small size (0.07% 
of Hsa21) that is expected to contain a very small number of genetic determinants able to exert a 
major influence on the manifestation of DS basic features. Remarkably, analysis of gain 
(duplication) CNVs reported in 21q22 fully confirmed the peculiarity of this trait as it appears to 
be selectively spared by duplication in healthy subjects and it is included in a wider zone 
presenting with the minimal number of gain CNVs among all proximal and distal surrounding 
zones (Pelleri et al., 2016). 
 As a consequence of the identification of an HR-DSCR, a relevant causative role in DS for 
genes located outside of it should be rediscussed. There are no known genes located in HR-
DSCR, while KCNJ6 and DSCR4 are the adjacent characterized genes, proximally and distally, 
respectively. Lack of support for the synergistic roles of RCAN1/DSCR1 and DYRK1A, or APP, 
as main contributors to many DS phenotypes had already been underlined (Korbel et al., 2009). 
While a relevant causative role of DYRK1A for DS has been widely discussed (de la Torre and 
Dierrsen, 2012), and while it certainly affects the development and function of the nervous 
system, evidence that it is located within the HR-DSCR were not found, although it lies close to 
it (Pelleri et al., 2016). Interestingly, a subject reported by Cetin and coll. (2012) manifests DS in 
the absence of duplication of DYRK1A as shown by both FISH and Array CGH. 
 The definition of the HR-DSCR allows to exclude a critical role for DS as such for other 
known genes whose role in DS has often been discussed, although they may be involved in 
individual, non-constant DS phenotypes, such as APP, SOD1, KCNJ6, ETS2 and DSCAM (Deitz 
et al., 2011).  
 Despite the predictions defining the HR-DSCR as intergenic, our research was focused on 
this region because no method of gene prediction is 100% reliable. This is demonstrated by the 
fact that new genes are continually described because the detailed analysis of a sequence of 
genomic DNA, computational biology analysis alone is not sufficient and must always be 
flanked by molecular biology analysis. Indeed, after the completion of the sequence of human 
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chromosome 21 and the resulting systematic cataloging of all active genes contained in it 
(Hattori et al., 2000), the large CYYR1 gene coding for protein was identified (Vitale et al., 
2002), not noticed in the previous analysis. The transcript has been identified thanks to partial 
homology with a single EST sequence of pig that, after analysis of molecular biology (RT-PCR, 
Northern Blot), has led to the description of a large locus of 107 Kb with final production of a 
short mature RNA encoding for a small protein of 150 amino acids containing a specific motif 
"CSSYAY" conserved in vertebrates. Therefore, it can be said that the catalog of human genes is 
constantly evolving and does not exclude the possibility of tracing novel uncharacterized 
transcripts. 
 Preliminary computational analysis of HR-DSCR nucleotide sequence shows that this region 
does not contain any known functional locus, that no undescribed protein-encoded gene is likely 
to lie in it and that good candidate microRNAs (miRNAs) sequences are present within it 
(preliminary data not shown). A miRNA might represent an excellent candidate for being a 
single major contributor to DS because of its pleiotropy of action. miRNA MIR155 
overexpression has been associated to DS through nexin 27 (Wang et al., 2013); however, no 
discussion was presented about its chromosomal localization proximally on 21q21.3 at 25.5 Mb, 
which is far from any described DSCR.  
  Our preliminary analysis with the TRAM program (Lenzi et al., 2011) identified 1,331 
EST clusters (cluster) located on human chromosome 21 that confirm the presence of many 
partial sequences of RNA not yet characterized. 
  The systematic analysis of the region was performed also searching for the presence of 
transcribed sequences with regulatory function, particularly for microRNA sequences, taking 
into account the sequence of the putative miRNA1 for the high similarity to the known miRNA: 
hsa-mir 1273a. 
 We have developed methods of molecular biology in order to amplify the sequence of the 
putative miRNA1 (data unshown). These analyses, in particular the Northern Blot, led us to 
identify a sequence of about 13 Kb (in the heart and skeletal muscle) transcribed from the 
opposite strand with respect to that of the locus DSCR4, and the characterization of an active 
locus (HRDSCR1) transcribed bidirectionally. 
 The prediction of potential sequences for miRNAs in the considered region will allows us to 
characterize the HRDSCR1 locus. Continuous interaction between methods of computational 
biology (in silico) and molecular biology (in vitro) is important to characterize novel transcripts, 
in particular in the human genome, as the complexity of organization shows the need for further 
work to make the catalog of human genes more complete. 
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 Detailed analysis of the HRDSCR1  locus has also led to the description of a new isoform of 
the known gene DSCR4. The gene was isolated from Nakamura et al. (1997), thanks to the 
finding of homology with an EST sequence and the subsequent cloning of the cDNA. The gene 
consists of 3 exons of 1095 bp and contains a long open reading frame that specifies 118 amino 
acids, whose sequence has no significant homology with any known protein. The gene is 
expressed in placental tissue and in adult skeletal muscle and heart tissues. The new isoform, for 
now conventionally known as DSCR4.2, shares exons 1 and 2 with the isoform 1, is devoid of 
exon 3, has at the 3' an intron and two additional exons, extends significantly the known locus 
DSCR4 from 67,350 bp to 169,936 bp, conferring the status of transcribed region to more than 
the 100,000 bp previously considered intergenic. The locus DSCR4 is only present in humans, 
and the wider DSCR region, responsible for DS, is fully conserved only in higher primates and 
in humans (Luke et al., 1995).   
 However, many studies have focused on DS using the mouse model in spite of its genome 
not having an ortholog region with significant homology to human DSCR (Takamatsu et al., 
2002). 
 At this stage it is not possible to correlate the transcription profile observed in the locus to 
specific DS symptoms due to the lack of functional information in light of the observation that 
transcripts of the locus HRDSCR1 do not appear to be expressed in the human brain, as it might 
be expected of genes involved in intellectual disability (the most constant symptom). 
 The bioinformatic and molecular investigation on the HR-DSCR allowed us to identify a 
new locus and to determine its complexity at the level of a region critical for Down syndrome, 
emphasizing the need to continue the analysis of the human genome, constantly integrating 
computational biology and molecular methods in order to complete, as far as possible, the list of 
human genes, accurately characterizing also the regions that are defined as intergenic. 
 In conclusion, further studies are needed to define properties and functions of transcripts 
considered, also in relation to the possible excision of these transcripts into functional products 
of small size, and their relationship with the DS phenotype. This study confirms the importance 
of a systematic analysis of apparently silent regions of the human genome because the variability 
and complexity of genomic organization of human genes does not, so far, consider the catalog of 
human active loci to be exhausted . 
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